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Introduction and outline of the thesis
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Introduction and outline of the thesis
Sepsis can be defined as the body’s response to an infection. An infection is 
caused by microorganisms (e.g., bacteria, viruses, or fungi) invading the body. 
Bacterial infections in the lungs (pneumonia), bladder or kidneys (urinary tract 
infections), skin (cellulitis), abdomen (e.g., appendicitis), and other areas (such as 
meningitis) can all lead to sepsis. Severe sepsis/septic shock is a life-threatening 
complication of an infection. Due to associated organ-failure, treatment in an 
intensive care unit is often indicated.
The documented incidence of sepsis worldwide is 1.8 million each year1, but this 
number is confounded by a low diagnostic rate and difficulties in tracking sepsis 
in many countries. It is estimated that with an incidence of 3 in 1000 the true 
number of cases each year reaches 18 million, and with a mortality rate of 30% to 
50% it becomes a leading cause of death worldwide.1-6
In the Netherlands, an estimated 15,500 patients with severe sepsis and 6000 
patients suffering from septic shock are annually admitted to an intensive care 
unit.3 Intensive treatment and the long recovery period complicate the course of 
patients with sepsis and are accompanied with high costs. Direct medical costs of 
severe sepsis are estimated at 19,500 Euros per patient.6 Costs correlate strongly 
with the length of stay in the hospital. Annually, an estimated 168,6 million Euros 
is spent on severe sepsis, which represents 0.5% of all health care costs and 1.7% 
of the annual hospital budget in the Netherlands.6 Sepsis represents a burden for 
both the patient and society.
To eliminate confusion in communication for both clinicians and researchers, 
standardization of sepsis terminology is necessary. Several editorials and 
position papers have attempted to provide a framework for standardization and 
simplification of the sepsis terminology.7-10 In 1992, the ACCP/SCCM Consensus 
Conference Committee has offered recommendations for the standardization of 
the sepsis terminology illustrated in Figure 111:
Sepsis: the systemic response to a (strongly suspected or proven) infection, 
manifested by two or more of the following systemic inflammatory response 
syndrome (SIRS) criteria, as a result of infection: (1) temperature >38°C or <36°C; 
(2) heart rate >90 beats per minute; (3) respiratory rate >20 breaths per minute 
or PaCO2 <32 mmHg; and (4) white blood cell count >12,000/mm
3, <4,000/mm3, 
or >10% immature (band) forms.
Severe sepsis: sepsis associated with organ dysfunction, for example impaired 
renal function.
Septic shock: sepsis with hypotension despite adequate fluid resuscitation 
indicating the need for vasopressor therapy, along with the presence of perfusion 
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abnormalities that may include, but are not limited to, lactic acidosis, oliguria, 
and an acute alteration in mental status. Patients who are receiving inotropic or 
vasopressor agents may not be hypotensive at the time perfusion abnormalities 
are measured, but are also considered as suffering from septic shock.
Figure 1. The relationship of infection, SIRS, sepsis, severe sepsis, and septic shock
An infection leading to sepsis can be acquired outside the hospital (known 
as ‘community-acquired’) or in the hospital (known as ‘nosocomial’ or ‘hospital-
acquired’). Hospital-acquired infections are generally more difficult to manage 
than those acquired in the community, because of the patient’s underlying 
disease, previous use of antibiotics, the presence of drug-resistant bacteria in 
the hospital, and/or the fact that patients often require an intravenous cannula, 
urinary catheter, or wound drainage.
Consequently, the presence of hospital-acquired infections is one of the major 
causes of death and increased morbidity among hospitalized patients.12;13 It has 
been estimated that, in the European Union alone, approximately 37,000 lives are 
lost to hospital-acquired infections each year, with an associated monetary cost 
of roughly 7 billion Euros, which is mainly attributable to the increased length of 
hospital stay.14 In the Netherlands, the prevalence of hospital-acquired infections 
was 6.6% (74,000 people/year) in the period 2007-2009. The four most common 
hospital-acquired infections were symptomatic urinary tract infections, post 
operative wound infections, pneumonia, and (central venous catheter-related) 
sepsis.15
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Prevention of sepsis
The strategies to reduce hospital-acquired infections are complex.16 The 
performance of (protective) isolation measures, the use of antibiotic prophylaxis 
in selected surgical patients, and, most importantly, basic hygienic measures 
including optimal hand hygiene compliance by all health care workers are 
important strategies to reduce hospital-acquired infections.17-19 However, 
although for example hand hygiene compliance by health care workers has been 
an important issue for years, the compliance rate is still a problem in health care 
today.19;20 
To improve the knowledge and compliance to hand hygiene, various 
improvement strategies have been described. Improving hand hygiene by 
multifaceted strategies seems superior to using a single strategy.21 However, 
most of the effects are small to moderate and often short-lived.22 A recent study 
on potential determinants of hand hygiene compliance in the Dutch hospital 
setting showed that - besides the perception of the health care workers that 
there is a lack of evidence that hand hygiene is effective in preventing hospital-
acquired infections - absence of positive role models and social norms may hinder 
compliance.23 Health care workers indicated that creating a stronger social norm 
and establishing more explicit social control would be important for improving 
hand hygiene compliance. Therefore, a multifaceted hand hygiene improvement 
program, including education, feedback, reminders, targeting adequate products 
and facilities, and social influence activities including the use of role models, 
should be carried out and its effects on hand hygiene compliance should be 
evaluated.
Diagnosis and treatment of sepsis
It has become increasingly clear that time is an important factor in patients 
with severe sepsis or septic shock, since they have a better chance of survival if 
sepsis is treated adequately at an earlier stage.24-26 Research has shown that in a 
hypotensive septic patient, every hour that the first administration of adequate 
antimicrobial therapy is delayed, is associated with an increase in mortality of 
8%.27  However, the identification of patients with sepsis in daily practice can be 
difficult as the signs of systemic inflammation response syndrome are not specific. 
They can also occur in other diseases such as trauma, pancreatitis, and burns.11;28
Diagnostic tests
In view of the difficulties with the clinical diagnosis of sepsis, the search for a 
laboratory value or marker to aid the diagnosis remains an important topic. Rapid 
tests that provide insight into the etiology of infection may guide the appropriate 
use of antibiotics and are urgently needed. Although blood cultures are 
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considered the gold standard for detection of bacteremia, delays between blood 
sampling and information returned to the clinician is an important disadvantage, 
but no alternatives are currently available.29 
Although C-reactive protein and procalcitonin have been most widely used30, 
these biomarkers provide limited abilities to distinguish sepsis from other 
inflammatory conditions, to indicate the severity of sepsis, or to predict outcome. 
New markers have become available, but their additional value in clinical practice 
is not clear.
It has been advocated that evaluation of combinations, or a panel of markers, 
may improve the predictive power, but this has not been thoroughly investigated. 
Therefore, further evaluation of a combination of different sepsis biomarkers 
should be carried out.31-34
Surviving sepsis campaign
In 2004, the surviving sepsis campaign (SSC) was launched to improve the 
recognition, diagnosis, management, and treatment of patients with severe 
sepsis or septic shock. The SSC provides helpful tools and techniques to measure 
and improve the quality of care for patients with severe sepsis or septic shock, 
especially for patients in the intensive care unit.
The most important SSC recommendations are summarized in a ‘6 hour’ and 
‘24 hour’ bundle: also called the resuscitation bundle and the management 
bundle.4;25;26 After introduction of these bundles, a vast amount of articles 
concerning the early recognition and treatment of patients with severe sepsis and 
septic shock have been published.35-47 Recently, the results of the international 
guideline-based performance program were reported.41 Patient data and bundle 
performance data on 14,209 patients from 165 sites worldwide demonstrated 
that compliance with the SSC bundles was associated with quality improvement 
in sepsis care and a sustained decrease in mortality.
Also in the Netherlands, the sepsis bundles have been adopted in intensive 
care units, emergency departments, and nursing wards. A national committee 
and SSC website were established, facilitating the possibilities to report bundle 
compliance and patient outcome to the international database. In addition, the 
Dutch association of hospitals (NVZ), Dutch Federation of University Medical 
Centres (NFU), Dutch Order of Medical Specialists (OMS), National Expert Centre 
for Nursing (LEVV), and the Association for Nurses in the Netherlands (V&VN) 
initiated the National Patient Safety Agency (VMS). VMS aims to reduce the 
unintentional and avoidable damage to patients in Dutch hospitals with 50% by 
December 2012. Among other VMS topics, the early diagnosis and treatment of 
patients with severe sepsis are specific guideline items. The goal of the VMS is 
to increase compliance with the resuscitation bundle and management bundle 
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elements to an average of 80%, and to reduce both the in-hospital mortality and 
the mortality within 30 days after the diagnosis of severe sepsis by 15% compared 
with mortality data from 2007.
At this moment, the bundle compliance rates and outcome results of patients 
in the Netherlands are unknown and the collected VMS data are not available yet. 
To obtain insight in the current care for patients with sepsis in the Netherlands, 
the Dutch SSC data should be analyzed and compared with international data. 
Based on these results, possibly further VMS implementation strategies have to 
be developed.
Professionals’ knowledge
Recognition of the systemic inflammatory response syndrome criteria is the 
first step in the early recognition of patients with sepsis.9-11 Although clinical signs 
such as fever, chills, and systolic blood pressure <90 mmHg are associated with 
the presence of bacteremia48;49, previous studies have demonstrated that only 
approximately 30% of physicians correctly identified the systemic inflammatory 
response syndrome criteria.50 Even after an active implementation of a sepsis 
teaching program, only 48% and 67% of the training-grade doctors could define 
severe sepsis and septic shock, respectively.51 Also, nurses experience difficulties in 
recognizing patients with sepsis; lack of detailed knowledge was shown to impair 
the recognition.52;53 For example, only about 20% of the nurses thought that a 
temperature <36°C or a low white blood cell count could be a sign of sepsis.52
Since recognizing the clinical signs of sepsis is paramount to prevent treatment 
delay50-53, sepsis education is of great importance to enable professionals to 
timely recognize and treat sepsis. Therefore, the knowledge about systemic 
inflammatory response syndrome criteria, recognition, and treatment of sepsis 
should be evaluated frequently, to facilitate further improvements.
Role of nurses in the emergency department
Due to the high mortality rate for patients with severe sepsis and septic shock 
presenting at the emergency department,54 this department is an important 
location for the early recognition and treatment of sepsis. Because nurses 
are often the first to see and triage a patient, they have a considerable role in 
observing patients’ signs and symptoms. Nevertheless, the role of nurses in the 
identification and treatment of patients with sepsis has not been formalized in 
guidelines and is not fully exploited.24;27;55
In daily practice, a multidisciplinary protocol for patients with sepsis has been 
demonstrated to facilitate the recognition and treatment of sepsis.56-58 However, 
in many hospitals, and specifically in the emergency department, the role of the 
nurses is not used to its full potential and the use of these multidisciplinary protocols 
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is lacking. Therefore, the effects of the implementation of a multidisciplinary care 
bundle based sepsis protocol in the emergency department should be evaluated.
Antimicrobial treatment
Antimicrobial therapy is the most important treatment in patients with sepsis. 
Early initiation of appropriate empirical antimicrobial therapy has been shown to 
improve survival in patients with sepsis and septic shock.27;59-62 The choice of the 
empirical antimicrobial therapy in sepsis mainly depends on the suspected site 
of infection and the antimicrobial susceptibility of the expected pathogens. To 
include more resistant, but often less prevalent pathogens, the empirical therapy 
of a severe infection is usually broad-spectrum.24;63 The downside of this strategy 
is that the spectrum of antibiotics prescribed often is broader than necessary, 
or that antibiotics are being prescribed in the absence of a bacterial infection. 
After culture results are available, the antibiotic therapy should be adjusted to 
the causative microorganism, but this is frequently delayed or omitted. Antibiotic 
overuse may have potentially deleterious consequences such as the risk of 
anaphylactic reactions, antibiotic resistance, and high costs.
Antimicrobial treatment guidelines have been developed to assure effective 
treatment, to decrease treatment diversity, prevent treatment delay, and reduce 
the unnecessary use of broad-spectrum antimicrobials, thereby reducing the 
selective pressure on antimicrobial flora and preventing the development of 
resistance. Due to geographical differences in pathogens and antimicrobial 
susceptibility, many countries and hospitals have their own antimicrobial 
treatment guidelines based on local epidemiological data, existing literature, and 
expert opinion.
Although many hospitals have implemented local antimicrobial treatment 
guidelines, there is a wide variation in the reported adherence to this 
guidelines.60;63-65 To achieve an improvement in quality of care in patients with 
sepsis, an evaluation of the current care for patients with (severe) sepsis should 
be performed. Therefore, each hospital should regularly evaluate the adherence 
to the antimicrobial treatment guidelines in patients admitted with sepsis.
Aim of this thesis
The three aims of this thesis focus on the prevention, diagnosis, and treatment 
of sepsis. To improve the prevention of infections and sepsis in the hospital, the 
effects of implementation of a multidisciplinary hand hygiene improvement 
program were studied. Second, the potential of different biomarkers to facilitate 
the diagnosis of sepsis was investigated. Third, the effects of implementation of 
the surviving sepsis campaign in various hospitals in the Netherlands and the 
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recognition and treatment of patients with sepsis in the emergency department 
of our hospital, including the adherence to antimicrobial treatment guidelines, 
were evaluated.
The specific aims of this thesis are:
•	 To evaluate the hand hygiene knowledge and hand hygiene compliance 
in nurses and physicians before and after implementation of a 
multidisciplinary hand hygiene improvement program;
•	 To evaluate the predictive value of a single biomarker, biomarker panels, 
biomarkers combined with clinical signs, and serial determinations of 
biomarkers in the prediction of bacteremia in patients with sepsis;
•	 To evaluate the potential of different biomarkers to discriminate between 
viral and bacterial lower respiratory tract infections in patients with sepsis;
•	 To evaluate the surviving sepsis campaign bundle compliance in the 
Netherlands and to compare the results with compliance reports from 
other countries;
•	 To evaluate the knowledge about the identification and management of 
sepsis and the effect of education of internal medicine residents;
•	 To evaluate the effects of implementation of a nurse-driven, care bundle 
based, sepsis protocol for the early recognition and treatment of patients 
with sepsis in the emergency department;
•	 To evaluate the physicians’ adherence to antimicrobial guidelines in 
patients with sepsis in the emergency department.
Outline of the thesis
Our performed studies are reported in seven different chapters. Following the 
introduction in this chapter (Chapter 1), the short-term and long-term effectiveness 
of a multifaceted hand hygiene improvement program, including education, 
feedback, reminders, social influence activities including the use of role models, and 
improvement of hand hygiene facilities, is described in Chapter 2. We measured 
hand hygiene knowledge and hand hygiene compliance before, directly after, and 
6 months after the performance of the hand hygiene improvement program in 
nurses and physicians.
In Chapter 3, we evaluated the predictive value of four biomarkers 
(procalcitonin, interleukin-6, lipopolysaccharide binding protein, and C-reactive 
protein), the combination of the best performing biomarker with one to three other 
biomarkers (panel analysis), the combination of the best performing biomarker 
with clinical signs of the patient, and serial determinations of the best performing 
biomarker in predicting bacteremia in emergency department patients with sepsis. 
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In addition, in Chapter 4, we determined the value of supplementary laboratory 
tests (C-reactive protein, lipopolysaccharide binding protein, procalcitonin, 
interleukin-6, interleukin-18, and soluble triggering receptor expressed on 
myeloid cells-1) to differentiate between proven viral infections and bacterial 
infections in patients with lower respiratory tract infections.
In Chapter 5, we describe the compliance with the entire SSC bundles, 
and change in the completion of the ten individual bundle elements after 
implementation of the SSC in four hospitals in the Netherlands and compare 
these results with the published international SSC results.
The short-term and long-term effectiveness of a brief and single teaching 
intervention on internal medicine residents’ knowledge about the identification 
and management of sepsis is described in Chapter 6. By use of a written 
questionnaire, we measured sepsis knowledge in internal medicine residents 
immediately before, 3 hours after, and 4-6 months following a teaching 
intervention.
The effects of the implementation of a nurse-driven, care bundle based, sepsis 
protocol in the emergency department is described in Chapter 7. The sepsis 
protocol consisted of two parts: a sepsis screening list to support the nurses 
in the emergency department in better recognition of sepsis in patients with a 
probable infection, and a sepsis performance list, including recommendations 
for nurses and physicians to initiate diagnosis and treatment. After identifying 
a patient with sepsis, the responsible nurse should start immediately with the 
diagnostic procedures such as obtaining blood for chemistry tests and culture, 
and urine for urinalysis and culture. We measured the effects of implementation 
of the sepsis protocol on the compliance to measuring serum lactate, taking two 
blood culture samples before starting antibiotics, performing a chest radiograph, 
obtaining urine for urinalysis and culture, starting antibiotics within 3 hours, and 
hospitalizing or discharge the patient within 3 hours.
The adherence to the local antimicrobial treatment guidelines in patients 
admitted to the emergency department with sepsis is described in Chapter 8. 
In addition, the in vitro susceptibility of the isolated pathogens to the treatment 
recommended by the guidelines is described in order to investigate whether or 
not deviations from the protocol were beneficial to the patient.
Chapter 9 provides a summary of results of the included studies in this thesis, 
and discusses the main findings as well as methodological issues. The discussion 
ends with the main conclusions and recommendations for future research and 
practice. Finally, the findings of this thesis are summarized in Dutch (Chapter 10).
19
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Abstract
Background: Although hand hygiene (HH) compliance has been an important 
issue for years, the compliance rate is still a problem in health care today.
Methods: This was an observational, prospective, before-and-after study. 
We measured HH knowledge and HH compliance before (baseline), directly 
after (post-strategy), and 6 months after the performance of HH team strategies 
(follow-up).
The study was composed of employed nurses and physicians working in the 
department of internal medicine of a university hospital. We performed a 
multifaceted improvement program including HH education, feedback, reminders, 
social influence activities including the use of role models, and improvement of 
HH facilities.
Results: Ninety-two nurses and physicians were included. Compared with 
baseline, there was a significant improvement in the overall mean HH knowledge 
score at post-strategy (from 7.4 to 8.4) and follow-up (from 7.4 to 8.3). The overall 
HH compliance was 27% at baseline, 83% at post-strategy, and 75% at follow-up. 
At baseline, the compliance rate was 17% in nurses and 43% in physicians and 
significantly improved to 63% in nurses and 91% in physicians at follow-up. 
Conclusion: Our multifaceted HH improvement program resulted in a sustained 
improvement of HH knowledge and compliance in nurses as well as physicians. 
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Introduction
The presence of health care-associated infections (HAIs) is one of the major 
causes of death and increased morbidity among hospitalized patients.1;2 The 
strategies to reduce HAIs are complex.3 One important strategy for the prevention 
of HAIs is optimal hand hygiene (HH) compliance in all health care workers.4-6 
Although HH compliance has been an important issue for years, the compliance 
rate is still a problem in health care today.6;7 In many studies, the effectiveness of 
different HH improvement strategies are described.8-12 The improvement of HH 
because of multifaceted strategies seems higher as compared with using a single 
strategy. Education with written material, reminders, and continued feedback of 
performance can have an important effect on HH compliance.8;9 Unfortunately, 
most of the effects are small to moderate and often short-term.10 
A recent study on potential determinants of HH compliance in the Dutch 
hospital setting showed that, besides the perception of the health care workers 
that there is a lack of evidence that HH is effective in preventing HAIs, a lack of 
positive role models and social norms may hinder compliance.13 Health care 
workers mentioned that creating a stronger social norm and establishing more 
explicit social control would be important for improving HH compliance. Strategies 
with specific activities on social influence are rarely applied in previous studies: 
role models changed health care workers HH behavior by showing them how to 
improve HH practices and the best way to perform HH in the unit.12-14
Using this information on HH improvement strategies9-14, we developed 
a multidisciplinary improvement program, including education, feedback, 
reminders, and social influence activities including the use of role models, 
to improve the HH knowledge and compliance in our department of internal 
medicine. The aim of the current study was to test the short-term and long-term 
effects of a multifaceted HH improvement program for nurses and physicians, on 
nurses’ and physicians’ knowledge of HH guidelines, and their HH compliance.  
Methods
Study design
To improve HH knowledge and HH compliance among nurses and physicians, we 
performed an observational pilot study in the department of internal medicine of 
a 953-bed university hospital in the Netherlands. Our study consisted of four study 
phases (Table 1), including the performance of a multifaceted HH improvement 
program (Phase II). HH knowledge tests and HH compliance tests were performed 
at baseline (Phase I), post-strategy (Phase III), and follow-up (Phase IV). 
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In view of the observational and anonymous nature of the study, and the 
performance of non-patient-related strategies, the local medical ethics committee 
waived the need for written informed consent.
Table 1. Study phases and performed tests during the study
Study setting and population
At the department of internal medicine, 45 nurses and 54 physicians are 
employed. The nurses work at the 32 bed nursing ward (n=42) and the outpatient 
clinic (n=3). All physicians (30 staff physicians, 24 residents) alternately work at 
the nursing ward, the outpatient clinic, emergency department, or are involved in 
medical scientific research and teaching. The nurses at the outpatient clinic were 
excluded for this study because of their limited patient contact and their dissimilar 
activities in contrast to the nurses in the nursing ward. Furthermore, 1 nurse and 
3 physicians were excluded because of their involvement in the HH improvement 
strategies. At the start of the study, each patient room included 1 wall-fixed, 
alcohol-based liquid hand disinfectant dispenser; 1 wall-fixed unmedicated soap 
dispenser; and 1 wall-fixed paper towel dispenser.
Hand hygiene improvement strategies
We developed an improvement program from current literature: a ‘state of 
the art strategy’, which includes education, feedback, reminders, and targeting 
adequate products and facilities.8;9 To these, we added strategies with specific 
activities on social influence. These strategies were built on relevant behavioral 
science theories and include gaining active commitment and initiative of ward 
management, modeling by informal role models at the ward, and setting norms 
and targets within the team.13-17 All performed strategies are summarized in Table 
2 and were aimed at the nurses as well as the physicians.  
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Measurements
We measured the HH knowledge of the nurses (n=41) and staff physicians 
(n=27) at baseline, post-strategy, and follow-up. Furthermore, we measured the 
HH compliance of nurses and physicians (staff physicians and residents, n=51) in 
the nursing ward as well as the HH compliance of physicians in the outpatient 
clinic at baseline, post-strategy, and follow-up.
Hand hygiene knowledge
To obtain data about participants’ knowledge regarding the indications for 
HH, an anonymous questionnaire was developed. The questionnaire consisted 
of 19 questions (yes/no). Each question described a situation in daily patient care 
and asked whether HH was necessary. The questionnaire was pilot tested by an 
infectious disease registered nurse and an infectious disease physician. 
Because of the high turnover of the residents and their absence during several 
educational trainings, only nurses and staff physicians were included in this part 
of the study. 
Table 2. Performed hand hygiene improvement strategies during the study
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Hand hygiene compliance
Based on the five moments for HH7 and the Dutch national infection prevention 
guideline, an observation list was developed. In many cases in which professionals 
go from one patient to another, the ‘after patient contact’ category is immediately 
followed by an indication of the ‘before’ category (generally ‘before patient 
contact’) in another patient. Given this overlap, the Dutch guideline on HH in 
hospital care does not include the HH indication ‘hand hygiene before touching 
a patient’. Furthermore, the HH indications ‘after taking care for an infected 
patient’ and ‘after removing sterile or non-sterile gloves’ are included in the Dutch 
guideline. The final observation list contained six indications for HH: (1) before 
clean/aseptic procedure, (2) after body fluid exposure risk, (3) after touching a 
patient, (4) after touching patient surroundings, (5) after taking care of an infected 
patient, (6) after removing sterile or non-sterile gloves.
HH compliance was defined as hand disinfection using alcohol-based hand rub 
or washing hands with soap and water following one of the above-mentioned 
indications. The observers had to mark the applied HH indication(s) and the 
performed HH action. In addition, the presence of jewelry and whether the 
nurses and physicians wore long-sleeved clothes under their short-sleeved 
uniforms or white coats was observed.7 All observers were trained during three 
2-hour meetings on HH indications, HH actions, and observation techniques. 
Subsequently, the observation technique of the students and the observation list 
was pilot tested in a nursing ward of a hospital not participating in our study. 
Every student performed 20 observations jointly with a ‘gold standard’ observer. 
Concordance between the observers was determined by comparing the results 
of each student with the ‘gold standard’ observer. For that, we used a 3-step 
approach. First, we calculated the concordance between the number of recorded 
HH opportunities of the student nurse and the ‘gold standard’ observer; next, the 
concordance between the number of recorded HH indications; and, finally, the 
concordance between the number of recorded actions. The Wilcoxon rank test 
showed that neither of the student results differed significantly (α=.05) from the 
results of the ‘gold standard’ observer (Z scores of every student on every step 
between -1.96 and 1.96). 
Students from the faculty of health and social studies were responsible for 
the unobtrusive observations of the nurses. They mentioned the observation of 
patient safety-related items (such as medication safety and fall prevention) and 
their own learning experience as explanations for their observations. Two nurse 
practitioners, one physician assistant, and two staff physicians performed the 
observations of the physicians in the nursing ward and the outpatient clinic during 
their daily practice, so the physicians were unaware that their HH was under 
observation. Because of the closed consulting rooms, in the outpatient clinic only 
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the presence of jewelry and wearing long-sleeved clothes could be observed. 
All participants were observed for a maximum number of four occasions for the 
purpose of including as many different nurses and physicians as possible. All 
observations took place on week days, during day shifts.
Data analysis
All data were analyzed using SPSS version 16.0 (SPSS Inc, Chicago, IL, USA). 
Descriptive statistics included percentages, means, and standard deviations. 
All questions about HH knowledge were given an equal weight of 1 point 
per question, and the sum scores were recalibrated to a 0-10 scale. They were 
analyzed using linear regression, with independent factors period, gender, and 
nurse/staff physician/resident. 
The HH compliance rates were expressed as percentages. To determine 
the effects of the improvement strategies on the compliance rates, we used a 
generalized linear model, with linear link function and Bernoulli distribution; 
such a model evaluates the absolute differences between the percentages in 
each period, in contrast to a logistic model, which determines odds ratios. The 
logistic approach was not used because odds ratios overestimate rate ratios 
when the occurrence of the dependent variable is not rare. Fixed factors included 
strategy period and gender. To account for the fact that the professionals (nurses 
and physicians) were observed repeatedly, the random factor ‘professional’ was 
included in the model. When the results for all professionals were evaluated, an 
additional factor that distinguished among the three types of professionals (nurse/
staff physician/resident) was included. In a secondary analysis, we investigated 
whether the effect of the strategies depended on gender and type of professional 
by including the interaction factors period, gender and period, and nurse/staff 
physician/resident in the models. Results with p<0.5 (2-sided) were considered 
statistically significant.
Results
Hand hygiene knowledge 
At baseline, as well as post-strategy and follow-up, 68 HH knowledge 
questionnaires were distributed. Forty-four participants (65%) returned the 
questionnaire at baseline, 41 (60%) at post-strategy, and 39 (57%) at follow-up 
(Table 3). Compared with baseline, there was a significant improvement in the 
overall mean HH knowledge score at post-strategy (from 7.4 to 8.4) and follow-
up (from 7.4 to 8.3). Overall, the questionnaire score was significantly better in 
nurses than in staff physicians (0.5 points more; 95% confidence interval [CI]: 0.1-
1.0). There was no evidence that this difference varied among the periods. There 
were no statistically significant differences in the overall score for gender.
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Table 3. Hand hygiene knowledge scores and hand hygiene compliance scores 
in the nursing ward
Hand hygiene compliance 
Nursing ward
In the nursing ward, a total of 294 HH opportunities were observed. The most 
frequently observed indications for HH were ‘after touching a patient’ (51%) and 
‘after touching patient surroundings’ (34%). For physicians, the most frequently 
occurring HH indication was ‘after touching a patient’; for nurses also, ‘after 
touching patient surroundings’ was a frequent indication. 
The overall HH compliance was 27% at baseline, 83% at post-strategy, and 75% 
at follow-up (Table 3). In the subgroup of nurses, the HH compliance significantly 
improved with 66% points (95% CI: 47%-86%) to 83% at post-strategy and with 
46% points (95% CI: 27%-64%) to 63% at follow-up. In the subgroup of physicians, 
the HH compliance significantly improved with 41% points (95% CI: 22%-59%) to 
83% at post-strategy, and with 48% points (95% CI: 31%-66%) to 91% at follow-
up. Overall, the HH compliance of the physicians was significantly better than the 
nurses’ compliance: 16% points (95% CI: 2%-29%) better compliance in residents 
and 24% points (95% CI: 7%-39%) better compliance in staff physicians. There 
was no evidence that this difference depended on the period. Overall, there 
was no significant difference in compliance rate for gender. For both groups, the 
compliance for ‘not wearing jewelry’ and ‘not wearing long-sleeved clothes’ was 
already high at baseline (≥90%) and did not change at post-strategy and follow-
up.
Outpatient clinic
The compliance rate for ‘not wearing jewelry’ significantly improved from 51% 
at baseline to 79% at post-strategy and to 91% at follow-up. Overall, women were 
significantly more compliant to ‘not wearing jewelry’ than men (20%; 95% CI: 2%-
37%). The compliance rate for ‘not wearing long-sleeved clothes’ improved from 
57% at baseline to 85% at post-strategy and to 86% at follow-up. After adjustment 
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for type of professional and gender, the differences were 34% (95% CI: 16%-51%) 
and 28% (95% CI: 11%-44%), respectively. Overall, men were significantly more 
compliant to not wearing long-sleeved clothes than women (33%; 95% CI: 17%-
49%). There was no evidence that the differences between men and women’s 
compliance rates depended on the period. Overall, no statistically significant 
differences in compliance rates for ‘not wearing jewelry’ and ‘not wearing long-
sleeved clothes’ between staff physicians and residents were found. 
Discussion
Our study showed that overall as well as in the subgroups of nurses and 
physicians, a considerable increase in the HH knowledge (about 1 point increase 
at post-strategy and at follow-up) and in HH compliance (about 50% increase at 
post-strategy and at follow-up) was achieved. 
In line with Naikoba and Hayward’s conclusion,8 we developed a multifaceted 
strategy. It is impossible to conclude which components were – to what degree – 
responsible for our achieved improvement. However, there was only a relatively 
small increase in HH knowledge – knowledge was already rather high at baseline 
(>7), relative to the low initial compliance and the large increase in compliance. 
Based on this information, one might conclude that only providing education on 
the indications for HH would have been insufficient. 
Our study showed that our strategies were highly effective for the nurses as 
well as the physicians. In contrast to other studies,4;18 the overall compliance in 
our study was significantly higher in physicians than in nurses. Possibly differences 
in observed HH indications have influenced the HH compliance results among the 
subgroups.
Although the HH improvement program in our study was mostly focusing on 
the nurses and staff physicians, and not on the residents, there was no significant 
difference between the staff physicians’ and residents’ compliances. Probably, the 
staff physicians functioned as role models for the residents.19;20 
For measuring the HH compliance, we used unobtrusive observations: the 
gold standard as defined by the World Health Organization.7 By mentioning the 
observation of patient safety-related items and their own learning experience as 
explanations for their observations and by performing observations during the 
researchers’ daily practice, the nurses and physicians were unaware of the true 
reason for the observations. Nevertheless, observation bias and the Hawthorne 
effect cannot be excluded. 
Some possible limitations of our study must be considered. Sixty-eight nurses 
and staff physicians anonymously received the HH questionnaire. Approximately 
60% of the distributed HH questionnaires were completed and compared; 
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there could be a matter of selection bias. Moreover, the HH compliance was 
anonymously observed. Although all participants were equally likely to have been 
selected for observation during the study periods, selection bias cannot be ruled 
out.
The effectiveness of HH on the prevention of HAIs depends not only on 
compliance but also on the HH technique.21 Although HH technique training was 
part of the program, it was not evaluated in this study.
Finally, the physicians’ HH compliance in the outpatient clinic was not 
observed. Sladek et al. concluded in their study that the observational setting had 
an effect on HH compliance: HH was significantly more likely during ward rounds 
than during clinics.22 Therefore, we highlighted during our improvement program 
that HH is important with inpatients just as with outpatients. However, the effect 
on the HH compliance in the outpatient clinic remains unclear. 
In conclusion, our HH improvement program for nurses and physicians had 
large positive effects on the HH knowledge and HH compliance, and these positive 
effects sustained after 6 months follow-up. This multifaceted HH improvement 
program will be tested in a multicenter controlled trial.
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Abstract
Objectives: We evaluated the value of a single biomarker, biomarker panels, 
biomarkers combined with clinical signs of sepsis, and serial determinations of 
biomarkers in the prediction of bacteremia in patients with sepsis.
Methods: Adult patients visiting the emergency department because of a 
suspected infection with at least two of the following symptoms: temperature 
>38.3°C or <36°C, heart rate >90/min, respiratory rate >20/min, chills, altered 
mental status, systolic blood pressure <90 mmHg, MAP <65 mmHg, and 
hyperglycemia in the absence of diabetes mellitus were included. Procalcitonin 
(PCT), interleukin-6 (IL-6), lipopolysaccharide-binding protein (LBP), C-reactive 
protein (CRP) were measured, and two blood cultures were taken. The analyses 
included: 1) To determine the biomarker with the highest predictive value for 
bacteremia and to examine the predictive value of this biomarker in combination 
with other biomarkers; 2) Analysis of the best biomarker data in combination 
with clinical signs of sepsis; and 3) Analysis of serial determinations of the best 
biomarker. 
Results: Of 342 included patients, PCT had the best predictive value for 
bacteremia with an area under the curve of 0.80, sensitivity 89%, specificity 58%. 
The predictive value of a combination of PCT plus a panel of other biomarkers, 
clinical signs, or analysis of serial PCT levels did not lead to a significant 
improvement of the predictive value of PCT alone.
Conclusions: The ability of PCT to predict bacteremia in patients with sepsis 
does not further improve when combined with IL-6, LBP, CRP, clinical signs, 
or serial measurements. Naturally, this does not exclude that a panel of other 
biomarkers may lead to different results.
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Introduction
It is becoming increasingly clear that early identification of patients with 
sepsis is important but difficult because signs of systemic inflammatory response 
syndrome (SIRS) are not specific1;2 and the predictive value of single biomarkers 
is limited.3 Although blood cultures are considered the gold standard for the 
detection of bacteremia, delays between blood sampling and information 
returned to the clinician is an important disadvantage, but no alternatives are 
currently available.4 
To improve survival in patients with sepsis and septic shock, early initiation 
of appropriate empirical antimicrobial therapy is essential.5-9 The choice of the 
empirical antimicrobial therapy in sepsis mainly depends on the suspected site 
of infection and the antimicrobial susceptibility of the expected pathogens. To 
include more resistant but often less prevalent pathogens, the empirical therapy 
of a severe infection is usually broad-spectrum.5;10 The downside of this strategy is 
that the prescribed antibiotics are often more broad-spectrum than necessary11 or 
even are used in the absence of a bacterial infection.12;13 This may have potentially 
deleterious consequences such as anaphylactic reactions, antibiotic resistance, 
and high costs. Rapid tests that provide insight in the etiology of infection may 
guide appropriate use of antibiotics and are urgently needed. 
To improve diagnosis and management of sepsis, the usefulness of single 
biomarkers (e.g., C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 
(IL-6), and lipopolysaccharide-binding protein (LBP)) are described in many 
studies.3;11-28 Of many biomarkers tested, some appear to have a sensitivity and 
specificity value above 90%.3 Although PCT and CRP have been most widely 
used14, these biomarkers have limited abilities to distinguish sepsis from other 
inflammatory conditions or to predict outcome. In patients with sepsis admitted 
to the emergency department (ED), PCT had a sensitivity of 0.62 to 0.71, and 
specificity 0.67 to 0.88.19;20;22 Therefore, further evaluation of a combination of 
different sepsis biomarkers is recommended.19;20;22
In patients with sepsis, only a few studies have examined the usefulness of 
biomarker panels.29-33 Beneficial effects of a panel to predict organ dysfunction, 
septic shock, and in-hospital mortality29 and the differentiation between bacterial 
and viral lower respiratory tract infections30 have been reported. Also, chills31 and 
increasing values during repeated PCT measurements32 predict the presence of a 
positive blood culture.
In view of the absence of a reliable biomarker to predict bacteremia4, we 
evaluated the predictive value of four single biomarkers (PCT, IL-6, LBP, and CRP), 
the combination of the best performing biomarker with one up to three other 
biomarkers (panels), the combination of the best performing biomarker with 
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clinical signs of the patient and conventional laboratory parameters, and serial 
determinations of the best performing biomarker in predicting bacteremia in ED 
patients with sepsis. We selected bacteremia to have a less disputable diagnosis of 
infection and aimed to find a reliable (panel of) marker(s) to predict the presence 
or absence of bacteremia, which may lead to a reduction of the number of blood 
cultures that needs to be taken. 
Because PCT and CRP are the most widely used single biomarkers, the value 
of IL-6 and LBP for the diagnosis and management of sepsis were frequently 
evaluated in earlier studies, and PCT, IL-6, LBP, and CRP are commercially available, 
we included these biomarkers in our panel analyses.
Materials and methods
Study design
The present study was a prospective single centre study, performed at the 
ED of a 953-bed university hospital in the Netherlands. Each year approximately 
20,000 patients visit the ED and 3%-4% is admitted because of sepsis, severe 
sepsis, or septic shock. During the 8 month study period, medical policy at the 
ED and the nursing wards was solely based on the clinical chemistry test results 
in combination with a physical examination and additional diagnostic procedures 
and not on the results of the inflammatory markers described in this manuscript. 
Prior to the conduct of this study, the local Medical Ethics Committee was 
informed. Although they waived the need for a written informed consent, patients 
were informed about the study and the acquisition of supplementary plasma. 
Study population
Inclusion criteria were: patients (≥16 years old) visiting the ED because of 
a suspected infection, who had at least two of the following clinical signs of 
sepsis1;34;35: temperature >38.3°C or <36°C, heart rate >90/min, respiratory rate 
>20/min, chills, altered mental status, systolic blood pressure <90 mmHg, MAP 
<65 mmHg, and hyperglycemia in the absence of diabetes mellitus. For the 
analysis of serial (3 days) biomarker data, all hospitalized patients admitted to 
one of the departments of internal medicine (internal medicine, rheumatology, 
haematology, nephrology, gastroenterology, oncology, and intensive care), were 
included. 
The final confirmed diagnosis at discharge, as described in Table 1, was based 
on a combination of clinical signs and symptoms of sepsis, the presence/absence 
of an infiltrate on chest X-ray, laboratory parameters, and culture results (e.g., 
blood, urine, sputum, and wound) obtained during the first 24 hours following ED 
admission.
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Table 1. Demographic data and infection characteristics of the subjects
Data collection
In the ED, blood samples were taken for basic clinical chemistry tests (e.g., 
lactate, blood gas, glucose, CRP, and leukocyte count) and two blood cultures. For 
measurement of PCT, IL-6, and LBP, an additional blood sample was taken. In the 
subgroup of hospitalized patients, blood samples were also drawn for standard 
analysis and for the measurement of the biomarker panel at day 2 and day 3. 
Samples for PCT, IL-6, and LBP determination were stored at -80°C until analysis.
Patient characteristics included gender, age, hospitalization, final confirmed 
diagnosis, length of hospital stay, and in hospital mortality. The required data 
(including the ≥2 clinical signs of sepsis) were collected from the clinical patient 
databases and medical records. 
Blood sampling
Blood was collected in 3 ml Lithium-heparin coated tubes: one tube for PCT, IL-
6, and LBP measurements and one tube for basic clinical chemistry tests including 
CRP. EDTA blood was collected for leukocyte counting. Plasma was obtained by 
centrifugation of the blood at 4°C and 2200 g for 10 minutes. Plasma for the 
measurement of PCT, IL-6, and LBP was frozen at -80°C. CRP was measured by 
use of the Abbott Aeroset® (Abbott Diagnostics, USA) with a detection limit of 
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5 mg/L. PCT was measured by use of the Kryptor PCT® (Brahms, Hennigsdorf, 
Germany) with a detection limit of 0.02 µg/L. IL-6 and LBP were measured by use 
of the Immulite 2500® (Siemens Healthcare diagnostics, Deerfield, IL, USA) with a 
detection limit of 2.00 pg/ml and 1.2 µg/ml, respectively. 
Blood for culture was collected in two sets of bottles (BACTEC plus Aerobic/F); 
one aerobic and one anaerobic. Directly upon arrival in the laboratory, blood 
cultures were entered in the BACTEC 9240 automated blood culture system 
(Bacton Dickinson Microbiology Systems, Cockeysville, MD, USA). Bacteremia 
was defined as growth of any pathogen in one or both blood culture sets. The 
isolation of coagulase-negative staphylococci was considered as contamination 
and therefore not defined as bacteremia.
Data analysis
In order to evaluate the predictive value of the biomarkers, the data analysis 
was performed in three steps: 1) Analysis of the single markers and a combination 
of the best performing biomarker with one to three of the other biomarkers 
(panels); 2) Combination of the best performing biomarker with the clinical signs 
of sepsis and conventional laboratory parameters; and 3) Analysis of serial data of 
the best performing biomarker. 
Analysis of single biomarkers and their combination
Receiver operator characteristics (ROC) curves were constructed for each 
single biomarker to evaluate their individual predictive value, together with 
the sensitivity, specificity, the negative predictive value (NPV), and the positive 
predictive value (PPV). Subsequently, the ROC curves of PCT, IL6, LBP, and CRP were 
compared.38 To investigate whether a combination of biomarkers increases the 
predictive value compared with the best performing single marker, a multivariate 
logistic regression analysis was performed, together with a threshold analysis. 
For the threshold analysis, we developed a program in Matlab (Matlab R2009b, 
MathWorks Inc., MA, USA) that uses an upper- and a lower- threshold which were 
defined as follows: when the value of one of the markers was below the lower 
threshold, the patient was predicted not to have a positive blood culture, except 
when the value of one of the other markers was above the upper threshold. The 
algorithm used every combination of cut-off values as thresholds and iteratively 
searched for the best combination based on sensitivity, specificity, NPV, and PPV. 
All possible combinations of biomarkers were analysed, resulting in a total of 18 
million comparisons.
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Analysis of biomarker data combined with clinical signs of sepsis and conventional 
laboratory parameters
For this analysis, we added the clinical signs of sepsis and conventional 
laboratory parameters, and combinations thereof to the best performing single 
marker and again calculated the sensitivity, specificity, NPV, and PPV. 
Subsequently, we analyzed if the best performing single marker combined with 
the number of SIRS criteria (0-4) could further improve the predictive value.  
Analysis of serial biomarker data
The best performing biomarker was determined on 3 consecutive days in 
hospitalized patients. Subsequently, a multivariate logistic regression analysis was 
performed with the values of the marker on the 3 days. Additionally, two other 
analysis methods were used. First, a trend analysis, in which all patients were 
divided into nine different categories depending on their increase or decrease in 
the determined biomarker on day 2 and day 3 compared to day 1. The predictive 
value of each category was determined by the area under the curve (AUC) of the 
ROC and regression plots. Secondly, patients were characterized according to the 
change in the value of the marker (as a percentage) from day to day (from day 1 
to day 2, day 2 to day 3, and day 1 to day 3), and derived whether there was a 
relation between this change and the presence of bacteremia, again by ROC curve 
analysis and regression plots.
Statistical analysis
Data are presented as percentages, medians, and interquartile ranges (IQR). 
Frequency comparison was done by the Chi-squared test. For the analysis of (serial) 
biomarker data, a multivariate logistic regression analysis and trend analysis was 
used. All included clinical parameters were changed into dichotomous variables 
(e.g., presence of temperature >38.3°C yes/no; presence of temperature <36°C 
yes/no; presence of leukocytes <4 x 109/L yes/no; presence of lactate >4 mmol/L 
yes/no). As the optimal cut-off value of an individual biomarker resulting in the 
best sensitivity and specificity does not imply that this cut-off value is optimal 
in the panel analysis, a threshold analysis was conducted in which all possible 
combinations of cut-off values were tested. Two-tailed p-values below 0.05 were 
considered statistically significant. All statistical calculations were performed in 
Matlab (Matlab R2009b, Mathworks Inc., MA, USA) and SPSS 18 for windows 
(SPSS Inc., Chicago, IL, USA). 
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Figure 1. Flow-chart of patients included for analysis
Results
During the study period, 394 patients with a suspected infection and ≥2 clinical 
signs of sepsis were admitted to the ED (Figure 1). We included 342 patients for 
further analysis. Patient demographics and the single biomarker measurement 
results are presented in Table 1. 
In the ED, the administration of antibiotics took place in 222 patients (65%). In 
the total group of 342 patients, 55 (16%) had proven bacteremia (positive blood 
culture). The most common causative agents were E. coli (29%) and Streptococcus 
pneumoniae (23%). 
Thirty-seven patients with proven bacteremia received antibiotics in the ED 
(67%). There was no significant difference in the administration of antibiotics 
between the patient group that turned out to have positive blood cultures and 
the patient group with negative blood cultures. 
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Figure 2. ROC curve of the single biomarkers procalcitonin (PCT), interleukin-6
(IL-6), lipopolysaccharide-binding protein (LBP), and C-reactive protein (CRP)
Single biomarkers and their combination
The biomarker concentrations in patients with a positive blood culture were 
significantly higher than the biomarker results in non-bacteremia patients (all 
p<0.05) (Table 1). Figure 2 represents the single biomarker ROC curves in which the 
sensitivity, specificity, and cut-off values of the single biomarkers were calculated. 
The predictive value of PCT with an AUC of 0.80 (95% CI: 0.75-0.84), sensitivity 
89% (95% CI: 78%-96%), specificity 58% (95% CI: 52%-64%), was significantly 
better than that of the other markers (all p<0.05). The PCT value associated with 
the highest AUC is 0.253 µg/L. The sensitivity, specificity, and likelihood ratios for 
PCT at different cut-offs (0.1 µg/L, 0.25 µg/L, 0.5 µg/L, and 1.0 µg/L) are described 
in Table 2.
Table 2. Different procalcitonin (PCT) cut-off values with corresponding sensitivity, 
specificity, and positive and negative likelihood ratio (LR)
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Next, we analyzed if a combination of PCT plus one to three of the other 
biomarkers could further improve the predictive value of PCT. Although the 
specificity improved in all combinations, the predictive value of PCT did not further 
improve because the sum of the sensitivity and specificity (and thereby the AUC) 
decreased due to a larger decrease in sensitivity in all tested combinations (Figure 
3). 
Figure 3. Combination of different biomarkers: the sensitivity and specificity of 
PCT plus one other marker (interleukin-6 (IL-6), lipopolysaccharide-binding protein 
(LBP), or C-reactive protein (CRP)) (A) and the sensitivity and specificity of PCT plus 
two or three other markers (B)
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Biomarker data combined with clinical signs of sepsis and conventional laboratory 
parameters 
In a subgroup of 248 patients (73%), complete documentation of the clinical 
signs of sepsis and conventional parameters was available (Table 3). 
Table 3. The division of clinical signs of sepsis and conventional laboratory 
parameters in patients with positive blood cultures (n=43) and patients with 
negative blood cultures (n=205)
Leukocytes <4 or >12 x 109/L, chills, and lactate >4 mmol/L had the best 
predictive value (Figure 4A). Combinations of PCT with these three parameters 
are illustrated in Figure 4B and Figure 4C. PCT combined with lactate >4 
performed best in discriminating between bacteremia and non-bacteremia 
patients (sensitivity 91%, specificity 57%), but this result was not significantly 
different from the predictive value of PCT alone. Also, addition of the number of 
SIRS criteria increased specificity, but sensitivity decreased to the same extent 
(data not shown). Therefore, the predictive value of PCT as single marker did not 
further improve by adding the number of SIRS criteria. 
Serial biomarker data
In a subgroup of 85 patients that were hospitalized, PCT was measured on 
day 2 and day 3. Of this subgroup, 14 patients had bacteremia. In addition to the 
PCT levels on day 1, PCT was also significantly higher on day 2 (p=0.002) and day 
3 (p=0.001) in the bacteremia patients compared with non-bacteremia patients. 
There was no significant difference in percentage change or trend analyses, 
between bacteremia and non-bacteremia patients (Figure 5). Bacteremia was not 
better predicted when the highest value of the serial PCT determinations was 
used (data not shown).
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Figure 4. Procalcitonin (PCT) combined with clinical signs and conventional 
laboratory parameters: the sensitivity and specificity of a single clinical sign of 
sepsis or conventional laboratory parameter (A), PCT plus one clinical sign of 
sepsis or single conventional laboratory parameter (B), and PCT plus two clinical 
signs of sepsis and/or conventional laboratory parameters (C)
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Figure 5. Serial analysis of procalcitonin (PCT): change in PCT concentration and 
the presence of bacteremia
Implications for clinical practice
In the overall patient group, 171 patients (50%) had a PCT value >0.253 µg/L. 
Hundred-thirty of these patients received antimicrobial treatment. In the patient 
group with a PCT value <0.253 µg/L (n=171), 92 patients received antibiotics 
during ED admission.
A total of 55 patients had positive blood cultures. Of this patient group, 6 
patients had a PCT value <0.253 µg/L. Nevertheless, 5 out of these 6 patients 
were treated with antibiotics based on the clinical suspicion of an infection. A PCT 
value >0.253 µg/L was found in 122 patients with negative blood cultures (43%). 
Ninety-eight of these patients were treated with antibiotics based on clinical 
grounds.
A total of 47 patients (14%) were sending home after they visited the ED. Despite 
negative blood cultures in 44 patients, most of these patients were treated with 
antibiotics on clinical grounds. In this patient group (n=47), PCT values between 
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0.02 µg/L and 20.82 µg/L were found. Ten patients had a PCT value >0.253 µg/L.
Afterwards, 3 of the patients who were sending home were found to have 
positive blood cultures. Interestingly, all these 3 patients had a PCT value >0.253 
µg/L. During their ED visit, oral antimicrobial therapy was prescribed in 2 of these 
3 patients. Following the culture results, 2 patients were contacted and admitted 
to the nursing ward.
Following their initial ED visit, a total of 6 out of the 47 patients who were sent 
home were admitted to one of the nursing wards because of a severe infection 
within 30 days (including 2 patients with positive blood cultures). In these 6 
patients, PCT values between 0.02 µg/L and 2.13 µg/L were found. A PCT value 
>0.253 µg/L occurred only in the 2 patients with positive blood cultures.
Discussion
Out of four inflammatory biomarkers tested in the present study, PCT was 
the best single marker for prediction of bacteremia in ED patients suffering from 
sepsis. The predictive value of PCT did not improve upon addition of one to three 
other biomarkers, clinical signs of sepsis and conventional laboratory parameters, 
or serial determinations of PCT.
In agreement with other studies that focused on patients presenting with 
sepsis in the ED (AUC 0.69-0.84)19;20;22, we found a comparable AUC of 0.80 to 
predict positive blood cultures, using PCT as a single inflammatory marker. In an 
earlier systematic review, PCT was evaluated for its predictive value to diagnose 
sepsis.14 Overall, the accuracy of PCT for sepsis diagnosis in critically ill patients 
resulted in an AUC of 0.78.14
In our study, we found that the optimal cut-off value of PCT to predict bacteremia 
is 0.253 µg/L. Interestingly, this cut-off value was also found and used in earlier 
studies which investigated PCT to predict bacteremia in patients with community-
acquired pneumonia25, febrile urinary tract infections26, and patients with growth 
of coagulase-negative staphylococci.27 Furthermore, in a recent systematic review 
of randomized controlled trials and recommendations for clinical algorithms 
for antibiotic treatment decisions, the measurement of PCT levels for antibiotic 
decisions in patients with respiratory tract infections and sepsis appears to reduce 
antibiotic exposure without a negative effect on survival.28 In this review, a total 
of 6 studies in the ED setting were identified. Although these studies included 
specifically patients with respiratory tract infections, all studies used a similar PCT 
algorithm: no initiation of antibiotic therapy or, if already initiated, discontinuation 
of antibiotic therapy in patients with PCT levels of <0.25 µg/L.
Earlier studies demonstrated that clinical signs such as fever, chills, and systolic 
blood pressure <90 mmHg are associated with the presence of bacteremia.36;37;39;40 
54
Prediction of bacteremia using analyses of biomarkersChapter 3
A clinical prediction rule to stratify ED patients according to the likelihood of 
developing bacteremia appears to enable a physician to make a bedside estimation 
of the risk of bacteremia.37 Either one major criterion or two minor criteria may 
serve as an indication to obtain blood cultures. Furthermore, in a prospective 
study of 464 consecutive patients in two hospitals, the sensitivity of chills in the 
prediction of bacteremia was 58% and 73%, and specificity 65% and 62%.36 We 
demonstrate that the predictive value of clinical signs of sepsis and conventional 
laboratory parameters is minimal and combining PCT with these items does not 
improve the predictive value of PCT. Our results confirm those of an earlier study in 
which the PPV of the presence of SIRS criteria for predicting bacteremia was only 
7%.41 Our study emphasizes that clinical signs of sepsis do not exert an additional 
value to the measurement of a single biomarker to predict positive blood cultures. 
However, this does not imply that the clinical signs of sepsis are not useful in the 
recognition of patients with bacteremia. To apply a general clinical decision, a 
good clinical judgment remains necessary and biomarkers must be part of, rather 
than be used in preference to, a clinical assessment.
Only a few studies have reported improved predictive values when a panel 
of markers is used.29-33 Surprisingly, up until now there appears to be no uniform 
way to calculate the optimal cut-off values for markers used in panel analyses. 
Importantly, the optimal cut-off value for each single marker may not result in 
the optimal predictive value of a panel. Therefore, we searched for the best cut-
off value of the panel of markers by combining all possible cut-off values of the 
individual biomarkers based on sensitivity, specificity, NPV, and PPV by variable 
threshold analyses. Nevertheless, exploring 18 million possible cut-off value 
combinations did not result in a higher predictive value of the panel in our study. 
Since all possible combinations of cut-off values were tested, we conclude that 
panel analysis does not have additional value compared to the determination of 
the single best marker. To our knowledge, this approach has never been used 
before and because of its completeness, we would like to recommend it for future 
studies.
While serial measurements of PCT have proven its value to discriminate 
between viral and bacterial infections in patients with lower respiratory tract 
infections42-45 and to avoid unnecessary use of antimicrobial treatment42;46, serial 
measurements of PCT appears not improve the prediction of bacteremia in our 
study. However, this analysis was based on a subgroup of 85 patients of whom a 
relatively small number of patients (14) had a proven bacteremia. Furthermore, 
only patients from one of the departments of internal medicine were included in 
this part of the study. Therefore, the generalizability of the result of the analysis of 
serial biomarker data is limited and a more extended clinical research is needed.
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Possible limitation of our study is that we included all patients with a 
suspected infection, who had at least two clinical signs of sepsis. Therefore, also 
immune-suppressed patients and patients with underlying autoimmune disease 
or other co-morbidity were included in the study. Furthermore, the use of anti-
inflammatory agents, corticosteroids, or other sepsis-modifying agents before 
enrolment or during the study period was not documented. Theoretically, the 
levels of PCT, CRP, IL-6, and LBP could be different in the above mentioned patient 
groups and could have influenced the results of our study. Furthermore, many 
of the included patients received antimicrobial treatment prescribed by their 
general practitioner prior to their ED visit. In a study of Müller et al., antibiotic 
pre-treatment and PCT serum levels were independent predictor for negative and 
positive blood cultures.25 Based on this result, antimicrobial pre-treatment may 
have had an important impact on the biomarker values and on the blood culture 
results. However, as we wished to evaluate the value of the biomarkers in a daily 
clinical setting, we chose to study all consecutive patients.
In view of the effects of the use of antibiotic treatment, negative blood culture 
results do not always exclude the presence of bacteremia. Although the presence 
of 16% positive blood cultures in our patient group is comparable with findings 
in other studies, e.g., 8% positive blood cultures in patients with community-
acquired pneumonia25 and 23% in patients with febrile urinary tract infections26, 
taking additional cultures may increase this percentage.
Out of four commercially available biomarkers, PCT is the best single biomarker 
to predict bacteremia in ED patients with sepsis. The value of PCT does not further 
improve when combined with other biomarkers, clinical signs of sepsis and 
conventional laboratory parameters, or serial measurements of PCT. Obviously, 
we cannot exclude the possibility that a panel of PCT plus other biomarkers may 
lead to different results.
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Abstract
Objectives: To investigate whether additional determinations of plasma 
lipopolysaccharide binding protein (LBP), procalcitonin (PCT), interleukin-6 (IL-
6), interleukin-18 (IL-18), or soluble triggering receptor expressed on myeloid 
cells-1 (sTREM-1) to C-reactive protein (CRP) improve the discrimination between 
bacterial and viral lower respiratory tract infections (LRTI).
Methods: Of 342 patients visiting the emergency department because of a 
suspected infection and ≥2 clinical signs of sepsis, 56 patients with proven bacterial 
(n=39) or viral (n=17) LRTI were included. The area under the curves (AUC) for the 
five possible combinations of CRP with one other biomarker were compared with 
the AUC for CRP alone. Next, the same analysis was performed in the group of 
patients with a CRP concentration with <95% specificity for bacterial LRTI.
Results: While CRP, PCT, IL-6, sTREM-1, and LBP concentrations were 
significantly different between patients with bacterial or viral LRTI, the AUC for 
CRP (0.82, 95% CI: 0.70-0.93) did not increase after combination analysis. After 
exclusion of patients with a CRP >150 mg/L, biomarker panel analysis did not 
improve diagnostic accuracy of CRP either. 
Conclusions: Combining CRP with LBP, PCT, IL-6, IL-18, or sTREM-1 does not 
improve differentiation between patients with a bacterial or viral LRTI compared 
with CRP alone.
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Introduction
Morbidity and mortality associated with lower respiratory tract infections 
(LRTI) remains significant, despite improved diagnostic and therapeutic treatment 
strategies in recent years.1 The early initiation of antibiotic therapy has a major 
impact on the clinical outcome of critically ill patients.2;3 Several laboratory 
diagnostic tests are currently used for establishing an etiologic diagnosis. However, 
difficulty in obtaining relevant specimens, the low sensitivity or specificity of the 
used tests, high costs, and the absence of test results within the critical window 
for initiating adequate treatment, often result in prescription of antibiotic therapy 
in the absence of a bacterial infection. This may have potentially deleterious 
consequences such as anaphylactic reactions, antibiotic resistance, and high 
costs.4 Rapid tests that provide additional insight in the bacterial/viral etiology of 
infection may guide appropriate use of antibiotics and are urgently needed.
Both C-reactive protein (CRP) and procalcitonin (PCT) concentrations have 
been used to initiate and monitor the antibiotic use for LRTI.5;6 However, the 
specificity of single biomarkers in terms of etiologic distinction between bacterial 
and viral inflammatory insults remains cumbersome7;8, and a combination of 
markers could prove more reliable. The usefulness of IL-18 as a viral marker is 
supported by the reported high concentrations in HIV, dengue hemorrhagic fever, 
EBV, and CMV infections.9-12 Triggering receptor expressed on myeloid cells-1 
(TREM-1) is expressed on neutrophils and monocytes upon exposure to bacteria 
and fungi. Soluble TREM-1 (sTREM-1) has been proposed to be of diagnostic 
value in bacterial infections.13 Lipopolysaccharide (LPS)-binding protein (LBP) is 
an acute phase protein produced by hepatocytes that binds LPS to form a LPS-LBP 
complex during bacterial infections.14 In children, LBP has excellent sensitivity for 
diagnosing invasive bacterial infections.15 Interleukin-6 (IL-6) is the chief stimulator 
of the production of most acute phase proteins, such as CRP and LBP. Thus, IL-6 is 
a potential marker for the early phase of infection.
It is suggested that determination of several biomarkers, or a panel of 
biomarkers, may improve their predictive value16-20, but clinical evidence for this 
notion is scarce.16-20 Also, differences in the plasma concentrations between, e.g., 
viral and bacterial infection groups are frequently reported, while the discriminating 
power for the individual patient remains unclear. Therefore, in the present study 
we assessed whether combination of the most commonly used biomarker CRP 
with LBP, PCT, IL-6, IL-18, or sTREM-1 can improve the discriminating ability in 
patients with a proven bacterial or viral LRTI.
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Materials and methods
Study design
This study was a prospective single centre study, performed at the emergency 
department (ED) of a 953-bed university hospital in the Netherlands between 
November 2006 and May 2007. During the study, medical policy at the ED and 
the nursing wards was based on the standard basic clinical chemistry test results, 
in combination with a physical and additional examination depending on the 
clinical suspicion, and not on the results of the novel inflammatory markers 
described in this manuscript. Prior to the conduct of this study, the local Medical 
Ethics Committee was informed. Although they waived the need for a written 
informed consent, patients were informed about the study and the acquisition of 
supplementary plasma. 
Study population
The study inclusion criteria were: 
1) Patients (≥16 years old) visiting the ED because of a suspected infection, who had 
at least two of the following clinical signs of sepsis: temperature >38.3°C or <36°C, 
heart rate >90/min, respiratory rate >20/min, chills, altered mental status, systolic 
blood pressure <90 mmHg, mean arterial pressure <65 mmHg, hyperglycemia 
(plasma glucose >6.8 mmol/L) in the absence of diabetes mellitus21;
2) Signs of a LRTI: fever, cough with or without sputum, chest pain, dyspnoea, 
and altered breath sounds on auscultation, and/or the presence of an infiltrate 
on chest X-ray;
3) Patients with a microbiologically confirmed bacterial or viral infection. Since 
the primary goal of this study was not to differentiate between patients with 
or without infection, but to establish the value of biomarkers in discriminating 
between bacterial and viral LRTI, we deliberately selected only patients with a 
microbiologically confirmed bacterial or viral infection. 
Data collection
Cultures from sputum and blood, PCR on nose and throat swabs, antigen 
tests and serology were used to establish a diagnosis. Blood samples were taken 
for basic clinical chemistry tests and the measurements of the inflammatory 
mediators. Two blood cultures for microbiological testing were performed. Only 
CRP results were known to the attending physician. Blood was collected into two 
3 ml lithium-heparin coated tubes for PCT, IL-6, LBP, sTREM-1, IL-18, and for basic 
clinical chemistry tests including CRP. Plasma was obtained by centrifugation of 
the blood at 4°C with 2000 rpm for 15 minutes after which the plasma was frozen 
at -80°C until measurements took place. CRP was measured by use of the Abbott 
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Aeroset® (Abbott Diagnostics, Chicago, USA) with a lower detection limit of 5 mg/L. 
PCT was measured by use of the Kryptor PCT® (Brahms, Hennigsdorf, Germany) 
with a detection limit of 0.02 µg/L. IL-6 and LBP were measured by use of the 
Immulite 2500® (Siemens, Breda, The Netherlands) with a lower detection limit of 
2 pg/ml and 1.2 µg/ml, respectively. Circulating IL-18 levels were measured using 
a commercial Luminex assay (BioRad, Hercules, USA) with a lower detection limit 
of 15 pg/ml. Circulating sTREM-1 was assessed by a commercial ELISA kit (R&D 
Systems, Minneapolis, USA), according to the instructions of the manufacturer 
with a lower detection limit of 62.5 pg/ml.
Statistical analysis
Data are expressed as medians with interquartile range. The Mann-Whitney 
U-test was used to determine the difference of each marker between the two 
groups of patients. Receiver operating characteristics (ROC) curve statistics were 
applied for each single marker. Logistic regression analysis was used to estimate 
the predicted probabilities for CRP alone and in a model with CRP in combination 
with one of the other five biomarkers. These data were used for the generation 
of ROC curves. The area under the ROC curves (AUC) for the five possible 
combinations of CRP with one other biomarker was compared with the AUC for 
CRP alone. The method described by Hanley and McNeil was used for comparing 
the AUC.22 As very high CRP values are highly specific for bacterial infections23 and 
no additional biomarkers are needed, we additionally analyzed the combination 
of markers in the subgroup of patients with a moderately increased CRP that 
may benefit the most from panel analysis. Therefore, the cut-off value for CRP 
leading to a specificity >95% for a bacterial LRTI (at the top end of CRP values) was 
determined. Next, a ROC curve for CRP with one other biomarker was constructed 
in a similar way as described above for the subgroup of patients with a CRP below 
this cut-off value. All tests were two-sided, and p<0.05 was considered statistically 
significant. Data were analyzed using SPSS 18 for windows (SPSS Inc., Chicago, IL, 
USA) and MedCalc version 11.3.1.0 (MedCalc Software, Mariakerke, Belgium).
Results
A total of 342 patients with a suspected infection and ≥2 clinical signs of 
sepsis were admitted to the ED. Of these patients, 123 had a pulmonary focus 
for infection of whom 58 had a microbiologically confirmed LRTI. Two patients 
were excluded because of a fungal infection (Pneumocystis jirovecii). Finally, 
we included 39 patients with a bacterial LRTI and 17 patients with a viral LRTI 
for further analysis. No patients with both a bacterial and a viral infection were 
diagnosed. 
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With the number of patients included, this study has 80% power to pick up an 
increase of the AUC of 10% in the whole group and an increase of the AUC of 20% 
in the subgroup of patients with a CRP concentration <150 mg/L. 
The demographic and clinical parameters of the two groups are shown in Table 
1. Table 2 shows the microbiological data. 
Table 1. Patient characteristics
Table 2. Isolated microorganisms
CRP, IL-6, LBP, PCT, and sTREM-1 were significantly higher in the bacterial group 
compared with the viral group. IL-18 did not differ between the bacterial and the 
viral group (Figure 1). 
The ROC for CRP had an AUC of 0.82 (95% CI: 0.70-0.93). The other biomarkers 
did not have a larger AUC. The combination of CRP with any of the other markers 
had no significant effect on the AUC compared with CRP alone (Table 3).
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Table 3. Area under the curve (AUC) for diagnosing bacterial lower respiratory 
tract infection of C-reactive protein (CRP) and CRP in combination with other 
markers (n=56). P-value for the comparison with the AUC for CRP
For CRP, a level of >150 mg/L was highly specific for a bacterial infection (95% 
CI: 0.80-1.0). However, only 49% (n=19) (95% CI: 0.32-0.65) of the patients with 
a bacterial LRTI had concentrations >150 mg/L. In the lower range, considerable 
overlap of CRP concentrations existed between patients with viral (n=17) and 
bacterial infections (n=20), which had a negative impact on the specificity of the 
test and impeded the generation of a cut-off value with an acceptable specificity 
for viral LRTI.
Apart from the patients with a bacterial infection and a CRP >150 mg/L (highly 
specific for bacterial LRTI), the combination of the CRP-value with any one of the 
other biomarkers in the remaining patients with a CRP <150 mg/L (n=37) did 
not increase the AUC to discriminate between a viral and bacterial LRTI in this 
subgroup of patients (Table 4).
Table 4. Area under the curve (AUC) for diagnosing bacterial lower respiratory 
tract infection of C-reactive protein (CRP) and CRP in combination with other 
markers of patients with a CRP <150 mg/L (n=37). P-value for the comparison 
with the AUC for CRP
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Figure 1. Plasma concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), 
lipopolysaccharide binding protein (LBP), procalcitonin (PCT), interleukin-18 (IL-
18), and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in 
patients with viral lower respiratory tract infection (LRTI) compared with LRTI of 
bacterial origin (n=56). Horizontal bars represent medians of the concentrations; 
the median is reported above the scatter plots in the different figures
Discussion
The main finding of the present study is that while several inflammatory 
markers are significantly different between a group of bacterial and viral LRTI 
patients, addition of these markers to CRP was not superior to CRP alone in 
discriminating between bacterial and viral LRTI in septic patients. CRP as a single 
biomarker is a useful parameter to suggest the bacterial etiology of an infection, 
since a concentration >150 mg/L is highly specific for a bacterial infection. 
However, lower concentrations of CRP are often observed during both viral and 
bacterial infections. Unfortunately, biomarker panel analysis in this subgroup of 
patients did not improve diagnostic accuracy of CRP either and are therefore not 
suitable to guide therapy for the individual patient.
Antibiotics are the cornerstone in the treatment of bacterial infections and 
early antibiotic administration has been a crucial part of the surviving sepsis 
campaign.24 On the other hand, a dramatic increase in antibiotic resistance has 
emerged without the prospect of development of novel classes of antimicrobial 
agents.4;25 Therefore, reduction of the unnecessary use of antibiotics is mandatory.
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Unfortunately, symptoms and signs routinely used in the diagnosis of 
LRTI have limited value in predicting the requirement of antibiotic therapy.23 
As a consequence, a multitude of biomarkers gained a lot of attention in 
differentiating bacterial from viral infections and prognostication. Among these, 
CRP and PCT have found their way into daily practice.5;6 LRTI caused by various 
classes of microorganism are characterized by different concentrations of PCT and 
CRP.16;23;26;27 However, the high a-priori chance of having a bacterial infection28;29, 
together with the considerable overlap between the biomarkers in the lower 
range, complicates the exclusion of a bacterial cause of an infection by the use of 
individual biomarkers.16;23;29
To overcome the problem with single marker analysis, some studies advocated 
panel analysis.16-19;29;30 While some promising results have been reported17;18, 
studies including only patients with LRTI found no relevant effects of combining 
markers on diagnostic accuracy.16;19;29;30 We used the addition of a second 
biomarker to CRP to examine the discriminatory power of laboratory testing, both 
in the group as a whole and in a subgroup of patients with relatively moderately 
increased CRP levels that potentially would benefit most from this approach. 
In contrast with most previous studies, we included both proven bacterial and 
viral markers aimed at increasing the discriminative power. For example, IL-18 is 
a cytokine playing an important role in antiviral immunity9-12, and was expected 
to be a sensitive marker for diagnosing viral infections, while other markers are 
mechanistically related to the immune response against bacterial infections. 
Most biomarkers examined in previous studies are stimulated both by 
bacterial and viral pathogens, but reach higher values during bacterial invasion. 
Therefore, moderately increased concentrations of these biomarkers can be 
found in both categories. Combination of these bacterial markers may only be 
beneficial if they do not correlate well with each other. Furthermore, a potentially 
suitable biomarker for combination analysis in future studies should demonstrate 
increased levels during viral infections. Bystanders of viral replication or proteins 
released upon virus recognition may be reasonable candidates.
There are several limitations of this study. First, the sample size is relatively 
small, especially for the viral infection group, although our study had enough 
power to detect a clinically relevant difference between the single and panel 
analysis. Second, this was a subset analysis of a prospective study in patients 
with LRTI that had a microbiological diagnosis. For an explorative study, we 
deliberately included only patients with a confirmed diagnosis. Because of 
the outbreak of acute Q-fever in the Netherlands between 2007 and 2010 
Coxiella burnetii infections represented a large part of the bacterial pathogens. 
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Patients with acute Q-fever are indistinguishable from other bacterial infection 
on clinical grounds.31 Furthermore, in the present study the distribution of the 
inflammatory markers was not importantly influenced by the inclusion of acute 
Q-fever patients. Third, viral infections predispose to bacterial super infections 
and these cannot be ruled out in all patients diagnosed as having a viral LRTI. In 
most of the patients admitted to the hospital, because of the severity of illness, 
antibiotic treatment was initiated, making it difficult to determine in hindsight 
the presence or absence of a bacterial co-infection. Fourth, although the results 
of our study may be different in LRTI patients with <2 clinical signs of sepsis, in 
general practice the vast majority of patients with a LRTI fulfil ≥2 of these sepsis 
criteria and consequently satisfy the sepsis definition. Therefore, the results of 
our study apply to most patients presenting with signs of LRTI to the emergency 
department. Finally, a group of control patients with other types of non-infectious 
inflammatory reactions was not included in our cohort, as our primary aim was 
to investigate whether additional biomarkers could improve the differentiation 
between viral and bacterial LRTI and not to determine their value to establish the 
presence of an infection.
In conclusion, while different markers of inflammation show statistically 
significant higher levels in the group of patients with a bacterial infection 
compared to the patients with a viral LRTI, the combination of CRP with LBP, 
PCT, IL-6, IL-18, or sTREM-1 does not improve the prediction of microbiological 
etiology in patients with LRTI, when compared with CRP as a single marker. Ruling 
out a bacterial infection remains troublesome and future studies should aim to 
identify better diagnostic markers.
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Abstract
Background: To reduce unintentional and avoidable adverse events in patients 
in hospitals in the Netherlands, a patient safety agency (VMS) program was 
launched in 2008. Among the VMS topics, the program ‘optimal therapy in severe 
sepsis’, according to the international surviving sepsis campaign (SSC), aims to 
improve early diagnosis and treatment of sepsis to reduce sepsis mortality by 15% 
before the end of 2012.
Method: We analyzed compliance data submitted to the international SSC 
database from the Netherlands and compared these data with published 
international SSC results.
Results: Data of 863 patients, representing 6% of the international data 
(n=14,209), were used for analysis. In the Netherlands, the resuscitation 
bundle compliance improved significantly from 7% at baseline to 27% after 2 
years (p=0.002). Internationally, the resuscitation bundle compliance increased 
significantly from 11% to 31% (p<0.001). In contrast with the international results 
(18% baseline, 36% after 2 years), the compliance with the management bundle 
did not improve (24% baseline, 25% after 2 years). 
At baseline, hospital mortality was significantly higher compared with 
internationally (52% versus 37%; p=0.03) and decreased significantly from 52% 
at baseline to 35% after 2 years (p=0.049). In the Netherlands, the decrease in 
mortality was significantly more pronounced after implementation of the SSC 
(p<0.001).
Conclusions: In the Netherlands, following implementation of the SSC 
guidelines, compliance with the resuscitation bundle increased significantly, 
while compliance with the management bundle remained unaffected. This was 
associated with a significant improvement in hospital survival. In view of the VMS 
program and goals, further implementation of the SSC is warranted.
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Introduction
In the Netherlands, it is estimated that 15,500 patients with severe sepsis and 
6000 patients suffering from septic shock are annually admitted to an intensive 
care unit (ICU).1 With a mortality rate of 30% to 50% severe sepsis/septic shock 
is the most important cause of death in non-cardiac ICU patients.2 To provide 
better guidelines to improve early diagnosis and treatment of severe sepsis and to 
reduce its mortality, the surviving sepsis campaign (SSC) was launched in 2002.3;4 
The most important SSC guideline recommendations are summarized into two 
bundles: the resuscitation bundle (six elements to start immediately and to be 
completed within 6 hours) and the management bundle (four elements to be 
completed within 24 hours), published in 2004.3;5 Since then, the sepsis bundles 
have been adopted in ICUs6-8, emergency departments9-11, and nursing wards.12-18 
In the Netherlands, a national committee and SSC website was established 
facilitating the possibilities to report bundle compliance and patient outcome 
to the international database. In addition, the Dutch association of hospitals 
(NVZ), Dutch Federation of University Medical Centres (NFU), Order of Medical 
Specialists (Order), National Expert Centre for Nursing (LEVV), and the Association 
for Nurses in the Netherlands (V&VN) initiated the national patient safety agency 
(VMS: www.vmszorg.nl). VMS aims to reduce the unintentional and avoidable 
damage in patients in Dutch hospitals by 50% by December 2012. Among other 
VMS topics, the early diagnosis and treatment of patients with severe sepsis are 
specific guideline items. The goal of the VMS is to increase compliance with the 
resuscitation bundle and management bundle elements to an average of 80% and 
to reduce both the in-hospital mortality and the mortality within 30 days after the 
diagnosis of severe sepsis by 15% compared with mortality data from 2007.
Recently, the results of the international guideline-based performance 
program were published.12 Patient data and bundle performance data of 14,209 
patients from 165 sites worldwide demonstrated that compliance with the SSC 
bundles was associated with continuous quality improvement in sepsis care and a 
sustained decrease in mortality. 
The aim of our present study was to analyse the data submitted by hospitals in 
the Netherlands and to compare these results with the international SSC results.
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Figure 1. Study population: SSC database the Netherlands and the international 
SSC database
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Materials and methods
Study design and population
Patient data and bundle compliance data were collected from December 
2005 to June 2009. Inclusion criteria were adult patients (>18 years) admitted 
to emergency departments, clinical wards, and ICUs with a suspected or proven 
infection, ≥2 systematic inflammatory response syndrome (SIRS) criteria, and ≥1 
failing organ system.11;18 Participating sites that included ≤20 patients and sites 
with <3 months of patient enrolment were excluded for this study (Figure 1). 
The global SSC improvement initiative was reviewed and approved by the 
Cooper University Hospital Institution Review Board. As patient data were 
obtained anonymously and no patient-related interventions were carried out, no 
additional approval from an Ethics Committee was necessary. 
Table 1. Patient characteristics: the Netherlands versus international12
Data collection and variables
The database used for this study was part of the international SSC database.12 
The relevant patient characteristics included department of admission (from 
emergency department, from other unit, or ICU with other diagnosis), site of 
infection, diagnosis, and hospital mortality (Table 1). In accordance to country-
specific privacy laws, patient age and gender were not collected in the international 
SSC database and were therefore also not available for our study. 
Performance data of the six resuscitation bundle elements and performance 
data of the four management bundle elements were collected (Table 2). 
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Table 2. Compliance with the resuscitation and management bundle elements in 
the Netherlands: percentages per quarter (n=863)
The bundle element ‘drotrecogin alfa policy followed’ implies that each 
hospital has formulated his own drotrecogin alfa policy. If the policy is to treat 
patients with drotrecogin alfa, a patient that did not receive the drug is classified 
as not compliant. If the policy is not to administer drotrecogin alfa, and the drug 
is not given, this is viewed as compliant to the local policy. 
If no formal policy is present, the patients that fulfil the criteria but did not 
receive the drug are scored as not compliant.   
All data were organized by quarter, with the first 3 months that a site entered 
patient data into the database defined as the first quarter, regardless of when 
those months occurred. Data from up to eight quarters from each site were used 
to analyse bundle compliances (Figure 1). Furthermore, data from the initial 
quarter (first quarter of data submission from each institution during the 2-year 
data analysis period) and the final quarter (the last quarter of data submission 
from each institution during the 2-year data analysis period) were used to 
compare changes in compliance with the bundle elements between the initial 
quarter and the final quarter and to compare the data from the Netherlands with 
the international data. 
Outcome measures
The primary outcome measure was change in compliance with the entire 
resuscitation bundle and management bundle, and change in the completion 
of the ten individual bundle elements. We included hospital mortality rate as 
secondary outcome measure.
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Statistical analysis
Data are presented as percentages and odds ratios (ORs) with 95% confidence 
interval (95% CI). To analyse the differences in compliance rates between the 
quarters, both overall and for each of the ten separate elements, we used the 
Chi-squared test. In a similar way, we analysed the differences in compliance rates 
between the Netherlands and the international results. Due to the relatively small 
number of patients from the Netherlands, the Fisher’s exact test was used to analyse 
the differences between bundle compliance in the initial quarter compared with 
the final quarter. To determine the effect of the SSC on the compliance rate of the 
bundles over the study period we used linear regression analysis. To analyse the 
impact of compliance with the individual bundle elements, a multivariate logistic 
regression analysis was performed. A two-tailed p-value <0.05 was considered 
statistically significant. Data were analysed using SPSS 16.01 (SPSS Inc., Chicago, 
IL, USA) and Graph Pad V 5.0 (Graph pad Prism software).
Results
Nationwide, 1172 patients from four different general hospitals were included 
in the SSC database (Figure 1). Internationally, 15,022 patients from 165 different 
sites were included. In contrast to the international data, where patients were 
most likely admitted to the ICU through the emergency department, most patients 
came to the ICU from the general nursing ward in the Netherlands. Furthermore, 
significantly more septic shock patients were included (p=0.001) and the sites of 
infection were not comparable with the international data (Table 1).
Since analysis of the bundle compliance was limited to the first 2 years of 
patient inclusion at each site, the compliance data of 863 patients, representing 
6% of the international analysed data, were used for further analysis. For the 
international bundle compliance analysis, data of 14,209 patients were available 
(Figure 1).
Change in bundle compliance
The compliance with the complete bundles and the individual bundle 
elements by quarter during 2 years in the Netherlands are represented in Table 
2. During the first quarter, the compliance rate with the resuscitation bundle and 
management bundle was 7% and 24% respectively, compared with 11% and 18% 
internationally.12 
Although in the initial quarter no significant differences in the overall 
bundle compliance rate between the Netherlands and the international bundle 
compliance rate were found (resuscitation bundle p=0.27; management bundle 
p=0.25), the compliance with three individual bundle elements (‘administration 
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of fluids and vasopressors’, ‘achieving a CVP >8 mmHg’, and ‘drotrecogin alfa 
policy followed’) was significantly higher (p<0.001) in the first quarter in the 
Netherlands (Figure 2).
Figure 2. Changes in compliance with the individual bundle elements in the 
initial quarter and the final quarter: results from the Netherlands versus the 
international results12
In the Netherlands, the compliance rate with the complete resuscitation 
bundle improved significantly to 27% (p=0.002) by the end of 2 years, and 
statistically significant improvement was achieved by the fifth quarter (Figure 
3A). Internationally, the compliance with the resuscitation bundle increased to 
31% by the end of 2 years, achieving statistical significance (p<0.0001) by the 
second quarter (Figure 3A). For the management bundle no statistically significant 
differences in compliance rates between baseline and the end of 2 years were 
found in the Netherlands (Figure 3B), while internationally, the compliance with 
the management bundle significantly increased from 18% to 36% by the end of 2 
years.12  
Changes in compliance with the individual bundle elements between the initial 
quarter and the final quarter are presented in Figure 2. In the final quarter, a 
significant improvement in the completion of the individual resuscitation bundle 
element ‘Scv02 >70%’ (8% to 48%; Figure 2A), and the management bundle 
element ‘steroid policy’ (63% to 88%; Figure 2B) was attained in the Netherlands. 
Internationally, the completion of all six resuscitation bundle elements and three 
out of four management bundle elements improved significantly.12
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Figure 3. Change in bundle compliance per quarter over 2 years of data collection: 
results from the Netherlands (n=863) versus the international results (n=14,209).12 
Compliance with the complete resuscitation bundle (A), compliance with the 
complete management bundle (B)
 
Hospital mortality
Data from the Netherlands showed that the hospital mortality at baseline 
was 52% and significantly decreased by the end of 2 years to 35% (p<0.05). 
Internationally, the baseline hospital mortality was 37% and significantly 
decreased to 31% (Figure 4).12 
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Figure 4. Change in hospital mortality per quarter over 2 years of data collection: 
results from the Netherlands (n=863) versus the international results (n=14,209)12
The hospital mortality at baseline was significantly higher in the Netherlands 
compared with the international hospital mortality (52% versus 37%; p=0.03) 
and the decrease in hospital mortality in the Netherlands was significantly more 
pronounced than the achieved decrease in hospital mortality in the international 
database: 17% versus 6% (p<0.001). 
The impact of the individual bundle elements on the unadjusted hospital 
mortality is represented in Figure 5. In the Netherlands, the performance of four 
out of ten bundle elements contributed to a lower hospital mortality, whereas 
seven out of nine bundle elements contributed to a lower mortality internationally 
(the impact of the tenth bundle element ‘fluids and vasopressors’ on hospital 
mortality was not known). The beneficial impact of ‘glucose control’ and ‘plateau 
pressure control’ found internationally, was not confirmed in the data from the 
Netherlands as the 95% CIs do not include the international data point. 
Independent of changes in time, of all patients who were treated in the 
Netherlands in compliance with the resuscitation bundle, mortality was borderline 
significantly lower (31% versus 39%, p=0.057) compared with the patients who 
were not.  
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Figure 5. Impact of the individual bundle elements on the unadjusted hospital 
mortality: results from the Netherlands (n=863) versus the international results 
(n=14,209)12
Discussion
The main finding of our study is that in the included hospitals in the 
Netherlands the compliance with the resuscitation bundle significantly improved 
by implementation of the SSC while, in contrast with the international results, the 
compliance with the management bundle did not improve. The hospital mortality 
decreased significantly after implementation of the SSC and compared with the 
international data, the hospital mortality in the Netherlands was significantly 
higher at baseline and decreased significantly more after implementation of the 
SSC.
Although the results of the implementation of the SSC bundles have been 
reported in several studies,7;8;15;17 we feel it is of importance to report the compliance 
rates and outcome results of patients in the Netherlands. Our data demonstrate 
and confirm that focus on the SSC guidelines can improve the care for patients 
with sepsis in the Netherlands, and that indeed this is associated with a better 
survival for sepsis patients. Importantly, our study does not describe the effect of 
implementation of the SSC bundles in all hospitals and data were only collected 
until June 2009. Since then, it seems likely that the SSC bundles are implemented 
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in more Dutch hospitals and the bundle compliance further improved because of 
the performance of several local and national implementation programs related 
to the VMS safety program.
While the compliance with the resuscitation bundle improved significantly, 
compliance with the management bundle did not. The management bundle 
consists of therapies with proven efficacy in patients in the ICU.3 The lack of 
improvement in therapies given in the ICU is a striking finding, especially since 
mainly intensivists are involved in the implementation efforts of the SSC guidelines. 
Therefore, the implementation of these therapies needs further attention. 
Overall, and possibly against general belief, the complete adherence to the 
bundles was poor at baseline. Despite the implementation of the SSC bundles, the 
completion of all resuscitation bundle elements as well as all management bundle 
elements occurred only in approximately a quarter of all patients with severe 
sepsis and septic shock following implementation. Nevertheless, these results are 
comparable with international results.6;7;12;20 In Spain, the implementation of the 
SSC bundles in 59 medical-surgical ICUs was associated with improved guideline 
compliance and lower hospital mortality. Compliance with the resuscitation 
bundle was only 13% at post-intervention and 7% during long-term follow-up. 
Compliance with the management bundle was 20% at post-intervention and 
27% during long-term follow-up.20 In other studies compliance varies from 4%6 
to 52%.21 
So far, the cost-effectiveness of the implementation of the SSC bundles in the 
Netherlands is not known. In Spain, a significant reduction in mortality resulted 
in an increase in costs per patient of only 1736 Euros, mainly attributable to the 
increased length of stay.22 
Several limitations of this study need to be addressed. At baseline, mortality 
was higher in patients in the Netherlands compared with the international 
database. Because of the significant differences in case mix (including a higher 
proportion of patients with septic shock, admitted from the ward, and differences 
in the site of infection) the relevance of this baseline difference in mortality is 
not clear. Since we had no access to individual patient data in the international 
database, adjustments could not be made. In addition, the methods used in other 
studies are not comparable with the methods used in our study and therefore it 
is not possible to benchmark the results from the Netherlands with the results 
from a country with a similar high baseline mortality. Nevertheless, the increase 
in bundle compliance associated with an improvement in mortality is paramount 
and in accordance with earlier studies.7;8;12-14;20-25 The fact that most patients in the 
Netherlands came from the ward, while most international patients were admitted 
to the ICU by the emergency department, may be relevant for the initiation of 
the resuscitation bundle, as sepsis patients are more likely to be treated within 
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the time frames of the SSC bundles than ward patients. For example emergency 
department nurses can play a vital role in recognizing and managing patients with 
severe sepsis.11 
Although the literature provides a large number of different strategies to 
implement innovations such as the SSC bundles, e.g., educational meetings, 
reminders, and feedback, not one of these implementation strategies seems to be 
superior to the other and most show mixed results.9-11;15;26;27 Due to the relatively 
small number of included patients and different implementation strategies per 
hospital, we were unable to evaluate the effects of the applied implementation 
techniques on bundle compliance. Furthermore, the expanded attention to severe 
sepsis and septic shock, changes in hospital practice, changes on the level of the 
organization, or not SSC related implementation techniques may (also) have 
contributed to the changes in bundle compliance. Therefore, it is not possible 
to conclude which factors were (to what degree) responsible for the achieved 
improvement.
In conclusion, implementation of the SSC bundles and the compliance 
registration improved insight into the current quality of care for patients with 
severe sepsis and septic shock. Comparable with other regions of the world, there 
is room for improvement in the treatment of these patients in the Netherlands. 
Both national and international improvements in SSC compliance were associated 
with sustained, continuous quality improvement in sepsis care and better outcome 
of septic patients, although in an observational study a cause-effect relationship 
cannot be established.
Especially the lack of improvement of the compliance with the management 
bundle needs further attention. To achieve a higher SSC bundle compliance and 
better patient outcome in the Netherlands, sepsis education, repeated evaluation 
of the SSC bundle compliance, and participation in the VMS safety program is 
necessary.
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Abstract
Background: The short- and long-term effects of a single teaching intervention 
for internal medicine residents are not known. Since sepsis is a prevalent and 
important disease and both therapeutic and diagnostic interventions have 
been protocolised, we investigated the effects of a sepsis based single teaching 
intervention. 
Methods: A prospective before-and-after education study was performed 
among residents who attended a regional professional training for internal 
medicine. All residents who participated were invited to complete a questionnaire 
about the assessment of symptoms and the diagnosis and treatment of sepsis. 
The questionnaire was filled out before, directly after, and 4-6 months after the 
teaching intervention. The overall questionnaire score was expressed on a 0-10 
scale.
Results: A total of 253 questionnaires from 109 training-grade doctors 
were collected. At baseline, the ‘assessment of symptoms of sepsis’ score was 
significantly lower than the ‘diagnosis and treatment’ score. Following the 
education session, training-grade doctors’ knowledge about sepsis definitions and 
diagnosis and treatment of sepsis increased from (mean±SD) 6.1±1.6 to 8.2±1.2 
(p<.0001). Moreover, 4-6 months after the teaching intervention, this effect was 
sustained (p<.0001 compared with test I), resulting in a mean score of 7.6±1.1.
Conclusions: Our single teaching intervention resulted in improved and 
sustained knowledge on the assessment of symptoms and diagnosis and 
treatment of sepsis. 
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Introduction
In 2004, the Central College of Medical Specialties (CCMS) of the Royal Dutch 
Medical Association presented guidelines for modernisation of all postgraduate 
speciality training programs and since 2006 all these programs should be based on 
these guidelines. To assess residents’ competencies, several methods of evaluation 
can be applied.1 Although the organised education for internal medicine residents 
is substantial, still little is known about its short- and long-term benefits.2
Over the last few years, several studies have shown that rapid diagnosis and 
management of sepsis is critical for successful treatment.3-6 The surviving sepsis 
campaign (SSC) provides helpful tools to improve the diagnosis and management 
of sepsis, especially for patients with severe sepsis and septic shock. However, 
implementation of these guidelines in daily practice appears to be troublesome.7-9 
As a result, about 30% to 40% of patients do not receive care according to the 
present scientific evidence and about 20% to 25% of the care provided is not 
needed or potentially harmful.10;11
Use of the SSC tools may be hindered by a variety of barriers to guideline 
adherence: lack of familiarity, lack of awareness, lack of agreement, lack of 
outcome expectancy, lack of self-efficacy, lack of motivation/inertia of previous 
practice, and external barriers.12 Previous studies have demonstrated that an 
important reason for not following the SSC guidelines is that the identification 
of patients with sepsis can be difficult, resulting in treatment delay.13;14 Only 
about 30% of physicians correctly identified the diagnostic criteria for systemic 
inflammatory response syndrome (SIRS).15 Even after active implementation of a 
sepsis teaching program, only 48% and 67% of the training-grade doctors could 
define severe sepsis and septic shock, respectively.16 
Another reason for not following the SSC guidelines is the lack of knowledge 
about the management of patients with sepsis.13;14 Therefore, extensive knowledge 
about sepsis is an important condition for early identification and management 
of patients with sepsis. In addition, none of the previous studies have evaluated 
the knowledge deficiency for different sepsis topics and the short- and long-term 
effectiveness of a teaching intervention aimed at improving physicians’ knowledge 
about sepsis. We performed the present study in which the potential variety in 
residents’ knowledge about the identification and management of sepsis and 
the short- and long-term effectiveness of a brief and single teaching intervention 
were examined.
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Materials and methods
Study design and population
We performed a prospective before-and-after education study among internal 
medicine residents who visited the regional professional training for internal 
medicine (RODIN) about sepsis. RODIN is part of the training program for internal 
medicine residents17 and is organised five times a year at the Radboud University 
Nijmegen Medical Centre (RUNMC). RODIN is attended by residents from the 
RUNMC or one of the six affiliated regional community hospitals. 
During a brief educational intervention based on the SSC guidelines, an internist-
intensivist (PP) gave a lecture about the SSC, diagnosis, and the management of 
sepsis.
Development of the questionnaire
The questionnaire was based on the two topics of the SSC-based teaching 
intervention and included ten multiple choice questions: five questions covering 
assessment of the symptoms of sepsis (topic 1) and five questions about diagnosis 
and treatment of sepsis (topic 2). In the questionnaire, respondents were 
presented with short case descriptions. Examples of two questions are shown in 
Table 1 (the complete questionnaire is available on request).
Data collection and variables 
All data were collected in three periods: immediately before, 3 hours after 
the education session about sepsis, and 4-6 months following the teaching 
intervention. Before and directly after the lecture, the residents were asked to fill 
out the first two questionnaires. All respondents were approached by mail and 
asked to fill out the third questionnaire. Non-responders received two reminders, 
including the questionnaire, by e-mail. Relevant respondent characteristics 
included gender and year of training. 
Statistical analysis
Descriptive statistics included frequencies, percentages, means, and standard 
deviations. All questions were given an equal weight of one point per question. The 
overall questionnaire score was expressed on a 0-10 scale. Potential differences 
in the total questionnaire scores between the three tests were analysed using a 
random-effects model with random-factor respondent and fixed-factor test. 
In a secondary analysis, gender and year of experience were added as 
covariates to investigate whether gender and experience had an impact on the 
scores. Finally, we investigated whether these factors influenced the learning, by 
adding the interaction terms with the test to the model.
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Table 1. Questionnaire with five questions covering assessment of the symptoms 
of sepsis (topic 1) and five questions about diagnosis and treatment of sepsis 
(topic 2); examples of two questions
Results
A total of 253 questionnaires were collected. Seven of these questionnaires 
were excluded: four questionnaires could not be linked to follow-up tests and 
three residents only filled out the questionnaire before or immediately after the 
education.  We used 246 questionnaires for further analysis.
Respondents
A total of 109 internal medicine residents participated, 91 of whom (84%) 
completed the questionnaire before and immediately after the education. Of 
these participants 39% were male and 45% had >2 years training experience. The 
set of all three questionnaires was completed by 64 participants (70%), 33% were 
male and 42% had a training experience of >2 years. 
Questionnaire data
Figure 1 illustrates the mean overall questionnaire scores and the mean scores 
per topic for all participants in the study. At test I and test II the mean overall 
questionnaire scores are comparable with the mean scores of the 64 respondents 
who filled out all three questionnaires: 6.1±1.5 for test I and 8.3±1.1 for test II. 
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In the subgroup of residents who filled out all three questionnaires, the baseline 
score of 6.1±1.6 increased to 8.2±1.2 after the lecture (p<.0001). Moreover, 4-6 
months after the teaching intervention this improvement was sustained (p<.0001 
compared with test I), resulting in a mean score of 7.6±1.1.
At baseline, questions concerning ‘diagnosis and treatment’ scored significantly 
better than ‘assessment of symptoms’ (Figure 1). As a result, only the score of 
‘assessment of symptoms’ improved significantly (p<.0001).
There were no significant differences between male and female residents 
in baseline score (data not shown). The mean scores for the years of training 
experience are summarized in Figure 2. After adding gender and experience 
as covariates to the analysis, we found that there was no significant difference 
between scores or increase in score per gender or year of training (all p>0.05).
Figure 1. Overall score per test and topic
* Significant improvement between mean score for test I (6.1±1.6) versus mean score for 
test II (8.2±1.2), and test I versus test III (7.6±1.1), respectively (both p<0.0001)
† Significant difference between mean score for assessment of symptoms (4.4±1.8) and 
diagnosis and treatment (8.0±1.9) at baseline (p<.0001)
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Figure 2. Scores per years of training experience
Discussion
Identification of patients with sepsis is essential for early diagnosis and 
treatment. In managing sepsis, delays can be life-threatening.3-5 Lack of adherence 
to recommended SSC guidelines is in part caused by lack of knowledge of these 
guidelines. Through the education of residents about the SSC guidelines, both 
diagnosis and treatment of sepsis may improve.18 
We demonstrated that following an educational intervention about sepsis, 
residents’ knowledge about assessment of symptoms of sepsis improved 
significantly. One of the main findings of this study is that apart from the short-
term effects, the improved test results were sustained after 4-6 months. In the 
first (baseline) questionnaire, the issues relating to the symptoms of sepsis scored 
significantly lower than those related to the diagnosis and treatment. This might 
be related to the fact that the SIRS criteria described by Bone19 demonstrate a 
high sensitivity, but low specificity for sepsis and may not equal the residents’ 
clinical perception of a septic patient. Interestingly, a previous study showed 
that a majority of physicians believe that other physicians within their specialty 
define sepsis differently from themselves: not more than 17% agreed on any one 
definition.20 This may explain why we found no association between years of 
experience and knowledge level at baseline or increase following an educational 
session. Importantly, only the Bone criteria are acknowledged and it remains 
important that everyone uses these sepsis definitions correctly. In addition, this 
finding emphasises our view that the effectiveness of educational activities and 
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progression of knowledge during the training of residents should be monitored 
more frequently and more closely.
The issues concerning the treatment of sepsis scored significantly higher at 
baseline, resulting in the fact that a further increase did not reach statistical 
significance.
Only a few previous studies have described physicians’ and nurses’ knowledge 
about sepsis.14-16;20 In accordance with our study, these studies showed an 
inadequate level of knowledge of the signs and symptoms of sepsis. It was 
demonstrated in one study that knowledge levels increased over time, when a 
group of residents in 1999 were compared with a different group of residents in 
2003.16 However, it is unclear whether or not this effect is linked to an unidentified 
more active teaching program as mentioned by the authors, or by other unknown 
time-dependent factors.
A possible limitation of our study is the fact that we used a questionnaire that, 
although based on the SSC guidelines, was not formally validated. In addition, 
repeated use of the same questionnaire may have positively influenced the 
overall questionnaire score. However, this does not seem likely on account of the 
decreased overall score 4-6 months after the teaching intervention. Interestingly, 
compliance to the SSC guidelines in the emergency department significantly 
improved from 3.0 to 4.2 on a 0-6 scale (number of recommendations that were 
correctly performed). However, several other implementation strategies were 
conducted at the same time, and these results cannot be associated with the 
education of the residents alone.
Conclusion
Our teaching intervention resulted in a sustained improved knowledge on 
symptoms, diagnosis, and treatment of sepsis. Short- and long-term quantitative 
determinations concerning the efficiency of educational activities should be 
performed more often.
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Abstract
Background: In 2004, the surviving sepsis campaign (SSC), a global initiative 
to reduce mortality from sepsis, was launched. Although the SSC supplies tools 
to measure and improve the quality of care for patients with sepsis, effective 
implementation remains troublesome and no recommendations concerning the 
role of nurses are given. 
Objectives: To determine the effects of a multifaceted implementation program 
including the introduction of a nurse-driven, care bundle based, sepsis protocol 
followed by training and performance feedback.
Design and setting: A prospective before-and-after intervention study conducted 
in the emergency department (ED) of a university hospital in the Netherlands.
Participants: Adult patients (≥16 years old) visiting the ED because of a known 
or suspected infection to whom ≥2 of the extended systemic inflammatory 
response syndrome (SIRS) criteria apply.
Methods: We measured compliance with six bundled SSC recommendations 
for early recognition and treatment of patients with sepsis: measure serum lactate 
within 6 hours, obtain two blood cultures before starting antibiotics, take a chest 
radiograph, take urine for urinalysis and culture, start antibiotics within 3 hours, 
and hospitalize or discharge the patient within 3 hours.
Results: A total of 825 patients were included in the study. Compliance with 
the complete bundle significantly improved from 3.5% at baseline to 12.4% after 
our entire implementation program was put in place. The completion of four of 
six individual elements improved significantly, namely: measure serum lactate 
(improved from 23% to 80%), take a chest radiograph (from 67% to 83%), take 
urine for urinalysis and culture (from 49% to 67%), and start antibiotics within 
3 hours (from 38% to 56%). The mean number of performed bundle elements 
improved significantly from 3.0 elements at baseline to 4.2 elements after 
intervention [1.2; 95% confidence interval: 0.9-1.5].
Conclusions: Early recognition of sepsis in patients presenting to the ED 
and compliance with SSC recommendations significantly improved after the 
introduction of a predominantly nurse-driven, care bundle based, sepsis protocol 
followed by training and performance feedback.
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Introduction
Approximately 2% of all hospitalized patients are diagnosed with severe sepsis 
or septic shock. Intensive care and the long recovery period for patients with sepsis 
come with considerable costs, and the mortality rate remains high: 30%-40% for 
patients with severe sepsis and 40%-50% for those with septic shock.1-3 Rapid 
diagnosis and management of sepsis are crucial for successful treatment4; early 
goal-directed therapy and antibiotic treatment within 3 hours after admission 
have proven their value.5;6
In 2004, the surviving sepsis campaign (SSC) was launched by the European 
Society of Intensive Care Medicine, the International Sepsis Forum, and the Society 
of Critical Care Medicine. The SSC is a global initiative to create an international 
effort to improve the treatment of sepsis and reduce sepsis mortality. The SSC 
provides helpful tools and implementation techniques for improving rapid 
diagnosis and management of sepsis and for measuring and improving the quality 
of care for patients with sepsis. The most important SSC recommendations 
are summarized in ‘6-hours’ and ‘24-hours’ bundles, also referred to as the 
resuscitation and management bundles.2 
A bundle is a group of three to six care elements related to a disease process. 
When executed together, the performance of the care elements produce better 
outcomes then when implemented individually. The individual bundle elements 
are built on evidence based practice guidelines and provide health care workers 
with a practical method for implementing evidence-based practice.7-9 According 
to the institute for health care improvement (IHI), the creator of the bundle, a 
bundle should be small and straightforward. The impact of a bundle depends 
both on the evidence that supports the recommended care process and on the 
implementation and spread of its recommendations.10 Various care bundles have 
been created, including the ventilator care bundle, the central line bundle, and 
the sepsis bundle. 
Although the SSC recommendations, described in the sepsis bundle, focus on 
those patients with severe sepsis or septic shock, all patients with sepsis need to be 
screened so that we can recognize those most affected. Since most patients with 
sepsis present themselves at the emergency department (ED), this department is 
an important location for early recognition and treatment of sepsis.11-13 However, 
implementation of the SSC recommendations at the ED appears to be difficult; 
the overall level of compliance to the bundle and the compliance to the individual 
elements remains low.14-16 
The literature provides a large number of different strategies to implement 
innovations like the SSC recommendations, e.g., educational meetings, reminders, 
and audit and feedback. Many studies have assessed the effectiveness of these 
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strategies for improving patient care and many reviews have summarized them; 
for example the numerous reviews listed by the Cochrane Effective Practice and 
Organisation of Care group (http://www.mrw.interscience.wiley.com/cochrane/
cochrane_clsysrev_crglist_fs.html). In general, evidence shows that none of these 
strategies is superior; most show mixed results. Substantial evidence suggests 
that successful implementation strategies should be based on obstacles and 
facilitators to change.17-19
Various obstacles and facilitators may influence successful implementation of 
the SSC recommendations. Nurses are often the first to triage a patient, and they 
have an important role in recognizing patients’ signs and symptoms. Nevertheless, 
the role of nurses is not formalized in guidelines and is not fully exploited at 
this time.20;21 In daily practice, a multidisciplinary protocol for patients with 
sepsis proved to facilitate the recognition and treatment of sepsis.22-24 However, 
recognizing patients with sepsis can be difficult; lack of detailed knowledge was 
shown to impair the recognition.25;26 For example, only about 20% of the nurses 
thought that a temperature <36°C or a low white blood cell count could be a sign 
of sepsis.26
Using this information on obstacles and facilitators, we developed an 
implementation program to implement the SSC recommendations in our ED. As 
nurses are important in the triage of patients presenting to the ED, we specifically 
focused on nurses and their role in the recognition and treatment of patients with 
sepsis. To improve nurses’ ability to recognize sepsis and SSC-recommended care, 
we introduced a care bundle based sepsis protocol and trained ED nurses about 
the signs and symptoms of sepsis. During the development of the implementation 
program, it turned out that insight into the performance of the sepsis bundle and 
the individual elements by the ED nurses was lacking. Therefore, feedback about 
their performance was part of the implementation program. 
The aim of the current study was to determine the effects of our implementation 
program for following SSC-based recommendations.
Methods
We conducted a prospective before-and-after intervention study in which we 
carried out two consecutive interventions: the use of a newly developed, nurse-
driven, care bundle based, sepsis protocol (intervention 1) and training about 
sepsis that included feedback about performance before and after the sepsis 
protocol was introduced (intervention 2).
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The study consisted of three dense measurement periods: 
Period 1: Before using the new care bundle based sepsis protocol (July 1, 
2006 - November 6, 2006);
Period 2: After the sepsis protocol was put to use (November 6, 2006 - 
June 25, 2007) and before training and performance feedback;
Period 3: After training and performance feedback (June 25, 2007 - 
October 1, 2007).
In most implementation programs, it is not possible to disentangle the 
separate effects of the various implementation activities.19 The two consecutive 
interventions were followed by measurement periods, so that we could measure 
the effects of introducing a protocol and the additional effects of training and 
performance feedback.
Study setting and population
Every year, approximately 20,000 patients visit the ED of a 953-bed university 
hospital in the Netherlands, where 35 registered nurses are employed. The study 
inclusion criteria were: adult patients (≥16 years old) visiting the ED because of 
the presence of a known or suspected infection, to whom at least two of the 
following diagnostic criteria for systemic inflammation apply: temperature 
>38.3°C, temperature <36°C, heart rate >90/min, respiratory rate >20/min, chills, 
altered mental status, systolic blood pressure <90 mmHg, mean arterial pressure 
<65 mmHg, and hyperglycemia in the absence of diabetes mellitus.5;27 Patient 
data were collected from July 1, 2006 until October 1, 2007.
Implementation program
The ED manager and three ED nurses (our ‘contact nurses’) were involved in 
the process of developing the implementation program.
Development of a care bundle based sepsis protocol
A sepsis protocol (hereafter referred to as ‘protocol’) for nurses and physicians 
in the ED was developed by a multidisciplinary team including an intensivist, ED 
internist, a surgeon, a medical microbiologist, a clinical pharmacist, ED nurses, 
and a nurse practitioner. Everybody involved was familiar with the hospital 
organization, organization of the ED, and the physicians and nurses working in the 
ED.28;29 They developed a protocol, based on the SSC care bundle mechanism.30-32 
For the selection of the required bundle elements, two different levels of 
evidence were used: evidence-based practices described in the present sepsis 
guidelines33-35, and expert opinion. 
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The content of the protocol was discussed with the ED manager and the three 
contact nurses. The nurses suggested including the hospitalization or discharge 
of the patient from the ED within 3 hours as an additional bundle element. The 
final protocol consisted of two parts: a sepsis screening list for nurses and a sepsis 
performance list, including seven bundle elements. 
Sepsis screening list. The screening list was developed to help the nurses 
identify patients with sepsis. The nurses had to note any focus suspected of 
being infectious and the two or more systemic inflammatory response syndrome 
(SIRS) criteria on the screening list. Then the physician had to be informed of the 
identification of a patient with sepsis. 
Sepsis performance list. To guide the nurses and physicians in the ED, we 
developed a list with seven relevant bundle elements. They were: 
1. Measure the serum lactate concentration within 6 hours; 
2. Obtain two blood cultures before starting antibiotics;
3. Make a chest radiograph; 
4. Take a urine sample for urinalysis and culture;
5. Start antibiotics within 3 hours;
6. Volume resuscitation in case of serum lactate >4.0 mmol/L or hypotension;
7. Hospitalize or discharge the patient within 3 hours. 
The nurses and physicians were expected to take elements 1-5 and 7 for all 
patients included in the protocol. Element 6 (volume resuscitation) was only 
necessary in case the included patient had a serum lactate >4.0 mmol/L or 
hypotension. 
It was agreed that, after identifying a patient with sepsis, the responsible nurse 
should start immediately with obtaining blood for chemistry tests and culture, 
and urine for urinalysis and culture. Furthermore, prior to the implementation 
of the protocol, we agreed with our radiologists that, in patients included in 
the protocol, a chest radiograph would be performed without a physician’s 
prescription. Finally, the nurses played an important role in timely obtaining the 
physician’s prescription for antibiotic treatment.
To collect all data and for the general necessity of accurate registration of the 
performed elements, the nurses had to sign off the performed elements and note 
the time they were done on the performance list.
After it was fully developed and accepted by all those involved in sepsis care, 
the protocol was placed on the University Medical Centre (UMC) Intranet website, 
available to all UMC employees, to facilitate access to it.
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Initiation of the sepsis protocol (intervention 1)
The new protocol was formally introduced during the change of duty in the ED 
on November 6, 2006. From that moment on, the protocol was available to the 
ED. In addition to the formal introduction, all the ED nurses received an e-mail 
message with instructions about how to use the screening and performance lists. 
They were emphatically asked to use the lists each time a patient met the inclusion 
criteria. If there were any questions, the nurse practitioner in the implementation 
team could be reached during office hours or by e-mail.
As part of this implementation strategy, the contact nurses were repeatedly 
requested to motivate and assist the other ED nurses in using the protocol. In 
the meantime, data collection was started. One of the contact nurses (LP) was 
frequently consulted about implementation issues, such as incomplete filled 
out screening and performance lists. The ED nurses’ questions were answered 
personally or by e-mail. 
Training and performance feedback (intervention 2)
Six months after initiation of the protocol, training began. Training about 
sepsis, and the presentation of feedback on performance data of periods 1 and 2, 
took place during a department meeting for all ED nurses on June 25, 2007. The 
training focused on sepsis, severe sepsis, septic shock, and the clinical importance 
of early recognition and treatment. Although they could not provide data to 
support this, the nurses presumed that their compliance to the bundle was already 
optimal at baseline. Therefore, the training also included performance feedback. 
Feedback about the group performance of the bundle elements in the first two 
periods was presented, as were changes in the performance of each element 
from the first to the second period. Feedback focused on the elements which 
the nurses and physicians were generally completing adequately and those that 
needed more attention. The aim of the presentation was to give the nurses a clear 
overview of their own practice and to encourage them to improve the diagnosis 
and management of sepsis. Further, the nurses’ experience with applying the 
protocol in daily practice was evaluated by means of short interviews. Finally, to 
reach the whole group of nurses in the ED, all of them received the presentation 
by e-mail, and a poster was presented in the ED. Besides the group training and 
performance feedback intervention, the contact nurses and nurse practitioner 
gave regular feedback to the individual ED nurses on their use of the protocol.
To improve the physicians’ knowledge about sepsis and the use of the protocol 
in the ED, the intensivist instructed every new group of ED residents every 2 
months. This training started at the end of February 2007. A training program and 
a conference for medical residents were organized.36 
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Data collection and processing
Data collection included patient data and performance data. The data collection 
team consisted of a nurse practitioner, an undergraduate, and an internist. 
Patient data
The relevant patient characteristics included gender, age, suspected focus 
of infection, and final documented diagnosis at the time of discharge from 
hospital. Information about the clinical end points included the length of the 
hospital stay and the in-hospital mortality rate. The baseline data were collected 
by retrospectively checking the diagnoses on the ED admission list for patients 
with sepsis. The required data (including the two or more diagnostic criteria for 
systemic inflammation) were collected from the clinical patient databases, medical 
records, and nursing records. The final documented diagnoses were obtained 
from medical discharge records. After use of the protocol was started, the data 
were prospectively collected from the screening and performance lists. Missing 
data were collected from the clinical patient databases, medical records, and 
nursing records. If, during the study period, a patient with sepsis was registered at 
the ED more than once, he/she was included in the study each time.
Although most of the patients with sepsis were triaged and included in the 
protocol by the nurses, some patients were erroneously not included in the 
protocol by them: the nurse did not recognize a patient with sepsis or forgot 
to fill out the screening and performance list. To compare the differences in 
the performance of the bundle elements between those patients included in 
the protocol by the nurses and those who were not, the patients who were not 
included in the protocol were still included in the study. To recover patients who 
were undeservedly not included in the protocol, we retrospectively checked the 
diagnoses against the ED admission list for patients with sepsis.
Performance data
The goal of the protocol was to improve and evaluate the care of the total 
group of patients with sepsis, and not only those with severe sepsis or septic 
shock. Since high serum lactate concentrations and/or hypotension only occurs 
in a small proportion of the patients with sepsis who present themselves at the 
ED, early goal-directed therapy was included as a bundle element in the protocol 
(element 6) but not included as a measure of protocol adherence for this study. 
Therefore, completion of six bundle elements and compliance with them were 
measured. Baseline performance data were collected from clinical patient 
databases, medical records, and nursing records. After use of the protocol was 
started, all data were collected from the performance lists. Missing data were 
collected from the clinical patient databases, medical records, and nursing records.
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Data analysis
The primary outcome measure was compliance with the bundle of six 
elements and the completion of the individual elements. The theory behind care 
bundles is that when several evidence-based interventions are grouped together 
in a single protocol, it will improve patient outcome. Although the study was not 
powered to demonstrate a statistically significant effect on the clinical end points, 
we included the length of the hospital stay and the in-hospital mortality rate as 
secondary outcome measures.
Descriptive statistics regarding the performance of the bundle of six elements, 
the performance of the individual elements, length of hospital stay, and mortality 
rate included frequencies, percentages, medians, and means. The compliance was 
expressed as a percentage, and the compliance to the bundle was also expressed 
as the total number of elements that were correctly performed (on a 0-6 scale). 
To analyze the differences in compliance between the measurements, both 
overall and for each of the six separate elements, we used a generalized linear 
model with a logarithmic link and Bernoulli distribution function. In our secondary, 
subgroup analysis, we added the impact of the nurses’ triage in periods 2 and 3 
as a cofactor.
In a similar way, analysis of variance was used to compare the mean of the total 
number of times that the elements were correctly taken between baseline and 
the two post-intervention measurements. Each of many nurses treated several 
patients, which had to be accounted for in the statistical analysis. Therefore, we 
estimated the intraclass correlation coefficient, based on a mixed model analysis 
of the cases in which the nurse was known, and we used this coefficient to adjust 
the results of the analysis of variance of all data.
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Results
Patient population
The study included 825 patients presenting with sepsis at the ED (Figure 
1). There were no statistically significant differences in patient characteristics 
per period (Table 1). Eighty-nine percent of the participants were admitted to 
a nursing ward or intensive care unit. The ED nurses registered pneumonia and 
urogenital infection as the most commonly suspected infections. In 680 of the 825 
cases (82%), the final diagnosis was a bacterial infection, most commonly in the 
lungs (33%), followed by urinary tract and/or genitalia infections (21%).
Figure 1. Overall number of patients presenting to the ED during the study and 
patients with sepsis included per study period
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Table 1. Characteristics of the patients (n=825)
Effects on performance of the bundle and the bundle elements
In 731 of 825 cases, information about all six elements was available. In 3.5% of 
the cases in period 1, all six elements were performed and improved significantly 
to 10.8% after period 2, and 12.4% after period 3 (Table 2).
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Table 2. The performance of the complete sepsis bundle and the six individual 
bundle elements at baseline (period 1), after introduction of the sepsis protocol 
(period 2), and after training and performance feedback (period 3) (n=731)
When analyzing the completion of the individual elements, there was a 
significant improvement in completing three of six elements after period 2 (Table 
2), and there was a significant improvement in completing four of the six elements 
after period 3: measure serum lactate (improved from 23% to 80%), take a chest 
radiograph (from 67% to 83%), take urine for urinalysis and culture (from 49% to 
67%), and start antibiotics within 3 hours (from 38% to 56%).
The mean number of performed bundle elements improved significantly in 
period 2 versus period 1 (from 3.0 to 3.9, 95% CI: 0.7-1.2) and further increased 
after period 3 (from 3.9 to 4.2, 95% CI: 0.03-0.5), as Figure 2 shows.
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Figure 2. Nurses’ compliance (%) in the performance of the protocol elements
(0-6 elements correctly performed), every 3 months
The outcome of the analysis of variance of all cases (n=825), is comparable to 
the outcomes of cases with complete data. Furthermore, no differences between 
the analysis of variance of all data and the analysis of only the cases for which the 
nurse was known were found. 
Recognition of patients with sepsis 
We examined whether patients were erroneously not included in the protocol 
by the nurses, and it turned out that in period 2, 71% of the cases were included 
in the protocol by the ED nurses and this percentage further improved to the 
inclusion of 82% patients with sepsis in period 3 (p=0.005). 
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Table 3. Differences between cases included by the ED nurses and cases initially 
not included by ED nurses, at the level of the performance of the complete sepsis 
bundle and the six individual bundle elements (n=589)
In the patients with sepsis that were erroneously not included in the protocol by 
the nurses, we also examined whether the compliance with the bundle elements 
was different. For 589 of the 666 cases included in periods 2 and 3, information 
about the completion of all six elements was available (88%). The subgroup 
analysis of the impact of the nurses’ inclusion showed that the completion of the 
six elements in the cases that were included by the nurses was significantly better 
(1.2 elements more; 95% CI: 1.0-1.4) than the completion of the six elements in 
the cases that were afterwards included by the study team (Table 3).
Effects on the hospital mortality rate and length of hospital stay
The in-hospital mortality rate decreased from 6.3% in period 1 to 5.5% in 
period 3, which was not significant. The median [interquartile range] length of 
hospital stay did not change (6 [2-12] to 6 [3-11] days). 
Discussion
Our study demonstrates that using a nurse-driven, care bundle based, sepsis 
protocol followed by training and performance feedback results in improved early 
recognition and treatment of patients with sepsis who present to the ED. The 
implementation program resulted in significant improvement of the compliance 
with the bundle (from 3.5% to 12.4%) and significant changes in four of the six 
individual elements. The process of obtaining two blood cultures before starting 
antibiotics did not improve significantly, probably because of the already good 
compliance at baseline. Further, the median time of hospitalization or discharge 
of the patient did not improve significantly.
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We can improve the quality of care for patients with sepsis by using a relatively 
simple and inexpensive implementation program. Although care bundles can be 
a powerful stimulus to focusing the multidisciplinary team on working together 
to deliver reliable care, the development of a bundle is only one component in 
an overall improvement strategy.10 To further improve the recognition of patients 
with sepsis and the performance of SSC-based recommendations in our ED, 
additional improvement activities are required.
Interestingly, subgroup analysis showed that compliance with the six bundle 
elements was significantly better in the cases that the nurses included than in the 
cases that they did not. This shows that recognizing sepsis with the use of the 
sepsis screening list alone resulted in better compliance with completion of the 
six elements. Without the list, some patients with sepsis were initially missed in 
the nurses’ triage, but the attending physicians ultimately identified and treated 
them.
As nurses are often the first to see and triage a patient, in our view their 
position in the current organization structure should be exploited to a greater 
extent. Therefore, the role of the nurses in the development and implementation 
of the protocol was emphasized in our study. By giving the nurses a greater 
responsibility in the recognition and treatment of patients with sepsis, the care 
for these patients obtained a more multidisciplinary character and our study 
demonstrates that this was associated with an improvement of the quality of care. 
In our study, the six bundle elements focused on all patients with sepsis. Most 
studies about implementation of the SSC bundles specifically focus on patients 
with severe sepsis and septic shock.37-39 In our patient group, 3.6% had septic 
shock. We deliberately included all patients with sepsis because the bundle 
should be performed in all patients so that we can identify the most affected ones. 
In addition, the first step to reduce the mortality due to severe sepsis or septic 
shock is to prevent the progression of sepsis to severe sepsis and septic shock.40 
The early recognition and treatment of patients with sepsis will help achieve this 
prevention. Our study was not powered to identify a positive effect on patient 
outcome. However, hospital mortality was low in our patient group and tended to 
decrease during our study.
Previous studies describe the effects of implementation activities to improve 
sepsis diagnosis and treatment in the ED. Our results confirm those of a smaller 
study evaluating the effectiveness of a standardized, SSC-based, set of elements 
for managing sepsis in the ED of a university medical centre.41 In this study, 
60 patients with septic shock were included before implementation of the 
standardized set of elements and 60 patients afterwards, and ten process-of-
care variables were evaluated. As in our study, formal clinical training was part 
of the implementation activities. Similarly to our study, several improvements 
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were reached, e.g., measurement of serum lactate improved from 17% to 78%. 
Contrary to Micek et al.’s study41, our study focused on all patients with sepsis, not 
only on those with septic shock. 
Our study is limited in being an uncontrolled study in only a single centre. 
Our implementation program was tailor-made to the situation of our hospital, so 
the results cannot be extrapolated. Theoretically it is possible that, in the course 
of time and based on the last evidence, diagnostic and therapeutic procedures 
change. Therefore, the possibility of a time effect, independently of our performed 
implementation strategies, cannot be excluded. However, no changes in hospital 
practice during the study that may have led to confounding were present, as local 
and national protocols and guidelines on the treatment of pneumonia, urinary 
tract infections, and sepsis remained unchanged during the study period. 
The sepsis screening and performance list itself may have limitations. The 
clinical signs included in the sepsis screening list are very sensitive, but not very 
specific34;42;43, which may have led to overdiagnosis and overtreatment. Of course 
this results in unnecessary treatment costs. However, unnecessary costs for a 
chest radiograph or a urine examination is probably outweighed by the high costs 
of treatment of patients with severe sepsis or septic shock or the consequences 
of missing a diagnosis of severe sepsis or septic shock. The fact that 82% of the 
patients were ultimately diagnosed with an infection indicates that not many 
patients who were false-positively found to have sepsis were unnecessarily 
treated with antibiotics. As only the physicians can prescribe antibiotic therapy, 
it remains the responsibility of the treating physician to decide whether to treat 
a patient with antibiotics, but better compliance with the bundle led to a more 
complete and appropriate work-up.
Conclusions
 
Our data suggest that the use of a predominantly nurse-driven, care bundle 
based, sepsis protocol combined with training and performance feedback can 
significantly improve the recognition of patients with sepsis at the ED and the 
taking of elements based on SSC recommendations for these patients. More 
attention should be given to the role of nurses in quality improvement of sepsis 
care. Our pilot study turned out to be both effective and feasible in a university 
hospital. Future research should aim at testing this promising implementation 
strategy in a multicenter controlled trial.
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Abstract
Purpose: Mortality in patients admitted with sepsis is high and the increasing 
incidence of infections with multiresistant bacteria is a worldwide problem. Many 
hospitals have local antimicrobial guidelines to assure effective treatment and 
limit the use of broad-spectrum antibiotics, thereby reducing the selection of 
resistant bacteria. 
We evaluated adherence to the antimicrobial treatment guidelines of our hospital 
in patients presenting to the emergency department (ED) with sepsis and assessed 
the in vitro susceptibility of isolated pathogens to the guideline-recommended 
treatment and the prescribed treatment. 
Methods: We included all adult patients with a known or suspected infection 
and ≥2 extended systematic inflammatory response syndrome (SIRS) criteria. 
Patients who did not receive antimicrobial treatment, presented with infections 
not included in the guidelines, or had >1 possible focus of infection were excluded. 
Results: A total of 276 ED visits (262 patients) were included. Guideline-
concordant treatment was prescribed in 168 visits (61%). In case of guideline-
disconcordant treatment, 87% was more broad-spectrum than guideline-
recommended treatment. A microbiological diagnosis was established in 96 visits 
(35%). The susceptibility of the pathogens isolated from patients treated with 
guideline-concordant treatment (n=68) and guideline-disconcordant treatment 
(n=28) to guideline-recommended treatment (91% versus 89%) and to prescribed 
treatment (91% versus 93%) was similar (p=0.77 and p=0.79, respectively). 
Conclusions: Non-adherence to the guidelines occurred frequently and resulted 
in more broad-spectrum empirical therapy. This did not result in a higher rate of 
susceptibility of the isolated pathogens to the prescribed empirical therapy.
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Introduction
The mortality rate in patients admitted to the emergency department (ED) 
with severe sepsis and septic shock is high.1;2 Early initiation of appropriate 
empirical antimicrobial therapy has been shown to improve survival in patients 
with sepsis and septic shock.3-7 The choice of the empirical antimicrobial therapy 
in sepsis mainly depends on the suspected site of infection and the antimicrobial 
susceptibility of the expected pathogens. To include more resistant but often less 
prevalent pathogens, the empirical therapy of a severe infection is usually broad-
spectrum.4;8
Antimicrobial treatment guidelines have been developed to assure effective 
treatment, decrease treatment diversity, prevent treatment delay, and reduce 
the unnecessary use of broad-spectrum antimicrobials, thereby reducing the 
selective pressure on antimicrobial resistance. Due to geographical differences 
in pathogens and antimicrobial susceptibility, many countries and hospitals have 
their own antimicrobial treatment guidelines based on local epidemiological 
data, existing literature, and expert opinion. Although many hospitals have 
implemented local antimicrobial treatment guidelines, there is a wide variation in 
the reported adherence to these guidelines.5;8-10
The local antimicrobial treatment guidelines in our hospital have been 
developed, adjusted, and evaluated over the years. The goal of our present study is 
to evaluate the adherence to these guidelines in patients admitted with sepsis and 
the in vitro susceptibility of the isolated pathogens to the treatment recommended 
in the guidelines. When the prescribed antimicrobial therapy deviated from the 
therapy advised in the guidelines, we compared the susceptibility of the isolated 
pathogens to the prescribed treatment and the treatment recommended in the 
guidelines. 
Methods
Study setting 
This is a retrospective cohort study of patients admitted with sepsis to the ED 
of the Radboud University Nijmegen Medical Centre, a 950-bed university hospital 
in the Netherlands. Every year, approximately 20,000 patients visit this ED, which 
is staffed by residents from the departments of internal medicine (including 
cardiology, pulmonology, hematology, general internal medicine, geriatrics, 
oncology, nephrology, gastroenterology and rheumatology), neurology, and 
surgery (including orthopedics, urology, and general surgery). Patients admitted 
to the ED are often referred by their general practitioner to a specific medical 
specialty, e.g., patients diagnosed with a pneumonia are not exclusively referred 
to pulmonology but also to other specialties of internal medicine. 
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All patients (≥16 years old) admitted to the ED between November 6, 2006 
and May 9, 2007 with a known or suspected infection and at least two extended 
systemic inflammatory response syndrome (SIRS) criteria (temperature ≥38.3°C 
or <36°C, heart rate >90 bpm, respiratory rate >20/min, chills, altered mental 
status, systolic blood pressure <90 mmHg, mean arterial pressure <65 mmHg, and 
hyperglycemia in the absence of diabetes mellitus) were eligible for the study.11 
Patients were excluded if they were diagnosed with an infection not included in 
the local antimicrobial treatment guidelines, if they did not receive antimicrobial 
therapy, or if the physician considered >1 specific site of infection (the guidelines 
do not provide an antimicrobial policy for these situations).
 
Antimicrobial treatment guidelines
Over the years, the antibiotic committee of our hospital, including a 
pharmacist, a medical microbiologist, and several clinical specialists, have 
developed antimicrobial treatment guidelines for the most common types of 
infection. The first version of these guidelines was introduced  more than 10 years 
ago as a booklet and was distributed among all clinicians throughout the hospital. 
Since then, many guideline revisions have been made. The latest editions of the 
guidelines have been available as an easily accessible and easy-to-use electronic 
version on the hospital intranet, available on every computer in the hospital, and 
a PDA version can be downloaded. Table 1 represents a summary of the guideline 
recommendations during the study period.
Data collection
Patient demographics, clinical diagnosis with respect to site of infection, the 
prescribed antimicrobial therapy at the ED, the medical specialty of the prescribing 
physician, intensive care unit (ICU) admission within the first 24 hours, and length 
of stay were retrieved from the patient files. The all-cause 30-day mortality was 
assessed by chart review. When this follow-up was incomplete, the municipal 
administration and, when necessary, the general practitioner was consulted. 
When the physical examination, laboratory results, and imaging results failed 
to identify a site of infection, the diagnosis was defined as sepsis of unknown 
origin. As the choice of therapy is based on the clinical diagnosis as well as factors 
such as where the infection is contracted (community, hospital, nursing home), 
previous adverse reactions on antimicrobial therapy, prior antimicrobial use, and 
culture results, the complete medical charts were reviewed for motivations for 
therapy adjustments in case of guideline-disconcordant treatment.12
Information about culture collection and culture results was retrieved from 
the laboratory information system. The clinical significance of culture results 
was assessed taking into account the clinical information and the quality of the 
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specimen. Bacteria isolated from blood or other sterile body sites were always 
considered to be significant, except when the isolate is known as a common skin 
contaminant. In addition, the clinical significance was evaluated by a microbiologist 
based on culture results, clinical diagnosis, and response to antimicrobial therapy. 
Isolates from sputum were considered significant if the sputum sample had 
<10 squamous cells and >25 leukocytes per low-power field. In patients with a 
clinical diagnosis of urosepsis, bacteria in concentrations of >105/ml urine were 
considered to be significant in the presence of leukocyturia without significant 
epithelial cells. Clinical significance was evaluated from the patient file if bacterial 
counts were in the range 104-105/ml and in case of a monobacterial culture with 
bacteria >105/ml in the presence of leukocyturia and epithelial cells. In patients 
with a diagnosis of skin/wound infection, isolates of true pathogens such as 
beta-hemolytic streptococci or Staphylococcus aureus were considered to be 
significant, and the significance of Gram-negative bacteria was determined from 
investigation of the patient file. 
Table 1. Empirical antimicrobial treatment guideline recommendations for the 
most common infections
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Guideline adherence
The prescribed antimicrobial therapy was divided into ‘guideline-concordant 
treatment’ and ‘guideline-disconcordant treatment’. Guideline-concordant 
treatment was defined as antimicrobial therapy prescribed empirically in 
accordance with the clinical diagnosis at the ED and the antimicrobial treatment 
guideline. Complete medical charts were reviewed for motivations for therapy 
adjustments in case of guideline-disconcordant treatment. When physicians 
deviated from the guideline-recommended treatment with good motivation, 
such as the presence of a known allergy or previously cultured pathogens, the 
therapy was considered to be guideline-concordant. 
Antimicrobial susceptibility 
Based on the in vitro susceptibility results (using Clinical and Laboratory 
Standards Institute [CLSI] breakpoints) of the isolated pathogens, we evaluated 
the appropriateness of the guideline-recommended treatment as well as the 
prescribed therapy. Pathogens were considered resistant to antimicrobial therapy 
when at least one of the isolated microorganisms categorized as a relevant 
pathogen was tested resistant by routine in vitro susceptibility testing or was 
intrinsically resistant to the antimicrobial therapy.
Statistical analysis
We compared the patient demographics and characteristics in patients treated 
with guideline-concordant treatment and guideline-disconcordant treatment. 
Categorical variables were analyzed using the Pearson’s Chi-squared test and 
continuous variables were analyzed using Student’s t-test or the Mann-Whitney 
U-test, as applicable. A p-value <0.05 was considered to be statistically significant. 
All calculations were performed using SPSS software, version 16.0 for Windows 
(SPSS Inc., Chicago, IL, USA).
Results
Of a total of 400 ED visits with a known or suspected infection and ≥2 extended 
SIRS criteria, 276 visits (262 patients) were included in the study (Figure 1). The 
mean (± standard deviation [SD]) age was 59±19 years and 63% were male. 
Blood cultures were positive in 49 patients (18%; contaminated blood cultures 
not included) and 22 patients were admitted to the ICU within 24 hours after 
admission (8%). The length of stay, ICU admission within 24 hours, and 30-day 
all-cause mortality were similar in patients receiving guideline-concordant and 
guideline-disconcordant treatment (Table 2). One patient was lost to follow-up.
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Figure 1. Flow-chart of included emergency department visits
Table 2. Patient demographics and characteristics by adherence to guideline-
recommended treatment
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Antimicrobial treatment guideline adherence 
The overall adherence to the guideline-recommended treatment was 61% 
(Table 3; n=168). This includes 25 ED visits where the prescribed treatment was 
considered to be guideline-concordant due to a well-motivated deviation from 
the guideline-recommended therapy. Adherence was the highest in patients 
diagnosed with urosepsis and febrile neutropenia (95% and 94%, respectively) 
and the lowest in patients with pneumonia (43%). Among the patients with 
pneumonia, adherence was above 50% in patients with severe pneumonia, as 
defined by the CURB-65 score, patients residing in a nursing home, and patients 
with recent antibiotic use, whereas adherence in patients with a mild pneumonia 
was only 34%.13
Table 3. Adherence to guideline-recommended treatment categorized by clinical 
diagnosis (n=276)
In 94 of the 108 patients (87%) with guideline-disconcordant treatment, the 
antimicrobial therapy was more broad-spectrum than the guideline-recommended 
therapy, and 66 patients were treated with a beta-lactam/beta-lactamase inhibitor 
instead of a narrow-spectrum beta-lactam. Treatment diversity was the highest 
among patients diagnosed with a pneumonia: a total of 12 different antibiotic 
regimens were prescribed in these patients. 
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Antimicrobial susceptibility
Positive cultures were found in 133 patients. Thirty-seven cultures were 
interpreted as non-significant or contamination. These cultures consisted of 
Candida species, Aspergillus species, or gram negative bacteria interpreted as 
colonization or contamination from 15 urine and 18 sputum specimens, one 
wound swab with coagulase-negative staphylococci, two blood cultures with 
coagulase-negative staphylococci, and one Propionibacterium acnes in a biopsy of 
an intracerebral lesion, later confirmed to be a malignancy. Four cultures that led 
to a different definite diagnosis than the clinical diagnosis made at the ED were 
left out of further analysis: two urine cultures diagnostic for urinary tract infection 
and one Enterococcus faecalis bacteremia of unknown source from patients 
suspected of pneumonia, and a sputum culture from a patient suspected of 
meningitis. A final microbiological diagnosis was established in 96 patients (35%). 
Table 4 shows the pathogens and their susceptibility to guideline-recommended 
treatment according to clinical diagnosis. 
Of the 96 patients with a microbiological diagnosis, 68 received guideline-
concordant treatment. The susceptibility of the isolated pathogens to the 
guideline-recommended treatment was similar in patients with guideline-
concordant treatment and guideline-disconcordant treatment (62/68; 91% and 
25/28; 89% respectively, p=0.77). Furthermore, the susceptibility of the isolated 
pathogens to the prescribed therapy was similar in patients with guideline-
concordant treatment (62/68; 91%) and guideline-disconcordant treatment 
(26/28; 93%; p=0.79).
Nine of the 96 isolated pathogens (9%) were resistant to guideline-concordant 
treatment (Table 4). The percentage of pathogens resistant to guideline-
recommended treatment was higher when an ED visit was preceded by a 
hospitalization in the last 3 months (6/26; 23% versus 3/70; 4%; p=0.005). 
Discussion
During the study period, the overall adherence to our local antimicrobial 
treatment guidelines in patients admitted to the ED with sepsis was 61%. 
However, differences between subgroups were substantial, with high adherence 
rates in patients with urosepsis and febrile neutropenia, and low rates in patients 
with pneumonia, skin or soft tissue infection, or cholangitis. The empirical 
therapy in patients treated with guideline-disconcordant treatment was more 
broad-spectrum than guideline-recommended treatment in the vast majority of 
patients. However, this use of more broad-spectrum antimicrobial treatment did 
not result in a higher rate of in vitro susceptibility of the isolated pathogens to 
the prescribed treatment in the patients with guideline-disconcordant treatment 
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Table 4. Isolated pathogens per diagnosis (n=96) and the pathogens which were 
in vitro resistant to guideline-recommended treatment (n=9)
compared to the patients with guideline-concordant treatment. In addition, the 
isolated pathogens were equally susceptible to the guideline-recommended 
therapy in both treatment groups. These results indicate that non-compliance to 
the guideline does not result in a clinical benefit for patients admitted with sepsis.
A small but significant proportion (9%) of isolated pathogens were resistant 
to the guideline-recommended therapy. These pathogens were mostly cultured 
from recently hospitalized patients. This is in keeping with an earlier study that 
identified frequent contacts with the health care system, especially recent 
hospitalization, prior to admission as an important risk factor for ineffective 
empirical therapy in patients admitted with a bloodstream infection.14 
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A more broad-spectrum empirical therapy for this specific group of patients needs 
to be considered.
Although many hospitals have their own antimicrobial treatment guidelines, 
little is known about the adherence to these guidelines in patients with sepsis. 
A high adherence of 90% to local antimicrobial therapy guidelines in patients 
with a suspected or documented infection (pneumonia, cellulitis or erysipelas, 
urosepsis, febrile neutropenia, or meningitis) has been described.8 However, 
the investigated guidelines were developed by internal medicine specialists for 
their own use in patients admitted to the internal medicine wards or the ICU. 
In contrast, we investigated the adherence to local antimicrobial treatment 
guidelines developed for use in the entire hospital, in patients admitted to the ED 
and treated by many different physicians and disciplines. 
Our adherence data are in agreement with other studies that investigated 
compliance to treatment guidelines in patients admitted with a pneumonia and 
reported adherence rates of between 41% and 77%.3;5;9;10
The obvious downside of the unnecessary use of broad-spectrum therapy 
is the increase in the selective pressure on bacteria, thereby, promoting the 
emergence of resistant pathogens.15;16 Over the last few decades, a dramatic 
increase of bacterial resistance has emerged with the increasing use of broad-
spectrum antimicrobials, whereas, on the other hand, the development of new 
antimicrobial agents is declining.17 The use of antimicrobial treatment guidelines 
based on local epidemiology, followed by de-escalation of the empirical 
antimicrobial therapy based on culture and susceptibility results, is one of the 
most important strategies to reduce the use of broad-spectrum antimicrobial 
therapy and prevent and control the emergence of bacterial resistance. The 
adherence rate to our local antimicrobial treatment guidelines illustrates the need 
for ongoing communication about culture and susceptibility results in relation 
to the prescribed antimicrobial treatment and the antimicrobial treatment 
guidelines. Previous research has demonstrated that antimicrobial treatment 
guideline adherence can be improved by close collaboration with representatives 
of the involved departments and feedback on antimicrobial use in combination 
with educational training sessions for physicians.18 
Our study has several limitations. First, it was a retrospective cohort study, 
which implicates that reasons for prescribing guideline-disconcordant treatment 
were only taken into account when they were recorded in the patients’ medical 
charts. Furthermore, the study results reflect the epidemiology and guideline 
adherence of a single centre; several subgroups such as patients with cholangitis 
and meningitis were very small, and the miscellaneous infections were very diverse. 
However, the goal of our study was to provide an overview of the antimicrobial 
treatment guideline adherence and the appropriateness of prescribed treatment 
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among all patients admitted to the ED of our hospital with sepsis, and we do 
believe that our data provide insights into daily clinical practice. The reasons for 
non-adherence to antimicrobial treatment guidelines were beyond the scope 
of the current study, but factors identified in other studies will most likely be 
applicable in our setting.19 For example, fear for an unfavourable outcome with 
narrow-spectrum guideline-recommended treatment and a lack of agreement 
with guidelines have been identified as the main barriers to prescribing empirical 
antibiotic treatment according to the recommended guidelines in patients with 
community-acquired pneumonia.20
Non-adherence to guideline-recommended treatment predominantly resulted 
in more broad-spectrum empirical therapy. However, pathogens isolated in 
patients treated with guideline-disconcordant treatment were equally susceptible 
to guideline-recommended therapy and the actually prescribed treatment. 
To minimize treatment diversity and the inappropriate use of broad-spectrum 
antimicrobials, prescribers should be aware that a more broad-spectrum empirical 
treatment does not result in more effective treatment, but does increase the 
selection of antimicrobial resistance. A multidisciplinary effort should be made to 
improve compliance with local antimicrobial treatment guidelines.
140
Non-adherence to antimicrobial treatment guidelinesChapter 8
References
1. Kumar, A; Roberts, D; Wood, KE; et al. Duration of hypotension before initiation of effective 
antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care 
Med, 2006, 34, 1589-96.
2. Shapiro, N; Howell, MD; Bates, DW; Angus, DC; Ngo, L; Talmor, D. The association of sepsis 
syndrome and organ dysfunction with mortality in emergency department patients with 
suspected infection. Ann Emerg Med, 2006, 48, 583-90.
3. Bodi, M; Rodriguez, A; Sole-Violan, J; et al. Antibiotic prescription for community-acquired 
pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of 
America guidelines on survival. Clin Infect Dis, 2005, 41, 1709-16.
4. Dellinger, RP; Carlet, JM; Masur, H; et al. Surviving Sepsis Campaign guidelines for management 
of severe sepsis and septic shock. Crit Care Med, 2004, 32, 858-73.
5. Frei, CR; Attridge, RT; Mortensen, EM; et al. Guideline-concordant antibiotic use and survival 
among patients with community-acquired pneumonia admitted to the intensive care unit. Clin 
Ther, 2010, 32, 293-9.
6. Gaieski, DF; Mikkelsen, ME; Band, RA; et al. Impact of time to antibiotics on survival in patients 
with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the 
emergency department. Crit Care Med, 2010, 38, 1045-53.
7. Leibovici, L; Shraga, I; Drucker, M; Konigsberger, H; Samra, Z; Pitlik, SD. The benefit of 
appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern 
Med, 1998, 244, 379-86.
8. Galayduyk, N; Colodner, R; Chazan, B; Flatau, E; Lavi, I; Raz, R. Adherence to guidelines on 
empiric use of antibiotics in the emergency room. Infection, 2008,  36, 408-14.
9. McCabe, C; Kirchner, C; Zhang, H; Daley, J; Fisman, DN. Guideline-concordant therapy and 
reduced mortality and length of stay in adults with community-acquired pneumonia: playing 
by the rules. Arch Intern Med, 2009, 169, 1525-31.
10. Mortensen, EM; Restrepo, M; Anzueto, A; Pugh, J. Effects of guideline-concordant antimicrobial 
therapy on mortality among patients with community-acquired pneumonia. Am J Med, 2004, 
117, 726-31.
11. Levy, MM; Fink, MP; Marshall, JC; et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis 
Definitions Conference. Crit Care Med, 2003, 31, 1250-6.
12. Friedman, ND; Kaye, KS; Stout, JE; et al. Health care--associated bloodstream infections in 
adults: a reason to change the accepted definition of community-acquired infections. Ann 
Intern Med, 2002, 137, 791-7.
13. Lim, WS; van der Eerden, MM; Laing, R; et al. Defining community acquired pneumonia severity 
on presentation to hospital: an international derivation and validation study. Thorax, 2003, 58, 
377-82.
14. McDonald, JR; Friedman, ND; Stout, JE; Sexton, DJ; Kaye, KS. Risk factors for ineffective therapy 
in patients with bloodstream infection. Arch Intern Med, 2005, 165, 308-13.
15. Safdar, N; Maki, DG. The commonality of risk factors for nosocomial colonization and infection 
with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, 
Clostridium difficile, and Candida. Ann Intern Med, 2002, 136, 834-44.
16. Singh, N; Rogers, P; Atwood, CW; Wagener, MM; Yu, VL. Short-course empiric antibiotic therapy 
for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for 
indiscriminate antibiotic prescription. Am J Respir Crit Care Med, 2000, 162, 505-11.
17. Spellberg, B; Powers, JH; Brass, EP; Miller, LG; Edwards, JE, Jr. Trends in antimicrobial drug 
development: implications for the future. Clin Infect Dis, 2004, 38, 1279-86.
18. Mol, PG; Wieringa, JE; Nannanpanday, PV; et al. Improving compliance with hospital antibiotic 
guidelines: a time-series intervention analysis. J Antimicrob Chemother, 2005, 55, 550-7.
141
Non-adherence to antimicrobial treatment guidelines Chapter 8
19. Mol, PG; Rutten, WJ; Gans, RO; Degener, JE; Haaijer-Ruskamp, FM. Adherence barriers to 
antimicrobial treatment guidelines in teaching hospital, the Netherlands. Emerg Infect Dis, 
2004, 10, 522-5.
20. Schouten, JA; Hulscher, ME; Natsch, S; Kullberg, BJ; van der Meer, JW; Grol, RP. Barriers to 
optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study. 
Qual Saf Health Care, 2007, 16, 143-9.

Chapter 9
Summary and general discussion

145
Summary and general discussion Chapter 9
Summary and general discussion
Worldwide, as well as in the Netherlands, severe sepsis (acute organ dysfunction 
secondary to infection) and septic shock (severe sepsis plus hypotension not 
reversed with fluid resuscitation) are major health care problems. When sepsis 
proceeds into severe sepsis, it is often initially managed by a non-intensive care 
medical team, e.g., on a general hospital ward. The severity of this condition is 
illustrated by the fact that an important proportion of these patients ultimately 
need further treatment in an intensive care unit. Severe sepsis accounts for 20% 
of all admissions to intensive care units and is the leading cause of morbidity and 
mortality for critically ill patients.1-3
In a study by Zhen et al.4, the mortality among septic shock patients admitted 
via the emergency department was 25.8% compared to 59.3% for patients 
admitted via the hospital ward. Use of mechanical ventilation during the first 24 
hours of shock was 44% in emergency department patients and 70% in hospital 
ward patients and was independently associated with increased mortality. 
Infections in the hospital ward group were likely more difficult to treat due to 
the presence of multi-drug resistant organisms, other infectious patients, and 
patients’ co-morbidity, and this may have played a role in the increased mortality.
Similar to multi-trauma, acute myocardial ischemic infarction, or stroke, the 
speed and appropriateness of therapy administered in the initial hours after 
severe sepsis develops are paramount to influence outcome.1-3;5;6 However, 
despite the presence of evidence-based clinical practice guidelines to optimize 
care for patients with sepsis, the mortality related to severe sepsis and septic 
shock remains high.
In this thesis, the results of seven studies aimed at improving the quality of 
care for patients with sepsis are presented. This final chapter provides a summary 
of results of the studies included in this thesis, and discusses the main findings as 
well as methodological issues. Finally, this chapter ends with the main conclusions 
and recommendations for future research and practice.
Prevention of sepsis
Optimal hand hygiene compliance by all health care workers is one of the 
most important strategies for the prevention of hospital-acquired infections and 
sepsis. Reducing hospital-acquired infections would be expected to decrease the 
incidence of sepsis, severe sepsis, and septic shock, thereby reducing hospital 
costs.4;7
In Chapter 2, the effects of the implementation of a multifaceted hand hygiene 
improvement program for nurses and physicians in a department of internal 
medicine is described. We performed an observational, prospective before-and-
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after strategy study. The hand hygiene knowledge and hand hygiene compliance 
of nurses and physicians was measured before (baseline), directly after (post-
strategy), and 6 months after the implementation of hand hygiene team strategies 
(follow-up).
Education, feedback, reminders, social influence activities including the use of 
role models, and improvement of hand hygiene facilities were included in the hand 
hygiene improvement program. We obtained data about participants’ knowledge 
regarding the indications for hand hygiene. Based on five relevant moments for 
hand hygiene according to the Dutch national infection prevention guideline, an 
observation list was developed to measure the hand hygiene compliance.
Compared to baseline, there was a significant improvement in the overall 
mean hand hygiene knowledge score at post-strategy (from 7.4 to 8.4) and 
follow-up (8.3). The overall hand hygiene compliance was 27% at baseline, 83% 
at post-strategy, and 75% at 6 months follow-up. In conclusion, a multifaceted 
improvement strategy including education, feedback, reminders, social influence 
activities including the use of role models, and improvement of facilities leads to 
sustainably improvement of adherence to recommended practices in nurses as 
well as physicians.
Our study was part of a multicenter controlled trial which included 67 different 
hospital wards in three hospitals. A total of 37 departments were randomized 
to a state of the art group (multifaceted strategy including education, feedback, 
reminders and improvement of facilities) and 30 departments were randomized 
to the team and leaders-directed group (state of the art strategy supplemented 
with interventions based on social influence and leadership, comprising specific 
team and leaders-directed activities). During the study, 10,785 hand hygiene 
opportunities were observed among 2733 different nurses. The compliance 
in the state of the art group increased from 23% at baseline to 42% at post-
strategy and to 46% at follow-up (6 months after strategy delivery). The hand 
hygiene compliance in the team and leaders-directed group improved from 20% 
at baseline to 53% at post-strategy and remained 53% at follow-up. The difference 
between both groups showed an Odds Ratio of 1.64 (95% CI: 1.33-2.02) in favor 
of the team and leaders-directed group (submitted data). These results are in 
accordance, although less pronounced, with the results of our pilot study. The fact 
that not only the nurses, but also the physicians were included in our multifaceted 
improvement program, may account for this difference as this was not the case 
in all wards included in the project. Probably, the physicians functioned as role 
models for the nurses and vice versa.
During the implementation of guidelines (including hand hygiene guidelines), 
individual factors can be experienced as barriers by the members of the target 
group, e.g., employees are not aware of the guideline, they are not aware of the 
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exact content, they do not agree with the guideline, or they have no confidence 
in their own professionalism. Also, when there is a lack of confidence that the 
guideline will lead to better results or if there is a lack of motivation to change, a 
successful implementation will be hampered.8;9 In addition, social factors within 
teams and networks of care givers and within the organization related to the 
department or hospital influence the success of implementation.10-14 To achieve 
successful implementation, a strategic approach is necessary in which the various 
barriers that prevent optimal hand hygiene performance are determined and 
dealt with. In our study, as well as in the study by Huis et al., the multifaceted 
improvement strategy was specifically built upon barriers (as described above) 
that may be present.8-14
Although a multimodal and multidisciplinary improvement strategy, including 
creating a stronger social norm and establishing more explicit social control, 
appears to be a good approach to sustainably improve guideline compliance rates, 
we did not achieve the essential 100% adherence to the hand hygiene guidelines 
at follow-up. Consequently, after participating in our improvement program, hand 
hygiene performance may still be hindered by unknown barriers to guideline 
adherence in our specific target group, as was also described in earlier studies.15;16 
Our study was limited by not specifically searching for potential barriers to change 
hand hygiene compliance at follow-up.
Another limitation of our study was that the effect on clinical outcomes and 
the cost-effectiveness of implementing the hand hygiene guidelines was not 
assessed, as the power of our study was not sufficient to do so. However, earlier 
studies already have shown that low hand hygiene rates lead to unacceptably 
high rates of health care-associated infections, resulting in unnecessary excess 
mortality and morbidity in the population and increased health care costs due to 
increased length of hospital stay and more complex care.17 Furthermore, Huis et 
al. concluded in their multicenter study that optimizing hand hygiene compliance 
through a team and leaders-directed strategy is cost-effective as compared to a 
state of the art strategy (submitted data). Currently, a cluster-randomized trial on 
the cost-effectiveness of a multi-component strategy to improve hand hygiene 
compliance and reduce health care-associated infections is performed.18 This will 
be the first randomized clinical trial to investigate the effects of a hand hygiene 
strategy program on the number of health care-associated infections.
The ultimate target of our study was to sustainably improve hand hygiene 
performance among nurses and physicians. In a recent study by Jamal et al., 
strong leadership, stakeholder engagement, the improvement of facilities, 
education, monitoring of staff, and contemporaneous feedback of performance 
data were included in a hand hygiene implementation program.19 Hand hygiene 
increased from 23% in 2006 to 87% in 2011. Furthermore, a significant decline 
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in hospital-acquired infections was also noted as hand hygiene rates improved. 
Major improvements were noted after installation of alcohol-based hand rub and 
when the performance feedback system was formalised.19
To further evaluate and improve the hand hygiene compliance in the 
department of internal medicine and other hospital wards, the continuation 
and development of new, barrier based implementation strategies, including 
a performance feedback system, is necessary. Furthermore, functioning of the 
health care workers is usually evaluated on a yearly basis. Compliance to clinical 
guidelines, including hand hygiene, should become part of that evaluation.
Diagnosis and treatment of sepsis
Diagnostic tests
Rapid diagnosis and management of sepsis is critical for a successful outcome. 
However, in view of the difficulties with the clinical diagnosis, the search for 
laboratory values or markers to aid the diagnosis and to predict the severity and 
prognosis of sepsis remains an important topic. 
To study patients with an unequivocal diagnosis of infection, we used the 
presence of bacteremia as the primary outcome and evaluated the predictive value 
of four single biomarkers, the combination of the best performing biomarker with 
one to three other biomarkers (panels), the combination of the best performing 
biomarker with clinical signs of the patient, and serial determinations of the best 
performing biomarker in predicting bacteremia in emergency department patients 
with sepsis (Chapter 3). Adult patients visiting the emergency department for a 
suspected infection with two or more clinical signs of sepsis (temperature >38.3°C 
or <36°C, heart rate >90/min, respiratory rate >20/min, chills, altered mental 
status, systolic blood pressure <90 mmHg, MAP <65 mmHg, and hyperglycemia in 
the absence of diabetes mellitus) were included. 
Procalcitonin (PCT), interleukin-6 (IL-6), lipopolysaccharide-binding protein 
(LBP), and C-reactive protein (CRP) were measured, and two blood cultures 
were taken. The analyses included: 1) To determine the biomarker with the 
highest predictive value for bacteremia and to examine the predictive value of 
this biomarker in combination with other biomarkers; 2) Analysis of the best 
biomarker data in combination with clinical signs of sepsis; and 3) Analysis of 
serial determinations of the best biomarker.
In this study, we included 342 patients of which 55 patients (16%) had proven 
bacteremia. Of all patients included, PCT had the best predictive value to predict 
bacteremia with an area under the curve of 0.80, sensitivity 89%, and specificity 
58%, and performed significantly better than the other markers did. The PCT 
cut-off value associated with the highest area under the curve is 0.253 µg/L. 
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Although the other markers measured were also found to be significantly 
higher in the group of patients with positive blood culture results, this does not 
imply that these markers are of additional value in an individual patient. We 
demonstrated that the predictive value of a combination of PCT plus a panel 
of other biomarkers, clinical signs, or analysis of serial PCT levels did not lead 
to a significant improvement compared to the predictive value of PCT alone, 
illustrating that the other markers are not of additional use to predict bacteremia.
Although the PCT cut-off value of 0.253 µg/L was also found and used in earlier 
studies that investigated PCT to predict bacteremia in patients with community-
acquired pneumonia, febrile urinary tract infections, and patients with blood 
cultures positive for coagulase-negative staphylococci, our study was performed 
in patients with sepsis evoked by infections of different body sites. Possibly, in a 
more homogeneous group of patients, e.g., patients with lower respiratory tract 
infections, inflammatory markers related to the specific pathways of the innate 
immune response to viral and bacterial infections may result in a better predictive 
value of viral and bacterial discrimination. This assumption was investigated in 
Chapter 4. The aim of this single-centre observational study was to investigate 
whether the addition of five different biomarkers to a single CRP measurement 
improves the discrimination between bacterial lower respiratory tract infections 
and viral lower respiratory tract infections. The additional biomarkers included 
LBP, PCT, IL-6, IL-18, and soluble triggering receptor expressed on myeloid cells-1 
(sTREM-1).
Out of 342 patients presenting at the emergency department with sepsis, 
56 patients with proven bacterial (n=39) or viral (n=17) lower respiratory tract 
infections were identified. The areas under the curves for the five possible 
combinations of CRP with one other biomarker were compared with the area 
under the curve for CRP alone. Next, the same analysis was performed after the 
exclusion of patients with a CRP concentration with more than 95% specificity for 
bacterial lower respiratory tract infection.
While concentrations of PCT, IL-6, sTREM-1, and LBP were significantly different 
between patients with a bacterial or viral lower respiratory tract infection, the 
area under the curve for CRP alone did not further improve following combination 
analyses. A CRP concentration >150 mg/L was highly specific for a bacterial infection 
(95% CI: 0.81-1.0). After exclusion of the patients with a CRP concentration >150 
mg/L, the area under the curve for CRP was 0.64 (95% CI: 0.45-0.83), but also in 
this subgroup, in which CRP does not discriminate adequately, panel analyses did 
not have an additional value to CRP alone.
From the results of these two studies we concluded that the ability of PCT to 
predict bacteremia in patients with sepsis did not further improve when combined 
with IL-6, LBP, CRP, clinical signs, or serial measurements. 
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Second, the combination of CRP with LBP, PCT, IL-6, IL-18, or sTREM-1 does not 
further improve differentiation between patients with a bacterial or viral lower 
respiratory tract infection compared with CRP alone.
Possible limitation of these studies is that also immune-suppressed patients 
and patients with underlying autoimmune disease or other comorbidity were 
included. Furthermore, the use of anti-inflammatory agents, corticosteroids, or 
other sepsis-modifying agents before enrolment or during the study period was 
not documented. Theoretically, the biomarker levels could be different in the above 
mentioned patient groups and could have influenced the results of our studies. 
Furthermore, many of the included patients received antimicrobial treatment 
prescribed by their general practitioner prior to their ED visit. In a study of Müller 
et al., antibiotic pre-treatment and PCT serum levels were independent predictor 
for negative and positive blood cultures.20 Based on this result, antimicrobial pre-
treatment may have had an important impact on the biomarker values and on 
the blood culture results. However, as we wished to evaluate the value of the 
biomarkers in a daily clinical setting, we chose to study all consecutive patients.
Although our results might be seen as disappointing, it does not exclude the 
possibility that other markers perform better. Nevertheless, it does temper the 
high expectations of the predictive value of various markers in the differentiation 
of infections and their potential role in the confirmation of a diagnosis. Based 
on the results of earlier studies21;22 and our own extensive analyses, it appears 
likely that an optimal biomarker or panel of biomarkers to predict bacteremia will 
probably not be found in the near future.
Currently, other indications for biomarkers are being explored. For example, 
PCT is investigated in clinical algorithms to aid termination of antibiotic treatment 
decisions in specific patient groups such as patients with respiratory tract infections 
or febrile urinary tract infections.23-26 Apart from the search for markers to aid the 
diagnosis in patients suspected to suffer from an infection, the results of these 
trials, which are expected in the near future, may result in other applications of 
the markers used.
Surviving sepsis campaign
To improve the recognition, diagnosis, management, and treatment of 
patients with severe sepsis or septic shock, the surviving sepsis campaign 
(SSC) was launched in 2004. The SSC provides helpful tools and techniques to 
measure and improve the quality of care for patients with severe sepsis or septic 
shock, especially for patients in the intensive care unit. The most important SSC 
recommendations are summarized in a ‘6 hour’ and ‘24 hour’ bundle: also called 
the resuscitation bundle and the management bundle.
Chapter 5 describes the compliance with the SSC bundles, and change in the 
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completion of the ten individual bundle elements after implementation of the SSC 
in four hospitals in the Netherlands. Furthermore, these results were compared 
with the international SSC results.
The database used for this study was part of the international SSC database. 
The compliance data on 863 patients, representing 6% of the international data, 
were used for the analysis. In the Netherlands, compliance to the complete 
resuscitation bundle improved significantly from 7% at baseline to 27% after 2 years. 
Internationally, compliance to the resuscitation bundle increased significantly 
from 11% to 31%, a comparable result. In contrast with the international results 
(18% at baseline, 36% after 2 years), the compliance with the management 
bundle did not improve in the Netherlands (24% at baseline, 25% after 2 years). 
As the management bundle elements are mainly to be performed in the intensive 
care unit, this indicates that more attention to compliance to protocols for the 
treatment of critically ill patients in the intensive care unit is warranted.
At baseline, the Dutch hospital mortality was significantly higher compared 
with the international hospital mortality data (52% versus 37%), possibly related 
to important baseline differences in the patient population admitted to the 
intensive care unit in the Netherlands compared to other countries. For example, 
internationally, more patients were admitted to the intensive care unit from the 
emergency department while in the Netherlands most patients were admitted 
from hospital wards. Furthermore, internationally, significantly more patients 
were included because of sepsis based on a urinary tract infection (with a better 
prognosis) compared with the patients in the Netherlands.
The hospital mortality of Dutch SSC patients decreased significantly from 52% 
at baseline to 35% after 2 years. This decrease in mortality in the Netherlands was 
significantly more pronounced compared with the international data.
In conclusion, the compliance registration provided insight into the current 
quality of care for patients with severe sepsis and septic shock in hospitals in 
the Netherlands. Although the adherence to the overall resuscitation bundle 
significantly improved after its implementation, further improvement of 
compliance to the individual bundle elements and the management bundle is 
necessary.
Since 2007, the Dutch national patient safety program, called ‘Safety 
Management System’ (VMS: www.vmszorg.nl), has been developed. This program 
is to be implemented in all general- and university hospitals in the Netherlands 
by the end of 2012. VMS aims to reduce the unintentional and avoidable harm to 
patients in Dutch hospitals with 50% by December 2012. One of the VMS topics is 
the treatment of severe sepsis. The goal of the VMS is to increase compliance with 
the resuscitation bundle and management bundle elements to an average of 80% 
and to reduce both the absolute in-hospital mortality and the mortality within 30 
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days after the diagnosis of severe sepsis by 15% compared with mortality data 
from 2007. Although our study was mainly performed before the official start 
of the VMS patient safety program, implementation of this national program 
probably further facilitated the outcomes of our study: it is likely that the bundle 
compliance was influenced by the performance of several local and national 
implementation programs related to the VMS safety program.
While the goal of the national patient safety program is to implement the VMS 
topics in all hospital departments in all Dutch hospitals, only four general hospitals 
in the Netherlands were included in our study. Therefore, the generalizability of 
our results may be limited.
In our study, the effect on clinical outcomes and the cost-effectiveness of 
implementing the sepsis guidelines was not assessed. However, earlier studies have 
reported that early management of septic shock in the emergency department 
using current guideline recommendations is not only associated with a better 
clinical outcome1;27, but also results in a meaningful reduction of the median per-
patient cost (from $21,985 to $16,103) after successfully implementing the sepsis 
bundles.28 Another study assessing cost-effectiveness demonstrated an increase 
in mean hospital costs of $8800 per patient (driven by an increased intensive care 
unit length of stay), and an incremental cost of $11,274 per life-year saved and a 
cost of $16,309 per quality-adjusted life year gained.29
Our study showed that, also in the Netherlands, it is possible to improve the 
compliance to the sepsis bundle elements. However, the bundle compliance is still 
far from optimal. To better understand the success of the individual hospitals, to 
analyze which improvement strategy was most effective, and to further implement 
the sepsis bundles in the hospitals, it is important to know the exact nature of 
the improvement activities. One of the weaknesses of our study is, however, that 
probably multiple – but unknown – improvement strategies were performed by 
the various hospitals, making it difficult to attribute success to specific strategies 
and to learn from each other.
Professionals’ knowledge
The short-term and long-term effectiveness of a brief and single teaching 
intervention on residents’ knowledge about the identification and management 
of sepsis is described in Chapter 6. By use of a written questionnaire, we measured 
sepsis knowledge immediately before, 3 hours after, and 4-6 months following 
the teaching intervention. The questionnaire was based on the two topics of the 
SSC-based teaching intervention and included ten multiple-choice questions: 
five questions covering assessment of the symptoms of sepsis and five questions 
about diagnosis and treatment of sepsis.
A total of 253 questionnaires were collected. At baseline, the ‘assessment of 
symptoms of sepsis’ score (4.4) was significantly lower than the ‘diagnosis and 
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treatment’ score (8.0). Following the education session, training-grade doctors’ 
knowledge about sepsis definitions and diagnosis and treatment of sepsis 
increased significantly from 6.1±1.6 to 8.2±1.2. Moreover, 4-6 months after the 
teaching intervention this effect sustained, resulting in a mean score of 7.6±1.1. 
After adding gender and years of training experience as covariates to the analysis, 
we found that there was no significant difference between scores or increase in 
score per gender or year of training.
Our single teaching intervention resulted in improved and sustained knowledge 
on the assessment of symptoms and diagnosis and treatment of sepsis. As the 
diagnosis and treatment score was already high at baseline, we concluded that 
the sepsis education of internal medicine residents should mainly be focused on 
the assessment of symptoms of sepsis.
Before we implemented the sepsis bundles in the emergency department 
of our hospital, it appeared that the identification of sepsis itself was a major 
barrier to implement the SSC guidelines.16;30-32 A recent review concerning 
the implementation of early goal-directed therapy for septic patients in the 
emergency department confirmed this notion.33 Operational and system issues 
were described to significantly influence the success of implementing sepsis 
protocols or bundles. In agreement with our findings, three of the seven studies 
that were reviewed reported that under-recognition of sepsis was one of the main 
barriers to treatment. Delaying a diagnosis of sepsis could potentially delay life-
saving care. Findings also indicated that facilities that incorporated collaboration 
among departments, preplanning, and/or education of emergency department 
and intensive care unit nursing staff were most successful in implementing 
the surviving sepsis campaign recommendations.33 These findings support 
the importance of our educational activities that focused on internal medicine 
residents’ and emergency department nurses’ knowledge about sepsis.
To further improve the physicians’ knowledge about sepsis and the use of 
the sepsis guidelines in the emergency department and hospital wards, every 
new group of emergency department residents should be instructed and sepsis 
education should become part of the standard educational program for internal 
medicine residents. Furthermore, assessment of the effects of educational 
moments during the training of internal medicine residents should be performed 
more frequently to determine which kind of training is effective and which is not. 
Limitation of our study is that we did not evaluate the effects of our education 
program during residents’ daily practice. Consequently, we cannot conclude 
if the performance of a teaching intervention itself practically leads to the 
earlier identification and management of patients with sepsis in the emergency 
department and general hospital ward. Therefore, further research should aim at 
testing the effects of our teaching intervention on clinical decision-making. 
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Role of nurses in the emergency department 
Although the surviving sepsis guidelines provide a comprehensive review 
of the medical management of patients with sepsis and septic shock, they 
are silent on the nursing care that is essential for optimal outcome of these 
patients.1;5;6 Expert nursing knowledge and skills are required for both the 
identification of the deteriorating patient as a result of newly developed sepsis 
and the ongoing provision of optimal care to the known severe sepsis patient. 
Aitken et al. formulated sixty-three recommendations relating to the nursing 
care of severe sepsis patients.34 The recommendations are related to infection 
prevention, infection management, initial resuscitation, hemodynamic support, 
and other supportive nursing care. Goal of the study was to provide a series 
of recommendations based on the best available evidence to guide clinicians 
providing nursing care to patients with severe sepsis. Consensus was reached on 
many aspects of nursing care for the severe sepsis patient.
We investigated the effects of implementation of a nurse-driven, care bundle 
based, sepsis protocol in the emergency department, described in Chapter 7. 
The sepsis protocol for nurses and physicians in the emergency department was 
developed by a multidisciplinary team. The sepsis protocol was based on the SSC 
care bundle mechanism. For the selection of the required bundle elements, two 
different levels of evidence were used: evidence based practices described in the 
present sepsis guidelines and expert opinion. The final protocol consisted of two 
parts: a ‘sepsis screening list’ to support the nurses in the emergency department 
to better recognize sepsis in patients with a probable infection and a ‘sepsis 
performance list’, including recommendations for nurses and physicians. We 
measured compliance with six bundled recommendations in 825 patients with 
sepsis before implementation of the sepsis protocol (period 1; n=159), during 
the implementation phase (period 2; n=447), and after training and performance 
feedback (period 3; n=219). Compliance with the complete bundle significantly 
improved from 3.5% at baseline to 12.4% after our entire implementation program 
was put in place. The completion of four of six individual elements improved 
significantly: measurement of lactate (improved from 23% to 80%), ordering a 
chest radiograph (from 67% to 83%), obtaining urine for urinalysis and culture 
(from 49% to 67%), and starting antibiotics within 3 hours (from 38% to 56%). 
The mean number of performed bundle elements improved significantly from 3.0 
elements at baseline to 4.2 elements after intervention.
Our study showed that we can improve the quality of nursing care for sepsis 
by using a relatively simple and inexpensive implementation program. Besides 
the use of care bundles, we also used other implementation strategies such as 
the use of a sepsis screening list, education, and feedback. Regrettably, it was 
impossible to conclude which components were – to what degree – responsible 
for our achieved improvement. 
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In a sub analysis we examined whether patients were erroneously not included 
in the sepsis protocol by the nurses, and it turned out that in period 2, 71% of the 
cases were included in the protocol by the nurses and this percentage further 
improved to the inclusion of 82% patients with sepsis in period 3. Possibly, the 
early recognition of patients with sepsis further improved due to the training 
and performance feedback intervention. Overall, the completion of the six 
elements in the cases that had been identified by the nurses (periods 2 and 3) 
was significantly better (1.2 elements more; 95% CI: 1.0-1.4) than the completion 
of the six elements in the cases that were identified afterwards by the study team. 
Although care bundles can be a powerful stimulus to focusing the multidisciplinary 
team on working together to deliver reliable care, the development of a bundle is 
only one component in an overall improvement strategy.
During our study, we did not specifically analyze the barriers that influence 
the compliance to the sepsis bundles. However, in advance, we did try to 
anticipate possible barriers that would hamper the implementation of the sepsis 
bundles. We formed a multidisciplinary implementation team, involving the 
emergency department manager, and gave the nurses an important role in the 
early recognition and treatment of patients with sepsis, followed by training and 
performance feedback.
In conclusion, our study confirmed that nurses indeed should have a more 
prominent role in the recognition and treatment of patients with sepsis. By giving 
them a greater responsibility in screening for sepsis and the early performance 
of diagnostic tests, patients with sepsis were recognized earlier and therefore 
received the necessary care, e.g., antimicrobial therapy and fluid resuscitation, 
at an earlier stage. To further improve the recognition of patients with sepsis 
and the performance of sepsis guidelines-based recommendations, additional 
improvement activities are required. 
Although the sepsis protocol 6 years after its introduction in our emergency 
department is still used in current practice, the adherence to the sepsis bundles 
has not been evaluated recently. To easily obtain and analyze the necessary 
bundle performance data, translating the paper version of the sepsis registration 
form into an electronic registration system is required.
Our study is limited in being an uncontrolled study in the emergency 
department of only a single centre. Our implementation program was tailor-made 
to the situation of our hospital and the emergency department, so the results 
cannot be extrapolated. Therefore, future research should aim at testing this 
promising implementation strategy in emergency departments, general hospital 
wards, and intensive care units in a multicenter controlled trial.
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Antimicrobial treatment
The sepsis resuscitation bundle recommends that, in patients with (suspected) 
severe sepsis, broad-spectrum antibiotics should be administered within 3 hours 
from time of presentation for emergency department admissions and within 1 
hour from time of presentation for non-emergency department intensive care unit 
admissions. This recommendation is based on numerous studies demonstrating 
that delayed start of antibiotics is clearly associated with increased mortality.2;5;35-38 
A study by Kumar et al. demonstrated that each hour of delay from the onset of 
hypotension to administration of appropriate antibiotic treatment was associated 
with an average increase in in-hospital mortality of 7.5%.5 Concerning the choice 
of the antibiotic to be administered, many hospitals have implemented local 
antimicrobial treatment guidelines. However, there is a wide variation in the 
reported adherence to these guidelines.
Chapter 8 describes the adherence to the local antimicrobial treatment 
guidelines in patients admitted in the emergency department with sepsis. In 
addition, the in vitro susceptibility of the isolated pathogens to the treatment 
recommended in the guidelines was determined. A total of 262 patients were 
included in this study. In these patients, the prescribed antimicrobial therapy 
was divided into ‘guideline-concordant treatment’ and ‘guideline-disconcordant 
treatment’. Guideline-concordant treatment was defined as antimicrobial therapy 
prescribed empirically in accordance with the clinical diagnosis at the emergency 
department and the antimicrobial treatment guideline. Based on the in vitro 
susceptibility results of the isolated pathogens, we evaluated the appropriateness 
of the guideline-recommended treatment as well as the actually prescribed 
therapy.
Guideline-concordant treatment was prescribed in 168 visits (61%). In case 
of guideline-disconcordant treatment, 87% of prescriptions were more broad-
spectrum than guideline-recommended treatment. Interestingly, this broader-
spectrum therapy did not result in a higher rate of in vitro susceptibility of the 
isolated pathogens to the prescribed treatment in the patients with guideline-
disconcordant treatment compared to the patients with guideline-concordant 
treatment.
Although the reasons for non-adherence to antimicrobial treatment guidelines 
were not included in our study, factors identified in other studies will most likely 
be applicable in our setting. For example, fear for an unfavorable outcome with 
narrow spectrum guideline recommended treatment and a lack of agreement 
with guidelines have been identified as main barriers.39;40
The obvious downside of the unnecessary use of broad-spectrum therapy 
is the increase in the selective pressure on bacteria, thereby promoting the 
emergence of resistant pathogens. Over the past few decades, a dramatic increase 
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of bacterial resistance has emerged with the increasing use of broad-spectrum 
antimicrobials, whereas, on the other hand, the development of new antimicrobial 
agents is declining. The use of antimicrobial treatment guidelines based on local 
epidemiology, followed by de-escalation of the empirical antimicrobial therapy 
based on culture and susceptibility results, is one of the most important strategies 
to reduce the use of broad-spectrum antimicrobial therapy and prevent and 
control the emergence of bacterial resistance.
The results from our study showed that non-adherence to the guidelines 
occurred frequently and resulted in more broad-spectrum empirical therapy, 
while this did not result in a higher rate of susceptibility of the isolated pathogens 
to the prescribed empirical therapy. Our study illustrates that the presence of 
antimicrobial guidelines does not guarantee an optimal adherence to these 
guidelines and deviation from the guidelines often does not result in a better 
antimicrobial therapy. Therefore, ongoing communication about culture and 
susceptibility results in relation to the prescribed antimicrobial treatment and 
antimicrobial treatment guidelines is needed.
Earlier studies have shown that in about half of the cases, physicians in the 
hospital are not prescribing antibiotics appropriately.41;42 Many strategies are 
available to influence professionals’ antibiotic use. In the Cochrane review by 
Davey et al., several interventions to improve antibiotic prescribing practices 
for hospitalized patients have been described.41 Most of the studies included 
in this review tested persuasive and restrictive methods to reduce unnecessary 
antibiotic use and most of the interventions were either educational or restrictive. 
Persuasive methods advised physicians how to prescribe or gave them feedback on 
how they prescribed. Restrictive methods put a limit on how they prescribed, e.g., 
physicians had to have approval from an infection specialist in order to prescribe 
an antibiotic. Although the persuasive strategies were effective, the restrictive 
strategies seemed to have a larger effect. Only a few studies used multifaceted 
interventions with both educational and restrictive elements. Interestingly, the 
use of single interventions showed similar effects compared with multifaceted 
interventions. In their review, Davey et al. concluded that interventions to improve 
antibiotic prescribing to hospitalized patients are successful, and can reduce 
antimicrobial resistance and hospital-acquired infections.41 However, there was 
no obvious relationship between the nature of the intervention and success rate. 
To fully assess the clinical benefits of these intervention methods, more studies 
are needed.
As described by Hulscher et al., determinants on various levels (cultural, 
contextual, and behavioral) might influence the prescription of antibiotics and 
cause antibiotic use to vary in different hospitals. Improvement strategies built on 
these determinants can make hospital antibiotic use more appropriate.42
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In view of the increasing costs and the development of multi-resistant bacteria, 
adherence to antibiotic treatment as described in protocols and guidelines 
becomes paramount. To improve the adherence to antimicrobial guidelines in 
hospitals, a guideline adherence improvement program including interventions 
at the cultural level, contextual level, as well as the behavioral level should be 
developed and executed. To reduce inaccurately and unnecessary antibiotic use, 
restrictive strategies should be part of this improvement program.
Main conclusions
•	 To reach an optimal and sustained implementation result, a multidisciplinary 
hand hygiene improvement program including education, feedback, 
reminders, social influence activities including the use of role models, and 
improvement of facilities is crucial;
•	 Although the hand hygiene compliance significantly improved after the 
performance of a multidisciplinary hand hygiene improvement program, 
further improvement of hand hygiene compliance is necessary;
•	 The ability of PCT to predict bacteremia in patients with sepsis does not 
further improve when combined with IL-6, LBP, CRP, clinical signs, or serial 
measurements;
•	 The combination of CRP with LBP, PCT, IL-6, IL-18, or sTREM-1 does not 
improve differentiation between patients with a bacterial or viral lower 
respiratory tract infection compared with CRP alone;
•	 The SSC bundle compliance registration improved insight into the current 
quality of care for patients with severe sepsis and septic shock in hospitals 
in the Netherlands;
•	 Although the adherence to the overall resuscitation bundle significantly 
improved after its implementation, further improvement of compliance to 
the individual bundle elements and the management bundle is necessary;
•	 The compliance with the sepsis resuscitation and management bundle 
is associated with continuous quality improvement in sepsis care and a 
sustained decrease in mortality;
•	 Knowledge on the diagnosis and treatment of sepsis is of great importance 
to enable professionals to timely recognize sepsis;
•	 By giving nurses in the emergency department a greater responsibility in 
the screening for sepsis and early ordering of diagnostic tests, patients with 
sepsis are recognized and treated earlier;
•	 Only the presence of antimicrobial guidelines does not guarantee an 
optimal adherence to these guidelines and deviation from the guideline 
does generally not result in a better antimicrobial therapy.
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Implications for future research and practice
With this thesis, a further step in the prevention of hospital-acquired infections 
(including sepsis), and in the improvement of the recognition and treatment of 
sepsis has been made. As described in this general discussion, several implications 
for future research and practice can be deducted from the results of the present 
thesis.
The main implications for future research and practice include:
•	 To further evaluate and improve hand hygiene compliance among both 
nurses and physicians, the continuation and development of new, barrier 
based, implementation strategies, including a performance feedback 
system, is necessary;
•	 More research is needed to overcome barriers to implementing hand 
hygiene guidelines;
•	 Compliance to clinical guidelines, including those on hand hygiene, should 
be part of the yearly evaluation of the health care workers’ functioning;
•	 The effectiveness of implementation of the surviving sepsis campaign 
guidelines on patient outcomes and the process of care in all hospitals have 
to be investigated;
•	 To better understand the success of the individual hospitals, to analyze 
which improvement strategy was most effective, and to further implement 
the sepsis bundles in the hospitals, it is important to know the exact nature 
of the improvement activities;
•	 More research is needed to overcome barriers to implementing the 
surviving sepsis campaign guidelines;
•	 To improve the physicians’ knowledge about sepsis and the use of the sepsis 
guidelines in an emergency department, every new group of emergency 
department residents should be instructed and sepsis education should be 
added to the standard educational program for internal medicine residents;
•	 To conclude if the performance of a teaching intervention itself practically 
leads to the earlier identification and management of patients with sepsis 
in the emergency department and general hospital ward, further research 
should aim at testing the effects of our teaching intervention on clinical 
decision-making;
•	 Assessment of the effects of educational moments during the training 
of internal medicine residents should be performed more frequently to 
determine which kind of training is effective and which is not;
•	 Because nurses are often the first to see and triage a patient, nurses should 
have a more prominent role in the recognition and treatment of patients 
with sepsis;
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•	 Future research should aim at testing the implementation of a sepsis 
protocol in emergency departments, general hospital wards, and intensive 
care units, including the extensive role of nurses, in a larger multicenter 
randomized controlled trial;
•	 To further improve the recognition of patients with sepsis and the 
performance of sepsis guidelines-based recommendations, additional 
improvement activities are required;
•	 To easily obtain and analyze bundle performance data, conversion of the 
paper version of the sepsis registration form into an electronic registration 
system is required;
•	 To improve the adherence to antimicrobial guidelines, a guideline 
adherence improvement program including interventions at the cultural 
level, contextual level, as well as the behavioral level should be developed 
and executed;
•	 In general practice, the prescribed antibiotics are frequently more broad-
spectrum than necessary or even are used in the absence of a bacterial 
infection. To reduce inaccurately and unnecessary antibiotic use, restrictive 
strategies should be part of a guideline adherence improvement program.
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Samenvatting
Sepsis is een ernstige aandoening die wordt gekenmerkt door een algemene 
ontstekingsreactie van het lichaam (‘systemisch inflammatoir respons syndroom’ 
of SIRS) op een bewezen of vermoedelijke infectie. Een infectie kan worden 
veroorzaakt door micro-organismen (zoals bacteriën, virussen of schimmels) 
die het lichaam binnendringen. Infecties zoals een bacteriële longontsteking, 
urineweginfectie of huidinfectie kunnen leiden tot sepsis. ‘Ernstige sepsis’ treedt 
op wanneer sepsis leidt tot het falen van één of meerdere organen. Voorbeelden 
hiervan zijn verminderde urineproductie (nieren), of verwardheid (hersenen). In 
het geval dat een lage bloeddruk of tekenen van onvoldoende doorbloeding van 
organen (hypoperfusie) bij een patiënt met ernstige sepsis niet verbeteren na 
het toedienen van vocht via het infuus, spreekt men van een ‘septische shock’. 
Bij een patiënt met septische shock is de toediening van een vaatvernauwend 
medicijn (bijvoorbeeld noradrenaline) nodig om de bloeddruk en orgaanperfusie 
te verbeteren.
Zowel ernstige sepsis als septische shock zijn levensbedreigende complicaties 
ten gevolge van een infectie en vormen een groot probleem in de gezondheidszorg. 
Alleen al in Nederland worden jaarlijks ongeveer 15.500 patiënten met ernstige 
sepsis en 6.000 patiënten met septische shock op een intensive care afdeling 
opgenomen en behandeld. De kans op overlijden voor patiënten met sepsis is 
5-20% en deze kans loopt op tot 30-50% voor patiënten met septische shock. 
Sepsis vormt hiermee wereldwijd één van de belangrijkste doodsoorzaken. 
Infecties die kunnen lijden tot sepsis kan men zowel buiten het ziekenhuis 
(‘community-acquired’) als binnen het ziekenhuis (‘hospital-acquired’) opdoen. 
Ziekenhuisinfecties komen in alle ziekenhuizen voor en worden meestal veroorzaakt 
door bacteriën die de patiënt zelf bij zich draagt of die door anderen worden 
overgedragen, bijvoorbeeld door handcontact of via de lucht. Ziekenhuisinfecties 
zijn over het algemeen moeilijker te behandelen vanwege een verminderde 
weerstand van de patiënt door onderliggende ziekten, eerder antibioticagebruik, 
de aanwezigheid van voor antibiotica ongevoelige bacteriën in het ziekenhuis 
en de aanwezigheid van een open toegangsweg (porte d’entrée) voor micro-
organismen door de aanwezigheid van bijvoorbeeld een infuus, urinekatheter of 
wonddrain bij de patiënt. Naast het feit dat ziekenhuisinfecties voornamelijk door 
de toename van het aantal ligdagen in het ziekenhuis veel geld kosten, vormen 
ziekenhuisinfecties één van de belangrijkste oorzaken van sterfte van in het 
ziekenhuis opgenomen patiënten. 
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Hoofdstuk 1 van dit proefschrift betreft een algemene inleiding waarbij de 
huidige problematiek op het gebied van de preventie, diagnostiek en behandeling 
van sepsis beschreven wordt. 
De drie hoofddoelen van dit proefschrift zijn:
•	 De evaluatie van het effect van de implementatie van een multidisciplinair 
handhygiëne verbeterprogramma met als doel het verbeteren van de 
preventie van ziekenhuisinfecties; 
•	 De evaluatie van de potentiële meerwaarde van verschillende biomarkers 
bij het aantonen van een bacteriemie en het onderscheiden van een 
bacteriële of lagere virale luchtweginfectie met als doel het verbeteren 
van de sepsis diagnostiek;
•	 Het beschrijven van de effecten van de implementatie van de ‘surviving 
sepsis campaign’ in verschillende ziekenhuizen in Nederland en de 
evaluatie van de herkenning en behandeling van patiënten met sepsis 
op de spoedeisende hulp, inclusief een evaluatie van de naleving van 
de aanwezige antibioticarichtlijnen met als doel het verbeteren van de 
behandeling van patiënten met sepsis. 
Deze doelen hebben geresulteerd in de uitvoering en beschrijving van 7 studies.
Preventie van sepsis
Ondanks het feit dat patiënten zelf kunnen bijdragen aan het voorkomen 
van infecties door bijvoorbeeld het regelmatig wassen van de handen en het 
hoesten in een papieren zakdoek, vormen gezondheidsmedewerkers een 
belangrijke bron van overdracht van ziekenhuisinfecties van patiënt naar patiënt. 
Goede handhygiëne bij zorgmedewerkers wordt beschouwd als de belangrijkste 
maatregel om het risico op overdracht van micro-organismen van medewerkers 
in de gezondheidszorg naar patiënten te verminderen. De effectiviteit van 
handhygiëne is in een groot aantal studies aangetoond. Hoewel het verbeteren van 
handhygiëne bij gezondheidsmedewerkers al jaren een belangrijk aandachtspunt 
is, worden de richtlijnen voor handhygiëne tot op heden nog steeds niet goed 
nageleefd.
Ter preventie van in het ziekenhuis opgelopen infecties, waaronder sepsis, is 
er een ziekenhuisbreed handhygiëne verbeterprogramma voor verpleegkundigen 
ontwikkeld waarbij gebruik is gemaakt van verbeterstrategieën die voortkomen 
uit de literatuur (educatie, feedback, reminders en het aanbieden van de 
benodigde producten en faciliteiten) in combinatie met op sociale invloed 
gerichte verbeterstrategieën (aanstellen van rolmodellen, actieve betrokkenheid 
van leidinggevenden en het vaststellen van normen en doelen binnen het team). 
In Hoofdstuk 2 worden de korte- en lange termijn effecten van de implementatie 
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van deze handhygiëne verbeterstrategieën bij zowel verpleegkundigen als artsen 
binnen de afdeling algemeen interne geneeskunde beschreven. 
De implementatieperiode vond plaats van januari 2009 tot en met mei 2009. 
Gedurende de studie werd op drie verschillende momenten de kennis over de 
handhygiënerichtlijnen en de naleving van deze richtlijnen gemeten: direct voor 
de uitvoering van de verbeterstrategieën (test 1), direct na de uitvoering van de 
verbeterstrategieën (test 2) en 6 maanden na uitvoering van de verbeterstrategieën 
(test 3). Bij zowel test 2 als test 3 was er, in vergelijking met test 1, een significante 
verbetering in de gemiddelde handhygiënekennisscore. Tijdens test 1 werden de 
handhygiënerichtlijnen in 27% van de gevallen nageleefd (verpleegkundigen 17% 
en artsen 43%). Tijdens test 2 en test 3 was er een significante verbetering in de 
naleving van de handhygiënerichtlijnen: 83% tijdens test 2 en 75% tijdens test 
3. Deze resultaten laten zien dat de uitvoering van multiple verbeterstrategieën, 
inclusief interventies gericht op sociale invloed, hebben geleid tot een verbetering 
van de kennis over handhygiëne en het naleven van de handhygiënerichtlijnen 
door zowel verpleegkundigen als artsen. 
Diagnostiek en behandeling van sepsis 
Gezien de associatie tussen de kans op overlijden en de mate van progressie van 
de aandoening is de vroegtijdige herkenning en behandeling van patiënten met 
ernstige sepsis en septische shock van essentieel belang. Eerdere studies hebben 
aangetoond dat het snel identificeren van patiënten met sepsis – en daarmee het 
tijdig starten van de juiste behandeling – de kans op overleving van deze patiënten 
vergroot. Een belemmerende factor bij deze directe herkenning is echter dat de 
symptomen van sepsis niet specifiek zijn. Verschijnselen als koorts, een hoge 
hartfrequentie (>90 slagen per minuut) of een snelle ademhalingsfrequentie 
(>20 per minuut) kunnen bijvoorbeeld ook voorkomen bij traumapatiënten of 
patiënten met brandwonden.
Diagnostische tests 
Hoewel het afnemen van bloedkweken wordt gezien als de ‘gouden standaard’ 
voor het vaststellen van een bacteriemie, is de tijd tussen het afnemen van 
bloedkweken en het bekend worden van de uiteindelijke kweekresultaten een 
belangrijk nadeel. Om de diagnostiek van sepsis te verbeteren, zou een biomarker 
van grote klinische en financiële waarde kunnen zijn. Hoewel er de afgelopen 
jaren al vele studies zijn gedaan naar de rol van biomarkers in de diagnostiek 
en behandeling van sepsis, is er tot op heden geen optimale diagnostische test 
beschikbaar.
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In Hoofdstuk 3 wordt de waarde van de individuele biomarkers procalcitonine 
(PCT), interleukine-6 (IL-6), lipopolysaccharide-bindend proteïne (LBP) en C-reactive 
proteïne (CRP), een combinatie van deze biomarkers, een combinatie van PCT 
met klinische verschijnselen van sepsis plus aanvullend laboratoriumonderzoek 
en de waarde van herhaalde afname van PCT gedurende 3 opeenvolgende dagen 
voor het voorspellen van een bacteriemie beschreven. 
Bij 394 volwassen patiënten die de spoedeisende hulp bezochten in 
verband met een (vermoede) infectie en twee of meer klinische verschijnselen 
van sepsis (temperatuur >38.3°C of <36°C, hartfrequentie >90/minuut, 
ademhalingsfrequentie >20/minuut, koude rillingen, acuut veranderd bewustzijn, 
systolische bloeddruk <90 mmHg, MAP <65 mmHg of hyperglycaemie in de 
afwezigheid van diabetes mellitus) werd naast het afnemen van twee bloedkweken 
en de standaard bloedbepalingen (waaronder lactaat, bloedgas, glucose, CRP en 
leukocytenaantal), extra bloed afgenomen voor de bepaling van PCT, IL-6 en LBP. 
De data van 342 patiënten konden worden gebruikt voor nadere analyse. Binnen 
deze patiëntengroep hadden 55 patiënten (16%) een bewezen bacteriemie. De 
meest voorkomende verwekkers waren E. coli (29%) en Streptococcus pneumoniae 
(23%). Hoewel de concentraties van zowel PCT, IL-6, LBP als CRP significant hoger 
waren in de groep patiënten met een bewezen bacteriemie, had PCT de best 
voorspellende waarde voor een bacteriemie (oppervlakte onder de curve (AUC) 
0.80, sensitiviteit 89%, specificiteit 58%). De PCT afkapwaarde met de hoogste 
AUC was 0,253 µg/L. 
Na de toevoeging van één of meer andere biomarkers, klinische verschijnselen 
van sepsis plus aanvullend laboratoriumonderzoek of bij afname van PCT 
gedurende 3 opeenvolgende dagen verbeterde de voorspellende waarde van 
PCT niet. Op basis van deze studie kan geconcludeerd worden dat PCT de beste 
marker is voor het voorspellen van een bacteriemie en dat de toevoeging van één 
of meer andere markers, een combinatie van PCT met klinische verschijnselen 
van sepsis plus aanvullend laboratoriumonderzoek en herhaalde afname van PCT 
geen aanvullende waarde heeft.
Sommige ontstekingseiwitten zijn vooral van belang bij een bacteriële infectie 
en andere bij een virale infectie. Door deze biomarkers als panel te bepalen kan 
er wellicht een beter onderscheid gemaakt worden tussen bacteriële en virale 
infecties. Hoofdstuk 4 beschrijft de studie waarin we onderzocht hebben of er 
op basis van de toevoeging van LBP, PCT, IL-6, IL-18 of soluble TREM-1 (sTREM-1) 
aan de bepaling van CRP een beter onderscheid gemaakt kan worden tussen de 
aanwezigheid van een bacteriële of virale lagere luchtweginfectie.
De AUC van de vijf verschillende markers plus CRP werd vergeleken met de 
AUC van CRP alleen. Na het uitsluiten van patiënten met een CRP >150 mg/L 
(>95% specificiteit voor een bacteriële lagere luchtweginfectie) werd dezelfde 
vergelijking nogmaals uitgevoerd.
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Van de 342 volwassen patiënten die de spoedeisende hulp bezochten in 
verband met een (vermoede) infectie en twee of meer klinische verschijnselen van 
sepsis hadden 39 patiënten een bewezen bacteriële lagere luchtweginfectie en 17 
patiënten een bewezen virale lagere luchtweginfectie. In vergelijking met de groep 
patiënten met een virale lagere luchtweginfectie waren de concentraties van CRP, 
PCT, IL-6, sTREM-1 en LBP significant hoger bij de patiënten met een bacteriële 
lagere luchtweginfectie. Van de zes individuele markers had CRP de hoogste AUC 
(0.82; 95% betrouwbaarheidsinterval: 0.70-0.93) waarbij een combinatie van CRP 
met één van de andere markers niet heeft geleid tot een significante verbetering 
van de AUC. Ook het uitsluiten van patiënten met een CRP >150 mg/L liet geen 
verbetering van de AUC van de verschillende markers in combinatie met CRP zien. 
Dit onderzoek heeft aangetoond dat de combinatie van CRP met andere markers 
geen meerwaarde heeft in het maken van een onderscheid tussen bacteriële en 
virale lagere luchtweginfecties ten opzichte van de bepaling van CRP alleen.
Surviving sepsis campaign 
De surviving sepsis campaign (SSC) is een internationaal initiatief om de 
bekendheid van sepsis te bevorderen en het navolgen van de richtlijnen betreffende 
de behandeling van sepsis te verbeteren. In 2002 werd door een initiatief van de 
Europese en Amerikaanse intensive care verenigingen en het Internationaal Sepsis 
Forum, de SSC opgericht. De SSC levert handvatten om de kwaliteit van zorg voor 
deze groep patiënten te meten en waar nodig te verbeteren. De missie van de 
SSC is om binnen 5 jaar de sterfte aan (ernstige) sepsis met 25% te verminderen.
De SSC heeft er voor gekozen om de belangrijkste diagnostische en 
therapeutische aanbevelingen te groeperen in 2 bundels: de ‘resuscitatiebundel’, 
bestaande uit diagnostische en therapeutische handelingen die binnen 6 uur 
uitgevoerd dienen te zijn, en de ‘managementbundel’ met therapeutische 
handelingen die binnen 24 uur voltooid dienen te zijn. Naast de oprichting van de 
SSC is in Nederland in 2007 het nationale veiligheidsmanagement systeem (VMS) 
ontwikkeld. Doel van het VMS is om binnen 5 jaar de onbedoelde en vermijdbare 
schade aan patiënten in Nederlandse ziekenhuizen met 50% te reduceren. Alle 
thema’s die beschreven worden in het veiligheidsprogramma dienen aan het 
einde van 2012 in alle Nederlandse ziekenhuizen geïmplementeerd te zijn. Eén 
van de thema’s van VMS is ‘voorkomen van lijnsepsis en behandeling van ernstige 
sepsis’, waarbij voor wat betreft de behandeling van ernstige sepsis gebruik 
gemaakt wordt van de SSC bundels. 
In 2010 werden de eerste wereldwijde resultaten van de implementatie van de 
SSC bundels beschreven. In Hoofdstuk 5 worden de Nederlandse resultaten van 
de implementatie van de SSC richtlijnen besproken en worden deze resultaten 
met de eerder beschreven internationale resultaten vergeleken. 
Data van 863 patiënten uit vier verschillende Nederlandse ziekenhuizen 
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werden gebruikt voor nadere analyse. Deze data waren tevens onderdeel van 
de data die gebruikt waren voor de internationale analyses. Twee jaar na de 
implementatie van de SSC richtlijnen was er zowel internationaal als in Nederland 
een significante verbetering van de uitvoering van de resuscitatiebundel. Hoewel 
er internationaal ook een significante verbetering was van de uitvoering van de 
managementbundel, bleef de uitvoering van deze bundel in Nederland gelijk. De 
mortaliteit van patiënten in Nederland daalde in deze periode van 52% naar 35%, 
vergeleken met een daling van de mortaliteit van 37% naar 31% wereldwijd.
De implementatie van de SSC richtlijnen en de registratie betreffende het wel 
of niet naleven van deze richtlijnen heeft geleid tot een verbetering van het inzicht 
in de huidige kwaliteit van zorg voor patiënten met ernstige sepsis en septische 
shock in Nederlandse ziekenhuizen. Vergelijkbaar met andere landen worden, 
ondanks de uitvoering van diverse implementatiestrategieën, de SSC richtlijnen 
nog onvoldoende nageleefd.
Kennis van professionals 
Het herkennen van de systemisch inflammatoir respons syndroom (SIRS) 
criteria is de eerste stap in het snel identificeren van patiënten met sepsis. Hoewel 
klinische verschijnselen zoals koorts, koude rillingen en een systolische bloeddruk 
<90 mmHg geassocieerd zijn met de aanwezigheid van een bacteriemie hebben 
eerdere studies aangetoond dat slechts ongeveer 30% van de artsen de SIRS 
criteria kan benoemen. Om het tijdstip van de start van de behandeling niet te 
vertragen is de scholing van zowel artsen als verpleegkundigen van wezenlijk 
belang. 
Het korte-termijn en langere-termijn effect van een scholingsinterventie 
gericht op de herkenning en behandeling van patiënten met sepsis op de kennis 
van internisten in opleiding wordt beschreven in Hoofdstuk 6. Door gebruikmaking 
van een door de onderzoeksgroep opgestelde schriftelijke vragenlijst werd de 
kennis over sepsis op drie verschillende momenten gemeten: direct voor een 
eenmalige scholing over de diagnostiek en behandeling van sepsis, 3 uur na de 
scholingsinterventie en 4-6 maanden na de scholingsinterventie. De vragenlijst 
bestond uit 10 meerkeuzevragen waarbij 5 vragen gericht waren op het herkennen 
van symptomen van sepsis en 5 vragen die gericht waren op de diagnostiek en 
behandeling van sepsis. 
Bij de voormeting werd een gemiddelde score van 6,1 behaald, waarbij 
de score voor de herkenning van symptomen van sepsis significant lager 
was dan de diagnostiek en behandeling score (4,4 versus 8,0). Drie uur na de 
scholingsinterventie was er een significante verbetering van de gemiddelde 
score (8,2) en 4-6 maanden later bleef de score significant hoger (7,6) dan bij de 
voormeting. Vergelijking van de scores op basis van geslacht en ervaringsjaren 
leverde geen significante verschillen op.
Het geven van een eenmalige scholing aan internisten in opleiding, gericht 
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op de herkenning en behandeling van patiënten met sepsis, heeft geleid tot een 
verbetering van de kennis over de symptomen, diagnostiek en behandeling van 
deze patiëntengroep. 
De rol van verpleegkundigen op de spoedeisende hulp 
Een aanzienlijk deel van de patiënten met (ernstige) sepsis of septische shock 
wordt via de spoedeisende hulp van het ziekenhuis opgenomen. In dat geval komen 
de verpleegkundigen van de spoedeisende hulp vaak als eerste in contact met de 
patiënt en hebben zij een belangrijke rol in de herkenning van de symptomen van 
sepsis. Echter, in de aanwezige SSC richtlijnen wordt de rol van verpleegkundigen 
bij de herkenning van de symptomen van sepsis en het inzetten van de benodigde 
diagnostiek niet beschreven. Zodoende wordt er mogelijk onvoldoende gebruikt 
gemaakt van de meerwaarde die verpleegkundigen kunnen hebben in het snel 
identificeren en behandelen van patiënten met sepsis. 
Hoofdstuk 7 beschrijft de studie waarbij het effect van de implementatie van 
een – in het bijzonder op verpleegkundigen toegespitst – sepsisprotocol op de 
spoedeisende hulp wordt gemeten. Het sepsisprotocol is ontwikkeld door een 
multidisciplinair team waarbij de SSC bundels de basis hebben gevormd. Het 
uiteindelijk sepsisprotocol bestaat uit een sepsis screeninglijst en een sepsis 
handelingenlijst. De screeninglijst ondersteunt de verpleegkundigen bij een 
snellere herkenning van patiënten met sepsis en de handelingenlijst beschrijft 
welke handelingen de verpleegkundigen binnen welke termijn dienen uit te 
voeren. 
Bij 825 patiënten die op de spoedeisende hulp werden opgenomen vanwege 
sepsis werd gemeten of de handelingen die op de handelingenlijst beschreven 
zijn ook daadwerkelijk binnen de gestelde termijn werden uitgevoerd. De meting 
bestond uit de uitvoering van de complete bundel van 6 handelingen en het 
meten van de uitvoering van de 6 individuele bundelelementen. De resultaten van 
de voormeting (periode 1), de resultaten na introductie van het sepsisprotocol 
(periode 2) en de resultaten na het geven van scholing en feedback over eerder 
behaalde resultaten (periode 3) werden met elkaar vergeleken. De uitvoering 
van de complete bundel verbeterde van 3,5% in periode 1 naar 12,4% in periode 
3. Na implementatie van het sepsisprotocol was er een significante verbetering 
van 4 van de 6 bundelelementen: het meten van lactaat (van 23% naar 80%), 
het maken van een röntgenfoto van de thorax (van 67% naar 83%), het afnemen 
van urine voor sediment en kweek (van 49% naar 67%) en de toediening van 
antibiotica binnen 3 uur na binnenkomst op de spoedeisende hulp (van 38% naar 
56%). Deze studie laat zien dat de uitvoering van een bundel van handelingen 
binnen een vooraf vastgestelde termijn verbeterd kan worden door een relatief 
eenvoudige en goedkope implementatiemethode met als meest belangrijke 
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component het vergroten van de verantwoordelijkheid van verpleegkundigen in 
de herkenning en het op eigen initiatief inzetten van de benodigde diagnostiek 
door verpleegkundigen op de spoedeisende hulp.
Antimicrobiële behandeling 
Eén van de aanbevelingen die beschreven wordt in de SSC resuscitatiebundel 
is de toediening van breedspectrumantibiotica binnen 3 uur na binnenkomst 
van een patiënt met sepsis op de spoedeisende hulp en de toediening van 
breedspectrumantibiotica binnen 1 uur na opname op een intensive care afdeling. 
Eerder gepubliceerde studies hebben aangetoond dat voor elk uur vertraging in 
de toediening van de juiste antibiotica bij patiënten met een septische shock, er 
een 7,5% stijging van de sterfte is. 
Om het antibioticagebruik te structureren hebben veel ziekenhuizen op basis 
van de bestaande landelijke antibioticarichtlijnen en lokale resistentiepatronen 
hun eigen ziekenhuisbrede antibioticarichtlijnen ontwikkeld. Ondanks de 
aanwezigheid van deze richtlijnen is er een grote variatie in de naleving hiervan in 
de dagelijkse praktijk. 
Eén van de grootste problemen ten gevolge van het niet goed naleven van 
de antibioticarichtlijnen is het ontstaan van resistentie. Om dit zo veel mogelijk 
te voorkomen is het noodzakelijk dat er een periodieke evaluatie plaatsvindt 
met betrekking tot het naleven van de aanwezige antibioticarichtlijnen in ieder 
ziekenhuis. De evaluatie van de naleving van de antibioticarichtlijnen bij patiënten 
met sepsis op de spoedeisende hulp van het UMC St Radboud wordt beschreven 
in Hoofdstuk 8. Tevens wordt de in vitro gevoeligheid van de bacterie voor de in 
de antibioticarichtlijnen aanbevolen antibiotica beschreven. 
In totaal werden 262 patiënten geïncludeerd waarbij 168 patiënten (61%) de 
in de antibioticarichtlijn voorgeschreven behandeling kregen voorgeschreven. 
Indien er afgeweken werd van de antibioticarichtlijn was de voorgeschreven 
antibiotische behandeling in 87% van de gevallen meer breedspectrum dan de in 
de antibioticarichtlijn aanbevolen antibiotica. 
Bij 96 patiënten kon de in vitro gevoeligheid van de bacterie voor antibiotica 
worden bepaald. De gevoeligheid van de gevonden micro-organismen voor de 
voorgeschreven antibiotica in de groep patiënten waarbij werd afgeweken van 
de antibioticarichtlijn (n=28) was vergelijkbaar met de gevoeligheid voor de 
voorgeschreven antibiotica in de groep patiënten die behandeld werden volgens 
de in de richtlijn aanbevolen antibiotica (n=68). De conclusie van deze studie is 
dat alleen de aanwezigheid van antibioticarichtlijnen onvoldoende is voor een 
optimaal antibioticagebruik in ziekenhuizen. Het afwijken van de richtlijn is 
geassocieerd met een verbreding van de antibiotische behandeling, zonder dat 
dit op basis van de kweekuitslagen van nut is voor de patiënt. 
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Tot slot is in Hoofdstuk 9 een Engelse samenvatting van dit proefschrift gegeven 
waarbij de belangrijkste bevindingen bediscussieerd worden. Aansluitend worden 
de belangrijkste conclusies van dit proefschrift en aanbevelingen voor de praktijk 
en nader onderzoek beschreven. 
De belangrijkste conclusies van dit proefschrift zijn:
•	 Voor een optimale implementatie van de handhygiënerichtlijnen en het 
behoud van behaalde resultaten is een multidisciplinair handhygiëne 
verbeterprogramma inclusief educatie, feedback, reminders, activiteiten 
op het gebied van sociale beïnvloeding waaronder de aanstelling van 
rolmodellen en het verbeteren van faciliteiten cruciaal;
•	 Hoewel verpleegkundigen en artsen de handhygiënerichtlijnen beter 
opvolgen na de uitvoering van handhygiëne verbeterstrategieën, blijft 
verdere verbetering van handhygiëne bij zowel verpleegkundigen als 
artsen noodzakelijk;
•	 In vergelijking met een eenmalige bepaling van PCT levert de toevoeging 
van IL-6, LBP, CRP of klinische verschijnselen aan PCT of de bepaling van 
PCT gedurende 3 opeenvolgende dagen geen verdere verbetering op in 
de voorspelling van een bacteriemie bij patiënten met sepsis; 
•	 De combinatie van CRP met LBP, PCT, IL-6, IL-18 of sTREM-1 heeft geen 
meerwaarde in de differentiatie tussen patiënten met een bacteriële lagere 
luchtweginfectie en patiënten met een virale lagere luchtweginfectie in 
vergelijking met de bepaling van CRP alleen;
•	 Door de registratie van de uitvoering van de sepsisbundels in de dagelijkse 
praktijk is er een beter inzicht verkregen in de huidige kwaliteit van zorg 
voor patiënten met ernstige sepsis en septische shock in de Nederlandse 
ziekenhuizen;
•	 Hoewel het opvolgen van de surviving sepsis campaign resuscitatiebundel 
significant verbeterd is na implementatie, blijft verdere verbetering 
van het opvolgen van de individuele adviezen in de resuscitatiebundel 
en het opvolgen van de adviezen beschreven in de managementbundel 
noodzakelijk;
•	 Het opvolgen van de sepsis resuscitatiebundel en managementbundel is 
geassocieerd met continue kwaliteitsverbetering in de zorg voor patiënten 
met sepsis en een daling van de mortaliteit ten gevolge van sepsis;
•	 Voor een vroege herkenning van patiënten met sepsis is de kennis van 
zorgprofessionals betreffende de diagnostiek en behandeling van sepsis 
van groot belang en deze kennis kan aantoonbaar en langdurig verbeterd 
worden door een korte scholingsinterventie;
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•	 Door verpleegkundigen een grotere rol en verantwoordelijkheid te 
geven in de screening van patiënten met sepsis en het uitvoeren van de 
benodigde diagnostiek op de spoedeisende hulp worden patiënten met 
sepsis sneller herkend en behandeld;
•	 De aanwezigheid van landelijke en lokale antibioticarichtlijnen geeft nog 
geen garantie dat artsen zich ook aan deze richtlijnen houden;
•	 Het afwijken van de antibioticarichtlijnen leidt in het algemeen niet tot 
een betere antibiotische behandeling.
De belangrijkste aanbevelingen voor de praktijk en voor nader onderzoek zijn:
•	 Voor een verdere evaluatie en verbetering van handhygiëne is de 
ontwikkeling van nieuwe, op barrières gerichte implementatiestrategieën 
voor zowel verpleegkundigen als artsen noodzakelijk;
•	 Er dient meer onderzoek gedaan te worden naar voorkomende barrières 
bij de implementatie van handhygiënerichtlijnen;
•	 Het opvolgen van richtlijnen, inclusief die voor handhygiëne, dient 
geëvalueerd te worden tijdens het jaarlijkse functioneringsgesprek van 
iedere gezondheidszorgmedewerker;
•	 Het effect van de implementatie van de sepsisbundels op ligduur, 
mortaliteit en zorgprocessen dient in alle ziekenhuizen gemeten te 
worden;
•	 Om het succes van de implementatie van de sepsisbundels beter te 
kunnen begrijpen en om te weten welke implementatiestrategieën in het 
verleden het meest succesvol waren, is het noodzakelijk om inzicht te 
verkrijgen in de uitgevoerde implementatiestrategieën per ziekenhuis en 
dit te koppelen aan de behaalde effecten;
•	 Er dient meer onderzoek gedaan te worden naar voorkomende barrières 
bij de implementatie van de sepsisbundels;
•	 Om de kennis van artsen over sepsis en het gebruik van de sepsisrichtlijnen 
op de spoedeisende hulp te verbeteren, dient iedere nieuwe groep 
artsen in opleiding op de spoedeisende hulp geïnstrueerd te worden 
en dient sepsiseducatie standaard onderdeel te worden van het 
scholingsprogramma voor artsen in opleiding;
•	 Om vast te kunnen stellen of sepsisscholing zelf leidt tot een snellere 
herkenning en behandeling van sepsis op de spoedeisende hulp, is nader 
onderzoek naar het effect van scholing op klinische besluitvorming 
noodzakelijk;
•	 Om na te kunnen gaan of scholingsinterventies voor internisten in 
opleiding daadwerkelijk effectief zijn, dienen de effecten van verschillende 
scholingsinterventies regelmatig geëvalueerd te worden;
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•	 Omdat een verpleegkundige in de meeste gevallen de eerste 
zorgmedewerker is die een patiënt op de spoedeisende hulp ziet, is het 
noodzakelijk dat verpleegkundigen een meer prominente rol krijgen in de 
herkenning en behandeling van patiënten met sepsis;
•	 Het effect van de implementatie van een sepsisprotocol op zowel 
spoedeisende hulp, verpleegafdelingen als intensive care afdelingen, 
inclusief intensivering van de rol van verpleegkundigen, dient in een 
toekomstige multicenter gerandomiseerde gecontroleerde studie 
geëvalueerd te worden;
•	 Voor een verdere verbetering van de vroegtijdige herkenning van 
patiënten met sepsis en het opvolgen van de op de surviving sepsis 
campaign gebaseerde richtlijnen is de uitvoering van aanvullende 
implementatie strategieën noodzakelijk;
•	 Om data met betrekking tot de uitvoering van de surviving sepsis 
campaign richtlijnen makkelijker te verkrijgen en te kunnen evalueren is 
de beschikbaarheid van een elektronisch registratiesysteem een absolute 
noodzakelijkheid; 
•	 Om het opvolgen van de antibioticarichtlijnen te verbeteren dient een 
verbeterprogramma inclusief interventies op het niveau van zowel 
cultuur, context als gedrag ontwikkeld en uitgevoerd te worden;
•	 Om inadequaat en onnodig gebruik van antibiotica te reduceren 
dienen restrictieve strategieën onderdeel te zijn van een 
richtlijnverbeterprogramma. 
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AUC   = area under the receiver operating characteristics curve
ED   = emergency department
CCMS   = central college of medical specialties
CI   = confidence interval
CRP   = C-reactive protein
ESBL   = extended-spectrum beta-lactamase
HAIs   = hospital-acquired infections
HH   = hand hygiene
ICU   = intensive care unit
IHI   = institute for health care improvement
IL   = interleukin
IQR   = interquartile range
LBP   = lipopolysaccharide (LPS)-binding protein
LOS   = length of stay
LRTI   = lower respiratory tract infection
NPV   = negative predictive value
OR   = odds ratio
PCT   = procalcitonin
PPV   = positive predictive value
ROC   = receiver operating characteristics
RODIN   = regional professional training for internal medicine
RUNMC  = Radboud university Nijmegen medical centre
SD   = standard deviation
SIRS   = systemic inflammatory response syndrome
SSC   = surviving sepsis campaign
(s)TREM-1  = (soluble) triggering receptor expressed on myeloid cells-1
UMC   = university medical centre
VMS   = safety management system
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Wauw, wat ben ik veel mensen dank verschuldigd voor hun hulp en steun bij de 
totstandkoming van dit proefschrift! Ik kan onmogelijk de volgorde bepalen van 
wie hoe belangrijk was, want al deze bijzondere mensen hebben een essentiële 
bijdrage geleverd. Zonder begin geen einde, dus laat ik ook wat mijn dankwoord 
betreft maar gewoon bij het begin beginnen.
(Co) Promotoren
Professor P. Pickkers, beste Peter, in 2005 werd ik als net afgestudeerd 
verpleegkundig specialist gevraagd om lid te worden van de ‘commissie 
patiëntenzorg’ van het toenmalige Nijmeegs Universitair Centrum voor 
Infectieziekten (NUCI). Een van de doelen van deze commissie was het in kaart 
brengen en het – waar nodig – verbeteren van de kwaliteit van zorg voor 
verschillende patiëntencategorieën binnen de afdeling infectieziekten. Het eerste 
(met name door jou voorgestelde) verbeterproject werd ‘de diagnostiek en 
behandeling van patiënten met sepsis’. Waar ik bij de eerste bijeenkomsten nog 
dacht dat er sprake zou zijn van een kortdurend project, bleek de werkelijkheid 
toch enigszins anders te zijn. Na onze eerste pilotstudie op de spoedeisende hulp 
werden jouw – en na wat meer ervaring ook mijn – plannen voor wat betreft 
het verbeteren van de zorg voor patiënten met sepsis alleen maar groter, waarbij 
je mij hebt meegenomen op een onbekende wetenschappelijke reis. Na alle 
inspanningen en het overwinnen van de nodige hobbels (soms bergen) blijkt 
de eindbestemming echt geweldig mooi te zijn. Ongelooflijk bedankt voor jouw 
kostbare tijd, voor de inbreng van (soms wat veel) nieuwe ideeën en overleg. Ook 
grote dank voor de zeer zinvolle feedback en het trekken van de kar. Ondanks – of 
dankzij? – de enorme inhoud van jouw mailbox is het jou een aantal keren gelukt 
om een door mij per ongeluk kwijtgeraakt bestand terug te vinden en mij weer 
toe te sturen. Zoals je zelf dan zei: ‘Als je mij toch niet had…’. Inderdaad, dan was 
dit proefschrift nog lang geen feit geweest! 
Professor B.J. Kullberg, beste Bart-Jan, gedurende de opleiding tot 
verpleegkundig specialist was jij mijn medisch mentor en zag jij de meerwaarde 
van deze nieuwe functie binnen de afdeling infectieziekten. Heel veel dank voor 
het mede ontwikkelen van de functie van verpleegkundig specialist infectieziekten, 
het vertrouwen in mijn kunnen, jouw steun in moeilijke tijden en de tijd die ik 
gekregen heb om mijn promotieonderzoek zo veel mogelijk in werktijd te kunnen 
uitvoeren. Ik realiseer me echt tot op de dag van vandaag dat dit heel uitzonderlijk 
is.
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Professor T. van Achterberg, beste Theo, alweer 8 jaar geleden begeleidde jij 
mij bij mijn afstudeeronderzoek voor de opleiding Master of Arts in Advanced 
Nursing Practice. Wie had ooit gedacht dat deze opleiding het begin zou zijn van 
mijn onderzoekscarrière. De functie van verpleegkundig specialist bevindt zich 
op het overgangsgebied tussen verpleegkundige en medische zorg. Vandaar 
dat ik jouw begeleiding, naast die van medici, gedurende mijn promotietraject 
een vereiste vond. Heel veel dank voor jouw verpleegkundig wetenschappelijke 
bijdrage, feedback, jouw altijd positieve instelling, vertrouwen en de persoonlijke 
interesse.
Professor M.E.J.L. Hulscher, beste Marlies, tijdens onze eerste kennismaking 
(inmiddels 6 jaar geleden) werd mij meteen duidelijk dat jouw bijdrage aan 
het sepsis verbeterproject – en wat later bleek, aan mijn proefschrift – van 
onschatbare waarde zou zijn. Jij hebt aan het begin van het project regelmatig 
aangegeven dat ik van onze verbeterinterventies een promotieonderzoek zou 
kunnen maken. Hoewel ik er in eerste instantie weinig vertrouwen in had en ik 
herhaaldelijk aangaf dat we wel zouden zien hoe het zou lopen, is het jou gelukt 
om mij te overtuigen van mijn eigen kunnen. Voordat we overgingen tot het 
bespreken van de inhoud van de door mij aangeleverde stukken was er ruimte 
voor een persoonlijk gesprek waarbij bleek dat ik niet de enige ben die soms 
emotioneel kan worden zonder dat op dat moment te willen. Toch lukte het om 
onze emoties aan de kant te zetten en over te gaan tot het bespreken van de 
documenten. Op het moment dat ik dacht dat een artikel bijna af was wist jij 
ieder artikel weer een stuk te verbeteren. Ik geef toe dat ik niet altijd even blij was 
met de hoeveelheid aanpassingen, maar na het verwerken van de opmerkingen 
zag ik een enorme verbetering. Bij deze wil ik je ontzettend bedanken voor onze 
tweewekelijkse afspraken waarin ik dankbaar gebruik heb kunnen maken van 
jouw implementatie-expertise. Daarnaast heel veel dank voor jouw vertrouwen 
en het op geweldige manier aanbrengen van structuur in ieder artikel. Wat mij 
betreft betekent de afronding van mijn proefschrift zeker niet het einde van onze 
prettige samenwerking!
Ondanks het feit dat jij gedurende mijn promotietraject de rol van copromotor 
hebt vervuld, ben je inmiddels benoemd tot hoogleraar met als leeropdracht 
‘kwaliteit van zorg voor infectie- en ontstekingsziekten’. Heel bijzonder om aan 
het einde van mijn promotietraject te kunnen zeggen dat ik begeleid ben door 
vier hoogleraren.
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Paranimfen
Heel veel dank aan mijn paranimfen Chantal Bleeker - Rovers en Linda Linders 
- Evers. Al voordat dit promotietraject begon, hebben jullie mij met volle overgave 
gesteund en hebben jullie op een eigen manier een geweldige bijdrage geleverd 
aan de totstandkoming van dit proefschrift. Mijn dank hiervoor is eigenlijk niet in 
woorden uit te drukken! 
Beste Chantal, heel erg bedankt voor het vertrouwen in mij en de tijd en 
energie die jij gestoken hebt in de ontwikkeling van de functie van verpleegkundig 
specialist infectieziekten en de totstandkoming van de artikelen in dit proefschrift. 
Hoewel niet officieel als zodanig benoemd ben jij voor mij gedurende het hele 
promotietraject ook mijn copromotor geweest. Ondanks je drukke agenda 
probeerde je altijd tijd vrij te maken voor het doorspitten van statussen en 
laboratoriumuitslagen, het lezen van mijn artikelen en het zetten van de 
spreekwoordelijke puntjes op de i. Naast het bespreken van werkgerelateerde 
zaken kon ik altijd bij jou terecht voor een persoonlijk gesprek (zeker ook in 
moeilijke tijden). Daarom ook op persoonlijk vlak heel veel dank voor jouw 
interesse, steun, begrip en zinvolle adviezen waarbij je soms terecht aangaf dat 
ik een pas op de plaats moest maken. Ik ben enorm blij en trots dat jij op deze 
bijzondere dag mijn paranimf wilt zijn.
En dan mijn beste vriendin Linda, lieve Lin, al sinds geruime tijd ben jij 
mijn hartsvriendin en hebben we ‘lief en leed’ met elkaar gedeeld. Belangrijke 
hoogtepunten die we samen hebben mogen delen waren de geboorte van Mick 
(2005), jouw huwelijk met Marco (2008), de geboorte van Anne (2010) en de 
geboorte van Thijmen en Julian begin dit jaar. Dieptepunten zijn er zeker ook 
geweest maar deze vallen, zeker bij een gebeurtenis als deze, in het niet bij alle 
gelukkige momenten. Ondanks onze drukke agenda’s hebben we de afgelopen 
jaren regelmatig samen genoten van een weekendje weg, een dagje winkelen 
of heerlijk relaxen. Jij was altijd geïnteresseerd in mijn artikelen en je had er alle 
vertrouwen in dat het goed zou komen. Zie hier het resultaat! Het feit dat wij 
vertrouwen hielden in een goed einde, heeft er voor gezorgd dat het moment van 
de uitgave van mijn boekje nu toch is aangebroken en ik mijn proefschrift in het 
openbaar mag gaan verdedigen. Heel speciaal dat ook jij als paranimf naast mij 
wilt staan op deze bijzondere dag.
Medewerkers verpleegafdeling EOV
Anita van Rossum, beste Anita, heel veel dank dat ik de tijd en ruimte heb 
gekregen om een promotietraject af te leggen. Hoewel het doen van onderzoek 
soms ten koste ging van andere belangrijke werkzaamheden op de afdeling, heb 
ik mij altijd gesteund gevoeld door jou. We hebben de afgelopen jaren regelmatig 
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persoonlijke gesprekken gevoerd die voor mij zoveel meer hebben betekend dan 
een formeel gesprek met de hoofdverpleegkundige.
Dr. Han Repping-Wuts, hoewel je niet meer officieel werkzaam bent op 
verpleegafdeling EOV ben je nog steeds een belangrijk onderdeel van de afdeling 
reumatische ziekten en endocriene ziekten. Lieve Han, jij bent mijn grote voorbeeld 
voor wat betreft rust, structuur en doorzettingsvermogen. In die zin heb ik veel 
van jou geleerd en ben ik blij dat ik de eerste jaren van mijn promotietraject 
samen met jou een werkkamer heb mogen delen.
Physician assistant Michael Heijnen, verpleegkundig specialisten Rene Bakker 
en Anke Hendriks, seniorverpleegkundigen Maaike Eeren, Judith Hendriks en 
Hanneke Jansen en alle overige medewerkers van afdeling EOV, heel veel dank 
voor jullie interesse en steun gedurende het gehele promotietraject. Ondanks dat 
jullie mij de laatste jaren weinig op de afdeling hebben gezien, heb ik altijd het 
gevoel gehouden dat ik welkom ben. Na het afronden van mijn promotietraject 
hoop ik weer meer met jullie samen te werken.
Medewerkers afdeling spoedeisende hulp
Alle medewerkers van de spoedeisende hulp, ontzettend bedankt voor jullie 
gastvrijheid, het includeren van alle sepsispatiënten en het afnemen van extra 
bloedmonsters. Vanaf het begin zagen jullie de meerwaarde van de implementatie 
van het sepsisprotocol, hetgeen tot zulke goede resultaten heeft geleid. Het feit 
dat het sepsisprotocol nog steeds een begrip is op jullie afdeling is hiervoor 
tekenend.
In het bijzonder wil ik Lilian Peters bedanken. Beste Lilian, bij de introductie 
van het sepsisprotocol op de spoedeisende hulp fungeerde jij als rolmodel voor de 
afdeling. Dank daarvoor, dank voor jouw kritische blik en heel veel dank voor het, 
voornamelijk tijdens jouw nachtdiensten, opzoeken van de benodigde gegevens 
in E-care.
(Overige) medeauteurs
Professor van der Meer, beste Jos, ik wil je uiteraard heel hartelijk danken voor 
onze prettige samenwerking tijdens het handhygiëneproject maar vooral ook voor 
de samenwerking en jouw belangstelling buiten dit project om. Vooral heel veel 
dank voor het feit dat jij mij er in 2008 van hebt weten te overtuigen dat ik mijn 
functie als verpleegkundig specialist infectieziekten niet zou moeten opgeven 
voor een functie elders. Wat ben ik achteraf blij dat ik jouw advies heb opgevolgd. 
Hoewel ik jouw vertrek enorm betreur, ben ik er trots op dat ik tijdens jouw laatste 
jaar als medisch hoofd van de afdeling algemeen interne geneeskunde toch nog 
samen met jou een artikel heb mogen schrijven.
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Drs. Anita Huis, hartelijk dank dat wij vanuit het project ‘Clean Care is Safer Care’ 
hebben mogen aansluiten bij jouw ziekenhuisbrede handhygiëneproject ‘Helping 
Hands’. Door onze krachten te bundelen, hebben we de implementatiestrategieën 
op zowel verpleegkundigen als artsen kunnen loslaten en kunnen we ons 
handhygiëne artikel allebei gebruiken voor ons proefschrift!
Inge de Guchteneire, beste Inge, sinds 2009 vervulden we samen de functie 
van verpleegkundig specialist infectieziekten (jij destijds in opleiding). Zodoende 
was jouw betrokkenheid bij mijn promotieonderzoek en met name bij het project 
‘Clean Care is Safer Care’ groot. Heel veel dank voor onze prettige en gezellige 
samenwerking en jouw bijdrage als rolmodel tijdens het handhygiëne onderzoek. 
Hoewel ik jouw vertrek naar Universitair Longcentrum Dekkerswald volkomen 
begrijp vind ik het nog steeds erg jammer dat we zodoende geen directe collega’s 
meer zijn.
Drs. Jaap ten Oever, Dr. Jacqueline Klein Gunnewiek, Professor Mihai Netea, Dr. 
Frank van de Veerdonk en Dr. Leo Joosten, ik wil jullie bedanken voor jullie rol bij 
de totstandkoming van de biomarkerartikelen. Zonder jullie geweldige expertise 
op het gebied van diagnostisch onderzoek waren deze artikelen er in deze vorm 
zeker niet gekomen.
Dr. Hazra Biemond - Moeniralam, Drs. Simone Gielen - Wijffels, Drs. Geertjan 
Goekoop, Drs. Dave Tjan, physician assistant Christine Wallenborg en Dr. Arthur 
van Zanten. Jullie zijn een van de belangrijkste kartrekkers van de Nederlandse 
surviving sepsis campaign. Hartelijk dank voor de samenwerking en het vrijgeven 
van de Nederlandse surviving sepsis campaign data.
Drs. Daniëlle van den Berg, heel veel dank voor het verwerken van een 
heleboel data in SPSS. Heel bijzonder dat jij als – destijds – student geneeskunde 
een bijdrage hebt willen leveren aan mijn proefschrift. 
Drs. Lieven van der Velden, Dr. Patrick Sturm en Dr. Johan Mouton, bedankt 
voor jullie expertise vanuit de medische microbiologie.
Tot slot, maar zeker niet het minst belangrijk, Professor George Borm, Drs. 
Benno Lansdorp en Dr. Mark van den Boogaard, super bedankt voor alle (in ieder 
geval voor mij) ingewikkelde analyses. Voor mij staat inmiddels vast dat analyseren 
nooit mijn favoriete bezigheid zal worden.
Manuscriptcommissie
Bij deze wil ik de leden van de manuscriptcommissie, Professor P. Verweij, 
Professor K. van Laarhoven en Professor P.J. van den Broek hartelijk danken voor 
het beoordelen van het manuscript.
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Collega’s polikliniek
Beste Marjolein Bosch, Karin Grintjes, Rolina Meijering en Bert Zomer, met 
jullie als kamergenoten heb ik volgens mij toch wel het leukste gedeelte van mijn 
promotietraject mogen delen, namelijk de afrondende fase. Hoewel ik in eerste 
instantie dacht dat ik het na het inleveren van het manuscript minder druk zou 
krijgen, hebben jullie mij de afgelopen maanden nog regelmatig horen zuchten en 
steunen. Ondanks dat was het vooral ook heel leuk om de totstandkoming van het 
uiteindelijke boekje en het regelen van het feest met jullie te kunnen delen. Ook 
jullie heel veel dank voor de prettige samenwerking, jullie luisterend oor en steun.
Beste drs. Anneleen Berende, dr. Hadewych ter Hofstede en dr. Fidel Vos, 
door samen met jullie te mogen werken op de poli voor patiënten met de ziekte 
van Lyme besef ik nog meer dan ooit dat patiëntenzorg het meest belangrijke 
onderdeel van de functie van verpleegkundig specialist is en zal blijven.
Vormgever
Beste Theo Hafmans, bij deze wil ik jou heel hartelijk danken voor de geweldige 
samenwerking voor wat betreft de vormgeving van dit boekje. Heel bijzonder dat jij 
speciaal voor mij een E-coli bacterie hebt opgewerkt voor elektronenmicroscopie 
om er volgens prachtige foto’s van te kunnen maken. Het eindresultaat van zowel 
de cover als het binnenwerk is echt geweldig!
Vrienden en familie
Lieve vriendinnen en vrienden, ik ben mij ervan bewust dat ik de afgelopen 
jaren vooral voor mijzelf en het afronden van dit proefschrift heb gekozen. 
Ondanks dat zijn vrienden net als sterren, je ziet ze niet altijd maar ze zijn er wel 
degelijk! Heel veel dank voor jullie interesse, begrip en luisterend oor tijdens de 
schaarse maar voor mij o zo waardevolle en ontspannende feestjes en avondjes 
uit.
Lieve (schoon-)ouders, zus, zwagers, en schoonzussen. Voor jullie was het 
wellicht soms moeilijk te bevatten waar ik al die tijd zo druk mee ben geweest. 
Hopelijk begrijpen jullie na de verdediging van mijn proefschrift waar ik mij, samen 
met een heleboel anderen, de afgelopen jaren mee bezig heb gehouden. Ik ben 
enorm trots en blij dat jullie deze bijzondere mijlpaal in mijn leven met mij kunnen 
en willen delen en ik heb zo’n vermoeden dat hier nog lang over nagepraat zal 
worden.
Lieve Mick, wat ben ik toch blij en dankbaar dat jij er bent! Door jou besef ik 
dat werk zeker niet het allerbelangrijkste is in het leven en geniet ik iedere dag 
van jouw vrolijkheid en kinderlogica.
Last but not least, dear sweetie, lieve Dennis, al voordat onze relatie serieuze 
vormen begon aan te nemen, ondersteunde jij mij bij het schrijven van de 
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artikelen ten behoeve van dit proefschrift. Na het behalen van een posterprijs 
organiseerden we ons eerste etentje samen. Dat was het begin van een geweldige 
tijd samen waarin je mij de ruimte hebt gegeven om aan dit proefschrift te kunnen 
werken. Jouw doorzettingsvermogen en motiverende instelling, zeker ook op de 
moeilijke momenten, hebben er absoluut toe bijgedragen dat mijn proefschrift 
nu een feit is.
De afgelopen twee jaar hebben we ons allebei op ons eigen project gestort: 
ik op de afronding van mijn proefschrift en jij op het plaatsen van de nieuwe 
badkamer. Dat we nu tegelijkertijd klaar zijn met ons project, kan toch geen toeval 
zijn. Ik hoop nog heel lang samen met jou te kunnen genieten van een warm bad. 
Dank je wel voor wie je bent!
       Liefs, Mir
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Curriculum Vitae
Mirjam Tromp werd geboren op 25 mei 1976 te Doetinchem. Na het behalen 
van haar MAVO-diploma aan het Dorenweerd College te Doorwerth (1996) volgde 
ze de opleiding HBO-Verpleegkunde aan de Hogeschool van Arnhem en Nijmegen 
(diploma 2000). 
Haar verpleegkundige carrière startte zij als gediplomeerd verpleegkundige 
op de afdeling algemeen interne geneeskunde en longziekten (E10) van het 
UMC St Radboud. Haar aandachtsgebied was de zorg voor patiënten met HIV. 
Na de opening van een nieuwe verpleegafdeling binnen het toenmalige cluster 
inwendige specialismen werden de patiënten met infectieziekten niet langer 
primair op afdeling E10 opgenomen. Op dat moment werd nóg duidelijker dat de 
interesse voor patiënten met infectieziekten groot was. Zodoende volgde ze deze 
specifieke patiëntengroep en werkte zij sinds februari 2002 als gediplomeerd 
verpleegkundige op de afdeling algemeen interne geneeskunde en reumatische 
ziekten (EOV), alwaar haar aandachtsgebied ‘HIV-zorg’ werd uitgebreid naar 
‘infectieziekten’. 
Om dit aandachtsgebied meer diepgang te geven startte zij in september 
2002 met de opleiding Master of Arts in Advanced Nursing Practice (diploma 
2004). Na afronding van deze opleiding nam ze deel aan diverse werkgroepen 
en verbeterprojecten. Zij was onder andere lid van de ‘commissie patiëntenzorg’ 
van het Nijmeegs Universitair Centrum voor Infectieziekten (NUCI), tegenwoordig 
Nijmegen Institute for Infection, Inflammation, and Immunity (N4i), waar in 2005 
het project ‘Verbeteren van de diagnostiek en behandeling van patiënten met 
sepsis’ startte. Daarnaast werd zij in 2009 projectleider van het twee jaar durende 
project ‘Clean Care is Safer Care’. Binnen deze twee projecten verrichtte zij in 
totaal 7 wetenschappelijke studies die geresulteerd hebben in dit proefschrift.
Mirjam Tromp woont in Elst (Gld), waar zij haar leven deelt met Dennis Brinke 
en haar zoon Mick (2005).

